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Abstract 
This research has examined a variety of different macromolecules; namely dendrimers, 
hyperbranched polymers, di-block co-polymers and colloidosomes. The architecture of these 
materials has been exploited for a variety of applications. 
 
The first area studied involved exploiting the peripheral groups of dendrimers. This project 
continued on from previous results within the group which showed a size based mechanism 
for dendrimer-protein interactions. The mechanism for complexation of a dendrimer and a 
protein was probed by CD spectroscopy and results revealed that, upon complexation, the 
protein’s structure does not change and binding takes place at the active site entrance of the 
interfacial area.
1
 Continuing on from this work, fluorescent labelled PAMAM dendrons (G1.5 
and G2.5), provided by Professor Neil Mckeown of Cardiff University, were used in a direct 
binding assay with cytochrome-c. G1.5 and G2.5 both showed strong interaction, giving 
association constants of 4.2x10
4
 (±2.5%) and 3.2x10
4
 (±2%) respectively. However, unusual 
stoichiometries were observed. 
 
The next area of study focussed on the interior properties of hyperbranched polymers. This 
work looked at controlling the environment surrounding a receptor and anion binding was the 
tool used to probe these properties. Hyperbranched poly 3, 5 diacetoxybenzoic acid of 
varying molecular weights was used to house an anion receptor and the effect upon binding 
affinities of a variety of anions was measured. The polymer had a negative effect upon 
binding the tetrahedral dihydrogen phosphate anion.  A similar effect was also observed for 
the smaller spherical anions (fluoride and chloride). However, a different observation was 
made for the larger spherical anions (bromide and iodide), where binding appears to be 
stronger in the polymeric receptors than in the free receptor. For the non-spherical anions, 
benzoate and acetate, the binding was similar when the small and medium sized polymers 
were used (1,600 and 4,000 respectively), although, binding dropped significantly for the 
highest molecular weight studied (10,500).  
 
For a water-soluble anion receptor system a different approach was employed.  This consisted 
of a biocompatible di-block co-polymer micelle composed of poly (ethylene glycol) and poly 
(ɛ-caprolactone) (mPEG-b-PCLn). A variety of hyperbranched polymers were encapsulated. 
Encapsulation was verified by particle sizing, UV/Vis spectroscopy and TEM imaging.  
 
The final area studied continued the theme of encapsulation using di-block polymers. The 
work involved collaboration with Professor Steve Armes, where the encapsulation properties 
of colloidosomes were probed using catalysis. The reaction studied was the oxidation of 
cyclooctene using a porphyrin catalyst, which was situated within the oil phase of the 
colloidosome. Results showed an increase in the yield of products when the reaction took 
place within the colloidosome. Furthermore, a change in product distribution was also 
observed.  
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Chapter 1 - Introduction to Dendritic Polymers 
 
1.1 General introduction to dendritic polymers 
Dendritic polymers represent a moderately novel aspect of polymer chemistry which, up until 
around 25 years ago, focussed primarily on linear polymers. Linear polymers still remain a 
focal point in research today; however, present day research now directs a great deal of 
attention towards dendritic macromolecules. The interest in dendritic polymers has increased 
at an accelerated pace since the work by Tomalia
2
, Vogtle
3
 and Newkome,
4
 with particular 
focus on dendrimers and hyperbranched polymers.  
 
 The study of dendritic polymers has developed over the years, ranging from synthesis and 
properties to potential applications. As a result, many dendrimers and hyperbranched 
polymers are available, with some specific dendrimers even being available commercially.
5
  
The main objective of this chapter is to supply the reader with the necessary information 
required to grasp the subjects’ specific concepts, which will be employed in this area of 
research. This review is not an extensive account and for this the reader is directed to a 
number of recommended reviews in the literature.
2, 6-10
  
 
1.1.1 Traditional polymer architectures 
Primarily it was considered that there were three main structural classes for polymeric 
molecules; linear, branched and cross-linked (figure 1). Linear polymers are comprised of 
monomer units that have been linked together in a continuous fashion, thereby generating a 
polymer molecule. A branched polymer is a molecule where linked monomer units form side 
branches; subsequently, these extend outwards from diverse branching points along the main 
polymer chain. Finally, a cross-linked polymer occurs when a bond is formed between 
individual polymer chains; either between parts of the same chain, or linking different chains 
together to create a polymer network.
11
 With these structural classes of polymers, the process 
required to generate the necessary architectures is largely statistical. As a result, products 
8 
 
which display a high level of polydispersity and limited structural control are fabricated. 
 
Figure 1 – Figure to illustrate the three traditional classes of polymer adapted with 
permission from [Esfand, R.; Tomalia, D. A. Drug Discovery Today 2001, 6, 427]. Copyright 
[2001] Elsevier.
12  
 
1.1.2 Dendritic polymers 
Synthetic strategies used to generate structure controlled macromolecules were discovered 
from as early as the 1970’s, bringing to pass a novel class of polymer termed dendritic. There 
are a variety of different types of dendritic polymers; dendrons, dendrimers, linear-dendritic 
hybrids, dendrigrafts, dendronised polymers, hyperbranched polymers, star polymers and 
hypergrafted polymers. These subclasses can be seen overleaf in figure 2. It is apparent that 
there is a wide array of architectures which fall into this category.
12
 However; this chapter 
will focus on dendrimers and hyperbranched polymers specifically, as they are used in the 
upcoming chapters. 
 
Linear Polymer                                 Branched Polymer         Cross linked Polymer 
9 
 
 
Figure 2 – Figure to illustrate the subclasses of dendritic polymers, reprinted with permission 
from [Gao, C.; Yan, D. Prog. Polym. Sci. 2004, 29, 183]. Copyright [2004] Elsevier. 
 
Dendritic polymers are macromolecules which contain a high degree of branching, and the 
monomers used in their construction are multifunctional. They differ from conventionally 
branched polymers, such as linear polymers containing branched units, due to the possibility 
of branching at each and every monomer repeat unit. As a result, a large quantity of 
functionalised terminal groups is attained. In addition, the branching present within dendritic 
structures has a large influence on physical properties, such as viscosity and hydrodynamic 
volume. These properties differ from existing linear analogues and, as a result, there has been 
a high level of investigation into the potential of these architectures in a range of applications; 
including non-linear optics, mechanical property modifiers, coatings and even stretching to 
the field of medicine.
5
 
 
1.1.3 Dendritic structure and terminology 
The term ‘dendrimer’ stems from the Greek words ‘dendron’, meaning tree and, ‘meros’ 
meaning part.
13
 Dendrimers are strongly recognised as polymeric molecules, despite their 
structural difference to linear polymers. Due to these differences, conventional polymer 
chemistry nomenclature is ineffective in describing these molecules adequately. 
Subsequently, this has given rise to new terminology, which has to be employed in order to 
best describe this novel class of materials. Both dendrimers and hyperbranched polymers fall 
10 
 
into the same class of polymer; however, they differ a great deal in structure. The varying 
nature in branching gives rise to their opposing architectures (figure 3). 
 
 
 
Figure 3 – Figure to illustrate the nature of branching within a dendron of a dendrimer and a 
hyperbranched polymer. 
 
Dendrimers comprise of a series of regular branching monomers throughout their structure, 
surrounding an inner core. They are symmetrical and monodisperse, subsequently possessing 
an exact molar mass.
14
 Dendrimers differ to classical polymers, due to their elevated degree 
of molecular uniformity and regularity. 
 
Due to the highly controlled synthesis required in the preparation of a dendrimer, the overall 
molecular architecture consists of only two different types of monomer residue. The first type 
of residue is known as a dendritic unit. A dendritic unit is one which has fully reacted, and 
thereby able to contribute to branching. The second type of monomer residue is described as 
a terminal unit, and is located at the periphery of the macromolecule. Moreover, the structure 
of a dendrimer comprises of three divergent regions; an initiator core, repeat branching units 
and functionalised terminal groups (figure 4), which are structural components unique to 
these macromolecules.  
11 
 
 
 
Figure 4 – Figure to illustrate the structural components of a dendrimer; a core unit, a 
perfectly branched unit and a terminal unit. 
 
Dendrimers are composed of ABn monomer units, where every layer of  repeat units 
generated with each stepwise reaction gives rise to a new ‘generation’ of branching units.  
These units are inter-reliant on each other, providing a dendrimer with its exclusive molecular 
shape.
5
 The value of n determines the amount of terminal groups on the periphery of the 
molecule; if n=2 the number of terminal groups will double with each increasing generation 
and if n=3 the number of peripheral groups will triple.
14
 As a general rule, low generation 
dendrimers form more open structures, with a higher molecular weight leading to a more 
globular and denser architecture. As is a result of increased branching, crowding of branches 
occurs, subsequently forcing a more closed structure.
10
 Dendritic growth is mathematically 
restricted; therefore, at a specific generation there is a steric limit to growth which is known 
as De Gennes packing.
15
 Growth may still occur past this critical point, but the result is the 
occurrence of structural flaws within the dendrimer. 
 
Hyperbranched polymers, however, are polydisperse and adopt a far less ordered structure in 
comparison to dendrimers (figure 3). These dendritic polymers are generally produced using 
12 
 
a non-iterative polymerization process; consequently leading to unreacted branch points 
within their structure. 
6
 
 
Dendritic units and terminal units are common to both dendrimers and hyperbranched 
polymers. In addition to these units, there is also the possibility for the occurrence of partially 
reacted repeat units, more commonly known as ‘linear units.’  The formation of these linear 
units gives rise to the structural imperfections within the hyperbranched polymer and as a 
result, structural control over layers of growth disappears.
5
 The structural components of a 
hyperbranched polymer can be seen below in figure 5. 
 
 
 
 
Figure 5 – Figure to illustrate the structural components of a hyperbranched polymer; a core 
unit, a dendritic unit, a linear unit and a terminal unit. 
 
The degree to which branching occurs is dependent on the type of synthesis used, the type of 
monomer (i.e. AB2 or AB3) and also the reactivity of the individual functional groups present 
on monomer units. In order to best describe hyperbranched polymers, taking into account 
both linear and branched units, Fréchet introduced the degree of branching (DB) in the form 
of an equation (equation 1).
16
 The degree of branching allows the quantification of linear and 
non-linear character within the polymeric architecture. 
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Degree of Branching (DB) =   D+T 
                                                  D+T+L 
 
Equation 1 - Fréchet’s equation for the Degree of branching (DB) 
 
D represents the number of dendritic units, T represents the number of terminal units, and L 
represents the number of linear units. Following on from the work of Fréchet, Fray developed 
an equation (equation 2) which does not regard the core itself as a branching point as it is 
only influential to the level of branching at the initial stages of a reaction.
17 
 
DB = 2D 
           2D+L 
      
Equation 2- Fray’s equation for the Degree of branching (DB) 
 
This equation allows the degree of branching of a polymer to be realised by the actual 
number of growth directions. As a result, both high and low molecular weight polymers can 
be analysed, thereby deeming this equation highly useful within this field of chemistry.
18 
The 
degree of branching for a hyperbranched polymer falls between 0 and 1, lying directly 
between the values of a linear polymer and a dendrimer respectively. There are two ways in 
which the degree of branching can be deduced; the first, which in turn is the most convenient, 
is the use of spectroscopy. This method makes use of peak area in nuclear magnetic 
resonance spectra and is relatively simple and effective. The second, which is less fitting, is 
via degradation of the polymer backbone.
5
   
 
It is important to note that hyperbranched polymers can adopt numerous isomeric structures 
for any degree of branching it may possess. Isomerism is a vital difference between 
hyperbranched polymers, and either dendrimers or linear polymers, meaning that a 
hyperbranched polymer could theoretically display a degree of branching also equal to 1 
without having a dendrimeric structure.
18
 
 
1.1.4 Properties of dendritic polymers 
The study of dendritic macromolecules has proceeded at an accelerated rate in recent years. 
Dendritic polymers are substantially different from analogous linear polymers, which has led 
to numerous noted differences in their physical properties.
19
 As a direct result of the highly 
14 
 
branched structures, these macromolecules exhibit contrasting behaviour to linear analogues 
in solution.
20
 With linear polymers, as the molecular weight increases so does the level of 
chain entanglement, producing an increase in viscosity. With dendritic polymers, viscosity 
increases with increasing molecular weight up until a certain point. This anomalous 
maximum in the relationship between intrinsic viscosity and molecular weight is a direct 
result of the globular structures dendritic polymers assume in solution. Dendritic 
macromolecules, with molecular weights higher than this maximum, exhibit a reduced 
solution viscosity, as the globular morphology inhibits chain entanglement.
21, 22
 Figure 6  is a 
graphical representation of this relationship; comparing linear polymers, hyperbranched 
polymers and dendrimers.
23
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Figure 6 – A Graphical representation of log[ƞ] (intrinsic viscosity against log M (molecular 
weight) of the polymer, adapted with permission from [Jikei, M.; Kakimoto, M. Prog. Polym. 
Sci. 2001, 26, 1233]. Copyright [2001] Elsevier. 
 
The relationship between molecular weight and intrinsic viscosity can be illustrated by the 
Mark-Houwink-Sakurada equation given below. 
 
Ƞ = kMα 
 
Where ƞ represents intrinsic viscosity, M the molecular weight and where k and α are 
constants, which are particular for the polymer-solvent system in question. In general, values 
of α fall within the range of 0.5 and 1.0 for linear polymers, whereas, dendritic polymers have 
been reported to have values of α lower than 0.5, providing evidence for the globular 
morphology they adopt in solution.
23
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In addition to reduced viscosity, another outcome of the compact globular morphology is that 
dendritic macromolecules possess smaller hydrodynamic volume compared to linear 
analogues.
19
 This particular property can pose a problem when utilising analytical techniques 
based on size, such as gel permeation chromatography (GPC).
5
 GPC is customarily calibrated 
with linear polymer standards, such as polystyrene, and the use of these polymers supplies a 
satisfactory estimate of molecular weight in the greater part of most cases. When non-linear 
polymers are analysed, the molecular weight values can be highly underestimated, due to 
misrepresentation of data. This effect becomes more pronounced for higher molecular weight 
polymers, due to an increase in the difference of hydrodynamic volume between linear and 
dendritic polymers. These analytical difficulties can be intensified further as a result of the 
high level of functionalised surface groups present on dendritic macromolecules. In linear 
polymers, peripheral groups play a small role in the overall determination of physical 
properties of the polymer. However, in dendritic macromolecules, the groups at the periphery 
of the molecule are extremely influential in determining solubility. In high molecular 
dendritic polymers, the surface groups protect the interior from circumferential solvent 
molecules, resulting in a more compacted structure and a greater level of underestimation. 
Contrary to this, the solubility can also be enhanced with appropriate functionalisation of the 
periphery.
 
1.2 Synthesis of Dendritic polymers 
 
1.2.1 Synthesis of Dendrimers 
Work by Flory in 1952
24
 gave rise to the true breakthrough into the field of dendritic polymer 
chemistry. Flory’s theory involves condensation between ABx (where x ≥ 2) monomer 
molecules. Following the theoretical work by Flory, Vögtle et al.
3
 published the first iterative 
synthetic procedure for the construction of a dendrimer. The synthesis involved aliphatic 
amine AB2 type monomer molecules. Condensation gave rise to the synthesis of ‘cascade’ 
polymers.
3
 
 
 Dendrimers are monodisperse symmetrical macromolecules, and to synthesise this class of 
polymer requires a high degree of synthetic control. This is accomplished via a highly 
controlled stepwise methodology, whereby the dendrimer is constructed one monomer layer 
at a time. The production of a dendrimer is a challenging task to perfect. The synthetic 
procedure involves numerous protection and deprotection steps at each stage of the synthetic 
16 
 
procedure. In addition to this, purification at each stage is both crucial and demanding. As 
previously stated, primary synthetic strategies were set in motion as early as 1978, by means 
of manufacturing these symmetrical and uniform macromolecules.
3
 There are two major 
synthetic approaches, which are currently in operation, to generate this unique type of 
macromolecule. These two strategies differ considerably from one another, and are known as 
the divergent and convergent approach respectively.
25
 
 
1.2.2 Divergent synthesis 
The divergent approach (figure 7) has arisen from the influential work of Tomalia, Newkome 
and Vögtle’s branched model. This particular approach involves building the dendrimer from 
an initiator core, increasing layers out towards the periphery of the molecule.
25
 Growth is 
initiated using repetition of coupling and activation steps. The peripheral end groups of each 
subsequent generation are reacted with the complementary reactive group on the monomer 
unit.
11
 Due to this, new branch points have been established at each site, leading to an 
increased number of terminal functionalised groups; this step is commonly referred to as a 
coupling step. Once the first coupling step is driven to completion, an activation step will 
take place. This is where the dormant functional groups can then be activated, so that further 
monomer can react, thus resulting in an increase in generation.
25
 Activation and coupling 
proceed in a repetitious fashion, resulting in an increase in the number of reactions at the 
perimeter. Furthermore, it can also be stated that the number of active hydrogen’s available 
will consequently establish the number of branches in the macromolecular intermediate. It 
can be noted at this point that these are sequentially connected to other interior generations.
2
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Figure 7- Growth of a dendrimer via the divergent approach, illustrative of one branching 
point of a multifunctional core. 
 
An advantage associated with this particular type of methodology is that the divergent 
approach is a moderately clear-cut synthetic procedure and, on proviso that favourable 
reaction conditions are maintained and fitting reagents are used, this method is perfectly 
suited for the manufacture of dendrimers on an industrial scale. However, there are certain 
disadvantages linked to this methodology. For example, the result of repetition on activation 
and coupling reaction steps produces an exponential increase in the number of reactions at the 
perimeter. As a result, there is a need for a large excess of reagents, in order to ensure both 
reaction steps reach completion.  
 
Another inconvenience to this synthetic route is due to the rise in the number of coupling 
reactions required with each increase in generation. This factor is accompanied by an increase 
in the probability of unwanted side reactions, and the formation of incomplete by-products. 
Should such unwanted side reactions take place, there is a possibility of architecturally 
similar by-products forming, which are extremely difficult to remove. It is also vital that the 
activating agent is fully eradicated, in order to prevent development of smaller, superfluous 
dendritic structures.
11
  
 
The first family of dendrimers to be synthesised and commercialised were the Polyamido 
amines (PAMAM’S). This dendritic family has also been referred to as ‘starburst’ dendrimers 
and was first characterised by Tomalia et al in 1985.
2
 This particular type of dendrimer has 
18 
 
received a great deal of attention in recent years and for more detailed information regarding 
this family of dendrimers, the reader is directed to numerous detailed pieces of literature.
2, 12, 
26, 27
 
 
1.2.3 Convergent synthesis 
The convergent method for dendritic polymers (figure 8) was first accounted for in the work 
carried out by Fréchet and Hawker.
6, 25, 28
 This synthetic approach commences with what will 
become the periphery of the end product and progresses inwards. By commencing at the 
periphery of the macromolecule and gradually working inwardly, a reactive dendron is 
generated. In order to create a globular dendritic architecture, several dendrons are further 
reacted with a polyfunctional core molecule.
12
 Therefore, the convergent method deviates 
from the divergent approach, as the core is incorporated to the macromolecule in the ultimate 
reaction step.
29
 
 
 
Figure 8- Growth of a dendrimer via the convergent approach. 
 
After coupling, the focal point of the dendron can be triggered using an activation step, which 
is further coupled to functional surface groups on more available monomer units. Working 
from the peripheral layer to the interior provides greater architectural control, as there are 
fewer coupling reactions at each stage of dendrimer growth. As a result, only slight surplus 
reagents are required to drive the reaction to completion, which aids purification. Therefore, 
it can be seen that the convergent approach has numerous advantages over the divergent 
19 
 
method. One of the most appealing features to this type of synthesis is its capability in 
distributing functional groups throughout the architecture in a selective fashion. 
Consequently, it is a suitable method for manufacturing accurate, well defined, symmetrical 
and unsymmetrical dendritic structures. 
 
There are also certain inconveniences to this methodology, such as steric crowding. This 
arises from construction of macromolecules from the perimeter towards the core. It is 
difficult to produce large generation dendrimers without an elevated level of defects within 
the structure.
11
 The most widely applicable dendrimers created by this synthetic procedure 
are poly (benzyl ethers), which have been manufactured by Grayson and Fréchet.
6, 29 
 
1.2.4 Synthesis of Hyperbranched Polymers 
In 1952, Flory built upon his previous work to develop a theory by which highly branched 
polymer molecules can be synthesised without gelation. Instead of utilising a bifunctional A 
monomer and a trifunctional B monomer in a polycondensation reaction, a monomer with 
one A functionality and two or more B functionalities was used.
24
 Although work by Flory 
was the initial breakthrough into dendritic chemistry, the first example of a hyperbranched 
polymer was not synthesised until 1988 by Kim and Webster.
30
 
 
In order to successfully synthesise dendrimers, an exhaustive iterative procedure involving 
numerous protection and deprotection steps is required. The synthesis of hyperbranched 
polymers does not require an exhaustive approach, as they can be conveniently synthesised in 
a one-pot process.
31
 Although this synthetic approach is less time consuming than dendrimer 
synthesis, the one-pot method involves random polymerisation of monomer units, giving rise 
to an extensive molecular weight distribution. 
 
The synthesis of hyperbranched polymers commonly involves the employment of one of 
three synthetic processes; step growth polymerisation, self-condensing vinyl polymerisation 
of AB* monomers and multi-branching ring opening polymerisation of dormant ABX 
monomers.
8
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1.2.5 Step growth polycondensation 
Step growth polycondensation involves the polymerisation of ABx monomers (X ≥ 2) in a 
one-step polycondensation reaction.
8
 Usually the monomer of choice is AB2 (scheme 1) 
however, it has been noted that monomers containing six B functionalities (AB6) have been 
employed, not to mention the polycondensation of paired monomers such as A2 and B3.
32, 33
 
This specific route can withstand numerous diverse functional groups and has, therefore, been 
widely used in the manufacture of many hyperbranched polymers, including 
polyphenylenes
30, 34
, polyesters
31, 35
, polyethers
36
 and polyamides
37
. An added advantage to 
this method is the low cost and commercial availability of ABx monomers. Although some 
features of this synthetic approach are beneficial, it is important to note the negative aspects 
associated with this particular method. Polymer gelation is a potential outcome, resulting in 
the need for a far more arduous purification process. A further disadvantage to step growth 
polycondensation is the potential occurrence of unwanted side reactions, such as cross 
linking. As a result, the ABx monomers selected must be synthesised before polymerisation 
can take place.
7,8 
 
 
Scheme 1 – Schematic representation of the process of step growth polymerisation of an AB2 
monomer. 
 
1.2.6 Self-condensing vinyl polymerisation of AB* monomers  
In 1995, Fréchet et al.
23, 38 
documented a novel, resourceful approach to synthesising 
hyperbranched polymers, known as self-condensing vinyl polymerisation (SVCP). This 
approach proceeds via self-polymerisation of a vinyl monomer, if it possesses a side group 
which can be converted into an initiating moiety. Such side groups include; a ‘living’ free 
radical, an electrophilic cation or even a carbanion. This transformation occurs by the action 
of an external stimulus; such as heat, light or an external additive. This type of 
21 
 
polymerisation can be viewed as a fusion of both vinyl polymerisation and classical step 
growth polycondensation reactions, as it functions via iterative coupling of growing moieties 
involving steps which are characteristic of classical vinyl polymerisations.
23, 38
 
 
The activated structural unit is most commonly denoted as an AB* inimer, where A 
represents the vinyl bond and B* represents the activated functional group. The term ‘inimer’ 
is used to describe a monomer with the capability to initiate monomers. In an SCVP system, 
chain initiation occurs when an activated species, B*, is added to a vinyl group of another 
inimer, leading to the formation of a dimer with two active sites and a double bond. A newly 
generated propagating centre, A*, and the activated centre, B*, can then react with the vinyl 
group of another molecule resulting in the formation of a hyperbranched polymer (scheme 
2).
39 
This particular synthetic approach has been employed to manufacture polystyrenes, 
poly(methacrylate)s and poly(acrylate)s.
8
 
 
Scheme 2 - Schematic representation for self-condensing vinyl polymerisation of AB* 
monomers; chain initiation is shown in black and the initiator side groups are shown in red. 
 
1.2.7 Multi-branching ring opening polymerisation of latent ABx monomers 
The third major approach to hyperbranched polymer synthesis is called multi-branching ring-
opening polymerisation. There has been less exploration into this method of polymerisation 
in comparison to the other strategies described beforehand. This approach, however, offers 
promise of a high level of control regarding synthesis of novel hyperbranched polymers.
40
 
This strategy was first introduced in 1992 by Suzuki, who reported the multi-branching 
polymerisation of cyclic carbamate with the aid of a palladium catalyst in order to generate 
polyamines. The idea Suzuki put across involved the initiator itself as the core, providing a 
dendritic macromolecule.
41
 The monomers utilised in this method of polymerisation are latent 
ABx type monomers. The monomers do not contain any branching points; the branching 
points are created via propagation.
23
 
 
Glycidol is a latent ABx monomer which has received a great deal of attention in the synthesis 
of hyperbranched polyglycerols. Frey and co-workers produced the first publication 
22 
 
involving this monomer in 1999 and, from this point, interest in this monomer grew at an 
escalated rate.
8, 40
 Polyamines, polyesters
42
 and other polyethers
44
 have also been prepared 
successfully using this strategy. 
 
1.3 Dendritic polymer applications 
 
1.3.1 Applications of Dendrimers 
The area of dendrimer chemistry has recently become one of the most quickly escalating 
areas of modern science, receiving a great deal of interest.
25
 Over the years, dendrimers have 
been used in the field of nanotechnology, bio-mimicry, diagnostics, catalysis and an 
assortment of therapeutic agents. These macromolecules have received a large amount of 
curiosity extending a great deal beyond that of classical polymers. Such increased interest is 
largely due the unique characteristics dendrimers possess. The peripheral surface, interior 
cavities and core unit can all be exploited and tailored for a specific reaction (figure 9). 
 
Figure 9– Figure to illustrate the structural elements of a dendrimer which can be exploited: 
(i) peripheral groups (ii) internal cavities and (iii) core unit 
 
The surface of a dendrimer possesses a large amount of peripheral units, making it useful for 
applications involving covalent interactions of functional groups. An example of an 
application which profits from this approach is chemical sensing. A dendritic sensor, which 
was researched by Balzani, Vögtle and co-workers
44
, was a fourth generation poly (propylene 
amine) dendrimer, possessing 32 dansyl units at the surface, demonstrating a fluorescence 
response to small Co
2+
 ions. However, it is not only inorganic species which can be detected; 
sensors designed for recognition of organic species are also involved in a large amount of 
research.
25, 44
 More recently, Akin et al.
45
 reported an amperometric alcohol biosensor. The 
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sensor was developed by the immobilisation of alcohol oxidase, via a PAMAM dendrimer, 
onto a cyste-amine modified gold electrode. The determination of ethanol was achieved 
through the depletion of oxygen by an enzymatic reaction. The biosensor showed a response 
time of 100 s and a detection limit of 0.016 mM. The biosensor also displayed up to 67 % of 
initial activity after storage for a period of four months. Biosensors of this nature can be used 
in the analysis of ethanol in numerous alcoholic drinks and also in the observation of the 
generation of alcohol in yeast cultivation. For more information regarding the use of 
dendrimers in the area of biochemical sensing, the reader is directed to the following review 
by Satija.
46
 
 
However, the most exciting prospect for the use of dendrimer surfaces is within medicine; 
with some areas including MRI contrast agents, gene delivery and drug delivery. There has 
even been research into the use of dendritic macromolecules as potential therapeutic drug 
molecules. MRI contrast agents are extremely important in medicine as diagnostic tools, 
which are used to generate anatomical images of high clarity of ‘soft’ tissue, such as organs 
or blood vessels. The process involves interaction of tissue with a defined magnetic field, 
resulting in a nuclear resonance signal of water; this signal itself is then allocated to its 
location of origin. The signals detected using this technique are then renovated and converted 
into the desired image. The role of a contrast agent is to improve sensitivity of this diagnostic 
approach, with Gadolinium (Gd) being a common element used.
25, 26
 Common low molecular 
weight Gd chelates do not remain in the blood vessels long enough after injection; therefore, 
their main drawback is rapid extracellular diffusion, meaning they will be rapidly eliminated 
from the blood stream. Some examples of common imaging agents include [Gd(DTPA)]
2-,
 
[Gd(DOTA)]
-
 and [Gd(HP-do3a)].
47
 The outcome of this resulted in research into utilization 
of dendrimers, which have been shown to have more extensive lifetimes in blood vessels 
when compared to lower molecular weight Gd chelates. Furthermore, they have demonstrated 
efficient acceleration in proton relaxation resulting in high quality tissue imaging.
25
 
 
Dendrimers have also been considered for use in gene delivery to act as carriers for genetic 
material. Gene therapy is crucial in the medical industry, as there is the likelihood that it 
could have a positive effect on either hereditary or acquired genetic disorders. Nucleic acids 
are particularly complicated to transport, meaning that non-viral vectors are actively sought 
out in this industry. It is assumed that non-viral vectors are able to prevent DNA from 
undergoing enzymatic degradation.
14, 25
 Polyamido amine and PPI dendrimers, possessing 
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amine surface groups, have been deemed potential non-viral carriers in gene therapy and have 
featured in numerous pieces of literature.
48-51
 Under physiological conditions, the surface 
groups become protonated; therefore, enabling polyanionic DNA to bind to the polycationic 
dendrimer surface via electrostatic interactions, which signify their potential as a non-viral 
vector for effective gene transfer. They also have a considerably low toxicity and have a high 
attraction for genes possessing a negative charge.
52
 The size of these molecules can be seen 
as added benefit, as it enables the transport of a high volume of genetic material.
25 
 
 
One of the most important biomedical applications, for which dendrimers are an ideal 
contender, is the area of drug delivery.
53
 Owing to the toxicity of a dendrimer increasing with 
higher generation, the biological properties of dendrimers become crucial.
26
 There are two 
proposed ways in which a drug can interact with a dendrimer; firstly it can be encapsulated 
within the dendritic cavities, or secondly, by electrostatic or covalent interactions to the 
periphery.
25
 Dendrimers have flexibility to their structure, particularly around the core, 
making them ideal as hosts for molecule entrapment.
52
 Dendrimers have therefore been 
considered to facilitate drug solubility and bioavailability, and also as vehicles which control 
release of drugs to their respective targets. In addition, they have been targeted for research 
for molecular entrapment, due to their open architecture. The drug which has been most 
frequently complexed to full generation PAMAM dendrimers is ibuprofen, a non-steroidal 
anti-inflammatory drug (NSAID) possessing carboxylate functional groups. Ibuprofen is able 
to interact with the amine groups on the surface of the dendrimer. A study by Kolhe et al. 
54
 
involved the interaction of G3 and G4 PAMAM dendrimers, with 32 and 78 ibuprofen 
molecules respectively, via ionic interactions, and was later concluded by NMR and IR 
spectroscopy. Testing in vitro revealed that there was slower release of ibuprofen to cells, 
when complexed to the dendritic architecture, compared to free ibuprofen.
54 
 
In 2002, Fréchet et al.
55
 developed three contrasting polyester based dendrimers. One 
macromolecule had hydroxyl peripheral groups, another had tri (ethylene glycol) 
monomethyl ether surface groups and the third, a star polymer type structure, had polyester 
units located on the surface. The star polymer exhibited the most potential in terms of 
cytotoxicity and half-life and, as a result, was used to covalently coordinate to the anticancer 
drug, doxorubicin. The drug was connected to the star polymer architecture by a hydrazone 
linkage. Results demonstrated a large reduction in the cytotoxicity of the drug and reports 
showed that doxorubicin was taken up within cancer cell lines sufficiently. This study shows 
25 
 
the promise of this type of material as a potential drug carrier. Dendrimers are preferable over 
classical polymers concerning polymer-drug interactions, as they are unique symmetrical 
molecules which are highly defined. As a result of their immense surface area, they can 
potentially accommodate high loadings of drugs.
52, 53
 
 
Another therapeutic application, which dendrimers can be applied to, is Boron neutron 
capture therapy (BNCT). This type of therapy has been used to treat numerous diseases, in 
particular, the treatment of cancer. It involves intravenous admission of a pharmaceutical 
containing 
10
B (the stable isotope of boron) to patients, which journeys to cancer cells. This is 
subsequently followed by irradiation of the patient using a low energy neutron beam. BNCT 
functions well when adequate amounts of 
10
B are being transported to tumour tissue, as it can 
then be irradiated by neutrons. Irradiation results in the generation of highly energetic alpha 
particles and Li
3+
 ions. The cations and energetic particles, which are formed, hinder the 
potential for tumour cells to replicate. A challenge associated with this technique is the select 
transportation and localisation of therapeutic agents, containing boron, inside tumour tissue. 
An important criterion of this is for agents to have a relatively low toxicity, and a potential 
solution was to create polymer scaffolds containing boron, in order to improve the selectivity 
and activity of it. PAMAM dendrimers have been used in research for preparation of 
immunoconjugates, yielding high concentrations of boron. Barth and co-workers synthesised 
the first PAMAM dendrimer containing Boron where they proclaimed that polyhedral borane 
[Na(CH3)3B10H8NCO] was able to be complexed to 2nd and 4th generation PAMAM 
dendrimers, via conjugation to the surface of the dendrimers.
26, 47, 52, 56
 
 
More recently, dendrimer encapsulated gold nanoparticles (Au DENPs) have been actively 
researched in the field of medicine. In 2012, Shan et al.
57
 have synthesised Au DENPs using 
amine terminated dendrimers as templates for non-viral vectors for gene delivery. Au DENPs 
showed higher gene transfection efficiency in comparison to dendrimers without entrapped 
nanoparticles. In 2013, Wang et al.
58
 have utilised Au DENPs for glutathione triggered 
release of anti-cancer drugs, both in vitro and also in live cells. These studies show the 
potential of these systems in the development of novel therapeutics. 
 
It is not only biomedically where these unique macromolecules have been applied; they have 
also been used to improve numerous industrial processes. The blend of both high solubility 
and large surface area makes them attractive for use in catalysis, with dendrimers also being 
26 
 
involved in research as potential catalytic supports. Catalysis is an area of expanding 
chemistry with regards to the incorporation and newly found importance of dendrimers 
within industrial science. Due to their architecture, there are two main ways in which 
dendrimers can be modified to function as a catalyst.
26,52
 Firstly, is the attachment of catalytic 
functional groups to the periphery of the dendrimer, and secondly, the introduction of a 
catalytic site at the central core of the dendrimer, giving the dendrimer nano-reactor 
properties. This occurs because of the internal cavities which lie in close proximity to the 
catalytic core being hidden from the external environment.
26,52
 The dendritic catalyst exhibits 
advantageous characteristics of homogenous catalysts, as well as benefits inherent of 
heterogeneous catalysts. An advantage of a homogenous catalyst is that they have 
unproblematic accessibility of active sites, however, unlike heterogeneous catalysts, they are 
difficult to extract from the reaction mixture. Dendrimers are easily recovered by techniques 
such as ultrafiltration, and the vast peripheral surface is multifunctional, causing all catalytic 
sites to be exposed to the reaction mixture. They therefore combine advantages of both 
homogeneous and heterogeneous catalysts, which is consequently the main basis of their 
appeal in industry. The Van Koten group established the first catalytic dendrimer for use in 
addition reactions for polyhaloalkanes.
26
 For more information regarding dendrimers in the 
area of catalysis, the reader is directed to the following reviews.
59-61
  
 
1.3.2 Applications of Hyperbranched polymers 
The development of hyperbranched polymers is intensifying a great deal within the field of 
macromolecular science. Hyperbranched polymers have similar capabilities to dendrimers, 
considering the core, periphery and branched interior all have the potential to be 
functionalised. There are a large number of suggested applications for these macromolecules; 
however, it is important to note how investigations into the use of hyperbranched polymers 
are still in their infancy when compared to dendrimers. In comparison to dendrimers, 
hyperbranched polymers are structurally imperfect. Nonetheless, despite the limited control, 
they provide a promising cost-effective alternative to dendrimers, being the primary motive 
for research into their commercial applications. 
 
It is the original and novel properties belonging to these macromolecules which deem them as 
excellent contenders for numerous diverse applications. Characteristic properties of 
hyperbranched polymers are highly dependent upon the degree of branching. The structural 
differences present in hyperbranched polymers, compared to linear analogues, gives rise to 
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amorphous materials, as branching thwarts crystallisation. Moreover, these materials also 
display low viscosity both in solution and in bulk. This low viscosity combined with potential 
for high functionality can be employed for numerous applications, such as cross-linkers, 
additives, rheology modifiers, coatings
62
 and tougheners for epoxy resins.
63, 64
 
 
One of the most common bulk applications of hyperbranched polymers is the generation of 
polymeric blends. There is a lot of interest with blending hyperbranched polymers with linear 
polymers, as the result is generation of novel polymeric materials. An example of this is a 
blend of hyperbranched polyphenylenes with polystyrene by Kim and Webster. This fusion 
resulted in the improved melt viscosity and thermal stability. Furthermore, the mechanical 
properties were changed upon blending, such as the enhancement of the initial modulus.
8,34
 
Exploiting hyperbranched polymers as a blend component is widespread amongst research 
into applications of dendritic macromolecules. Research in polymeric blends has triggered 
interest in other applications. Voit et al. investigated blending amphiphilic hyperbranched 
polyesters with an array of linear poly (olefins), which has given rise to an amphiphilic 
polyester derivative capable of transporting polar organic additives, such as dye molecules.
9
 
This system is comparable to nanocapsules or the dendritic box.
65
 The dye molecule is 
enveloped within the hyperbranched polyester and then blended with the linear poly (olefin) 
(scheme 3).
9
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Scheme 3-A schematic diagram showing the diffusion of the diffusion of an organic dye 
molecule into an amphiphilic hyperbranched polyester, followed by the inclusion into a poly 
(olefin) matrix. Diagram reprinted with permission from [Voit, B. Journal of Polymer 
Science Part a-Polymer Chemistry 2000, 38, 2505]. Copyright [2000] John Wiley & Sons, 
inc. 
 
Frey and co-workers took an alternative approach and investigated the use of hyperbranched 
polyglycerols as nanocapsules used to transport dye molecules. The work carried out showed 
how the topology of the hyperbranched polymer was fundamental in the encapsulation of the 
dyestuff.
66
 
 
Another application which has received attention is the use of hyperbranched polymers as 
surface coatings, especially polymer films. Möller produced ultra-thin films from arborescent 
graft polystyrenes. The films produced were of even thickness and the overall thickness was 
found to be dependent on the molecular weight and branching density of the hyperbranched 
polymer in question.
8, 67
 Asif et al. investigated a waterborne coating using ultraviolet curing 
technology. Waterborne coatings have achieved a great deal of interest, as they are known to 
reduce air pollution, lower the risk of fire and improve numerous areas of occupational health 
and safety. A succession of waterborne hyperbranched polyurethane acrylates for aqueous 
dispersion based upon hydroxyl functionalised polyester Boltoron H2O were shown to 
display good dispersability.
68
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Hyperbranched polymers have been considered for use as non-linear optical (NLO) materials. 
The majority of research in this particular area has focussed primarily on one dimensional 
NLO polymers, such as main chain or side chain polymers. The NLO chromophore can align 
in numerous different ways in one-dimensional polymers, for instance, head to head, head to 
tail and shoulder to shoulder. Zhang et al. have synthesised hyperbranched polymers with 
carbazole NLO chromophores, which displayed reasonable NLO properties. Zhang and co-
workers have also synthesised a novel hyperbranched polyester containing 4-(2-cyano-2-
methoxycarbonyl) aniline as the polar chromophore. In this particular hyperbranched 
polymer the chromophores link at the cross site of the branches, giving rise to a head to tail 
main chain backbone. This formation removes centrosymmetry, which would essentially 
thwart the polymer displaying non-linear optic activity.
69
  
 
The field of chemical engineering is a novel area which has exploited the use of 
hyperbranched polymers. Hyperbranched polymers can be used in extractive distillation, 
solvent extraction and membranes. Due to the intricate and multi-step synthesis required to 
generate structurally perfect dendrimers, the use of hyperbranched polymers offers a more 
cost effective alternative. Hyperbranched polymers display numerous properties which 
signify their promise as extraction solvents, and there are now hyperbranched polymers 
which are commercially available and approved by the FDA for this application. An 
alternative engineering application for these macromolecules is the separation of gases via 
absorption; however, research in this area is still in its infancy. Furthermore, the idea of using 
hyperbranched polymers as the stationary phase for preparative chromatography has also 
been put forward; thus, the potential of these polymers, for industrial purposes, is clearly 
recognisable.
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A great deal of research exists in utilisation of hyperbranched polymers as valuable drug 
carrier systems. A dendrimer remains the ideal competitor, due to its well defined 
architecture, large volume of functional groups and molecular uniformity. Dendrimers are 
thus considered as an attractive vehicle for drug delivery in modern science. Kolhe et al. have 
also investigated the use of the hyperbranched polymer Perstorp Polyol as a potential 
candidate. Perstorp polyol is a 5
th
 generation aliphatic polyester, possessing surface hydroxyl 
groups. The architecture itself bears a resemblance to that of a dendrimer, but is not as well 
defined. The potential of these polymers within the medical field is unequivocal and has 
30 
 
triggered a lot of interest into the study of these polymers and their relative complexation 
ability to a wide array of numerous marketable drugs.
55
 Due to their good solubility and 
excellent processability; three dimensional dendritic polymers have attracted much attention 
in numerous areas of science. They are therefore perfect for use in an ample range of 
applications, and the interest in these macromolecules is continuing to flourish. 
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Chapter 2 – Inhibition of protein-protein interactions using 
polyamidoamine (PAMAM) dendrimers 
 
2.1 Introduction 
2.1.1 Preface 
At the start of my PhD, I worked alongside Dr. Fumiko Chiba in the area of protein-protein 
binding. This chapter will highlight my contribution towards this project within the group, 
and the results presented are reported in the literature.
1
  
 
2.1.2 Introduction to Protein-Protein interactions 
Proteins can interact with other proteins, resulting in the formation of protein-protein 
complexes, of which there are two types; namely homocomplexes and heterocomplexes. 
Homocomplexes are normally stable and enduring, whereas heterocomplexes can also exhibit 
durability, as well the ability to be formed or broken apart by external factors. Therefore, a 
prerequisite for heterocomplexes is the involvement of a protein which can exist 
independently.  Protein-protein complexation is involved in practically all biological 
functions; including signal transduction
2
, cytoskeletal remodelling
3
, cell regulation
4
 and 
many others.
4-6
  Therefore, when two proteins interact with one another, it is neither a random 
nor unsystematic occurrence. Protein-protein association is meticulously scripted to 
accomplish a particular aim.
2
 
 
As formerly stated, protein-protein interactions are of fundamental importance in numerous 
biological processes; some examples include hormone-receptor, protease-inhibitor and 
antibody-antigen complexes. The roles of these particular complexes are well known and 
understood. There are also numerous complexes which are not well known, but are of no less 
significance. Abnormal protein-protein interactions can also take place, which can play a 
significant role in a variety of disease processes. The condition drepanocytosis (more 
commonly termed sickle cell anaemia) is a disease brought about by the oligomerisation of 
mutant haemoglobin. This ailment highlights the negative effect of these undesirable protein-
protein interactions. There are also protein-protein interactions which are less specific, 
occurring when proteins form aggregates. Misfolded protein aggregates, amyloid fibrils, are 
connected with numerous illnesses such as Alzheimer’s and numerous forms of rheumatoid 
arthritis.
7
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2.1.3 A Protein-protein binding interface 
As previously indicated, protein-protein interactions are extremely important in a vast array 
of biological processes, thereby triggering a large level of interest in the comprehension and 
potential manipulation of these interactions. In order to design molecules to interrupt protein-
protein interactions, it is essential to gain understanding of the nature of protein-protein 
interfaces.
8
 The protein-protein interface can be defined as the area of surface available on 
both protein partners in question, which become inaccessible upon interaction, and are 
predominantly hydrophobic in nature.
9
 
 
There are often conformational changes involved with protein-protein complexation and 
numerous different models have been proposed to explain the mechanism involved. In 1894, 
Emil Fischer brought about the concept of the ‘lock and key’ model, assuming some kind of 
shape selectivity. This model indicates that one protein has a crevice into which its ideal 
partner fits, with practically no conformational change. However, it is important to 
understand that this proposal is not suitable for interactions of proteins with substances 
varying in shape. This dilemma was overcome by Daniel Koshland in 1958, by the 
introduction of the ‘induced fit’ model. This particular model assumes that the active site has 
a certain element of elasticity, enabling it to accommodate a ligand, and thereby leading to a 
change in conformation. Finally, the last idea proposed is the idea of a pre-existing 
equilibrium. This hypothesis indicates that the native state of the protein in question, displays 
an assembly of conformations at the active site, resulting in the ligand being drawn to an 
active conformation.
10
 
 
The mechanism behind protein-protein interactions is complicated as a result of the large 
surface area involved. However, this is not the only factor to consider, electrostatics and 
hydrophobicity also play a crucial part. It is the cooperative effect from the combination of 
these numerous parameters which result in successful interactions.
4
 The mechanism itself is 
highly specific; a protein selects a partner with an interfacial area comparable in size, of three 
dimensional shape, and with complementary intermolecular forces and amino acids in the 
correct location. Figure 10 is a schematic representation for a simplified mechanism for 
protein-protein interaction, indicating the specificity of partner selection. 
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Figure 10- Schematic representation for the mechanism of protein-protein binding, 
illustrating the selection of a compatible partner. 
 
The principles behind these specific interactions of proteins are not fully realised and, to gain 
a better understanding, Bogan and Thorn combined the techniques of alanine screening with 
kinetic and thermodynamic measurements.
5
 These techniques were used to determine the 
contribution of individual residues to the key binding region, more commonly known as the 
‘hot spot.’  The idea of the hot spot was first pioneered by Clackson and Wells4, 11, and it 
originated from the discovery that the free energy of binding was not uniformly spread across 
the interface of a protein, but rather comprised of a small area of amino acid residues. It is the 
residues within this region which play a part in the stability of the protein complex.
8
 The hot 
spot is therefore a critical feature of the protein-protein interface.  
 
Bogan and Thorn demonstrated that ‘hot spots’ of binding energy are located near the centre 
of the interface, whereas residues located at the periphery rarely contribute to binding. 
Research also demonstrated that the surrounding residues of the hot spot most likely work by 
keeping bulk solvent away from interacting residues. The omission of bulk solvent from 
interacting residues has been shown to be a necessary condition for favourable interactions.
4
 
Bogan and Thorn also looked into amino acid preferences within the hot spot region, finding 
that the hot spots are enriched with three types of amino acid with a frequency larger than 
10%, namely; tryptophan (21%), tyrosine (12.3%) and arginine (13.3%). As the amino acid 
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composition present in hot spots was not random, it showed that there was a preference 
towards certain amino acids with regards to the high energy interactions between two specific 
proteins in a heterodimer.
5
 
 
Examining the structures of proteins at this level provides knowledge into the workings of 
protein-protein association; thereby enabling research into the design of synthetic agents 
which could disrupt unwanted interactions, which result in disease. 
 
2.1.4 Inhibition of protein-protein interactions 
Due to their fundamental role in biological systems, the interference and disruption of these 
interactions can result in the potential unearthing of new therapeutic agents.  Research into 
the design of synthetic agents to interrupt these interactions has advanced over the years, and 
there has been a great deal of investigative work into the design of both small and large 
molecular weight molecules as prospective protein-protein binding inhibitors.
6
 
 
When protein-protein complexation occurs, non-covalent interactions prevail; namely Van 
der Waals forces, electrostatic interactions, hydrogen bonding and hydrophobic effects. There 
are two different strategies which can be employed to inhibit protein-protein binding; firstly 
targeting the interior active site of the protein which is shielded from bulk solvent, and 
secondly, by targeting the exterior surface of the protein which is exposed to bulk solvent. 
 
2.2 Protein-protein inhibition using low molecular weight synthetic agents 
2.2.1 Small molecule inhibitors 
The majority of research within the pharmaceutical industry in this area has involved 
designing small molecules as potential inhibitors. Traditionally, small molecules are designed 
specifically to interact with the active site or a specific site of the enzyme. The interactions 
within a protein active site which predominate include hydrogen bonding, electrostatic 
interactions and salt bridges. Consequently, small ‘drug like’ molecules, which possess 
hydrophilic motifs and hydrogen bond donor groups, could prove effective.
12
 However, it is 
important to note that there are various challenges involved in the design of synthetic agents 
which are tailored to target protein-protein interactions. Firstly, the area required for 
recognition is quite sizeable (ranging between approximately 700-1500Å
2
 per protein).
4
 This 
creates a problem for small molecule inhibitors. Furthermore, interacting surfaces have been 
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ascertained as shallow cavities possessing no specific features, making selective targeting 
difficult to accomplish. Another drawback arises from the nature of the binding region of the 
protein partners in question. The binding site of the two proteins is frequently referred to as 
non-contiguous; thereby, meaning mimicry using straightforward synthetic peptides would be 
ineffective.
12
 In addition, unlike enzyme-ligand interactions, protein-protein interaction 
surfaces are more complicated. Instead of one partner possessing a pocket and the other 
occupying said pocket, both proteins could contribute protrusions and sub pockets, thwarting 
inhibitor design.
13
 Furthermore, when considering using small molecules as potential drug 
molecules, they need to be effective when in vivo. Not only must they demonstrate a high 
efficacy against the target protein, they must also reveal low toxicity and superior 
bioavailability. In general, molecules which exhibit these ‘drug like’ qualities have a 
tendency towards molecular weights less than 500.
14
 
 
In the late 1990’s, there were some advances in the development of small molecule inhibitors. 
In 1999, Quershi and co-workers developed a non-peptide antagonist 1 (figure 11). This 
molecule was discovered through the screening of a chemical library of inhibitors of human 
erythropoietin, binding to the extracellular region of the erythropoietin receptor. This led to 
the discovery of a biphenyl indole derivative, which showed competency as an inhibitor of 
interaction, with a maximal inhibitory concentration of 60µL.
14,15
 
 
 
 
Figure 11 – Figure to show the chemical structure for the non-peptide erythropoietin 
antagonist developed by Quershi and co-workers.
14, 15 
 
In addition to this, Tilley et al.
16
 identified small molecules with the capability to block 
cytokine receptor signalling. Interleukin-2 (IL-2) is a cytokine which plays a crucial role in 
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growth activation and differentiation of T cells.
13
 Initially, the small molecule 2 (figure 12a) 
was designed as a mimic for arginine and phenylalanine side chains of interleukin-2, which 
has crucial involvement in binding to the α subunit of the interleukin-2 receptor (IL-2Rα). 
Use as a mimic failed, but research has shown that it has subsequently been found to be a 
potent inhibitor of interleukin-2, binding to its receptor.
13, 14, 16
 This provided the first 
example of a small molecule inhibitor of protein-protein interactions, where the inhibitor 
bound to the protein partner, as opposed to the receptor. Braisted et al.
17
 expanded on this 
work to develop a more potent analogue 3(figure 12b). This compound had an IC50 of 60mM 
and bound to IL-2 with a 1:1 stoichiometry and a Kd of 100nM. In 2005, Waal et al.
18
 
continued on from these advances and fabricated a nonpeptidic, potent inhibitor 4 (figure 
12c). Continuing on from the work discussed beforehand, Waal and co-workers used 
chemical modification of previous analogues to enhance the ability of the inhibitor. Studies 
showed that the incorporation of furanoic acid resulted in a 23-fold improvement in the 
activity of the inhibitor. 
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Figure 12 – Figure to show small molecule inhibitors of the interaction between IL-2 and IL-
2Rα. (a) acylphenylalanine based compound16 (b-c) chemically modified derivatives of 
compound a. 
 
The unearthing of these molecules is a revolution within this area of research, with further 
examples to be expected to continue.
17, 18
 
 
An important protein target is inducible nitric oxide synthase (iNOS). Nitric oxide is a 
molecule which is vital in signal transduction and it is generated by the dimeric enzyme, 
nitric oxide synthase. The inducible isoform of this enzyme, iNOS, has been associated with 
tissue damage in a range of autoimmune diseases. An inhibitor designed specifically to target 
iNOS could therefore have valuable therapeutic use. McMillan and co-workers developed an 
inhibitor of iNOS, 5, by the use of combinatorial chemistry (figure 13). X-ray 
crystallography studies confirmed perturbation of the substrate binding site and dimerization 
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interface. The inhibitor acts by disrupting the formation of the dimer by an allosteric 
mechanism. In vivo studies, using a rat model, demonstrate that the inhibitor displayed 
activity with ED50 values <2 mg/kg. These results show the therapeutic potential of inhibitors 
of this nature.
13, 19
 
 
 
 
Figure 13– Figure to show the chemical structure of a small molecule inhibitor for inducible 
nitric oxide synthase (iNOS)
19
 
Another important target is the tumour necrosis factor alpha (TNF-α). TNF-α is also a 
member of the cytokine family and is involved in systematic inflammation. There have been 
developments in the direct inhibition of TNF-α in the way of numerous inhibitory antibodies; 
such as Enbrel, Remicade and Humira. These have shown to be effective for treatment of 
rheumatoid arthritis.
13
 Despite these advances; small molecule inhibitors are desirable due to 
advantages in cost and mode of administration. He et al.
20
 developed the potent inhibitor of 
TNF-α (6) shown in figure 14. The inhibitor displaces a subunit of the biologically active 
trimer, resulting in the formation of the inactive dimer. 
 
 
 
Figure 14– Figure to show the chemical structure of a small molecule inhibitor of tumour 
necrosis factor-α (TNF-α) developed by He et al.20 
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2.2.2 α-Helix Mimetics 
A breakthrough within this field was the discovery of the important role helical segments 
play in a range of protein-protein interactions. Therefore, the synthesis of helical mimics 
gives rise to potential therapeutic development.
21
 It has been deduced that approximately 
15% of the protein data bank (August 2009) is made up of protein-protein complexes. 
Furthermore, 62% of these complexes possess a helix at the interface. This data therefore 
highlights the importance of α-helices in protein-protein interactions.22 In 2008, work by Per 
Restorp and Julius Rebek Jr. described the synthesis of a series of heterocyclic piperazine 
based scaffolds 7 to 10 (figure 15), which are able to mimic the i, i+4, i+8 and i+11 side 
chains of an α- helix. The general synthetic procedure reported can be used in the synthesis of 
α-helix mimics, tailored to a specific interaction. These compounds were specifically 
designed to mimic the amphiphilicity of α-helices. This was accomplished by having a 
hydrophilic surface for hydrogen bonding and a hydrophobic surface which could interact 
with the protein.
23
 
 
 
 
Figure 15– Figure to show the chemical structure for the skeleton for a series of heterocyclic 
piperazine based scaffolds (compounds 7 to 10) developed by Per Restorp and Julius Rebek 
Jr.
23
 
 
The importance of inhibition of protein-protein interactions for cancer therapy is of vital 
importance. The tumour suppressor protein, P53, is a potent transcription factor which 
protects cells from harmful transformations. HDM2 is responsible for regulation of level and 
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activity of p53 and overexpression of hDM2 will subsequently result in the impairment of the 
protein’s function.24 The interaction between p53 and hDM2 involves three hydrophobic 
residues from the tumour suppressor protein coordinating in a helical conformation to a 
hydrophobic cleft present on hDM2. The key hydrophobic residues are Phe19, Trp23 and 
Leu26.
25
 Therefore, the inhibition of the interaction between hDM2 and p53 could stabilise 
the protein, providing a novel therapeutic approach to cancer therapy. Vassilev and co-
workers
24
 have developed a small molecule inhibitor which coordinates hDM2 within the 
binding pocket of p53, thus activating its pathway in cancer cells. Studies in nude mice have 
shown results of cell arrest, apoptosis and growth inhibition of human tumour xenografts. X-
ray crystallography studies have shown that hDM2 has a deep cavity filled with side chains 
from the helical region of the peptide. The small molecule antagonists were a series of cis-
imadazoline analogues referred to as Nutlins. After chemical optimisation, Nutlin-3 was 
developed (figure 16) and demonstrated inhibition of hDM2-p53 complexes with an IC50 of 
90nM. In addition, this small molecule antagonist displayed activity against xenografts in 
vivo. 
 
 
Figure 16– Figure to show the chemical structure of Nutlin-3, a cis-imadazoline based 
inhibitor developed by Vassilev and co-workers.
24
 
  
Research concerning the disruption of this particular interaction has continued as a result of 
the therapeutic potential regarding cancer therapy. In 2009, Plante et al.
25
 developed a series 
of oligobenzamide proteomimetic inhibitors. As stated previously, the three key residues 
present at the hDM2-p53 complex interface are Phe19, Trp23 and Leu26. An important 
strategy in the scaffold design of a helical mimic is that the scaffold is able to mimic the 
residues at i, i+4 and i+7 of the p53 helix. One of the compounds developed, the 
oligobenzamide (figure 17), was superimposed on the face of the p53 helix. It is apparent 
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that the O-alkyl substituents of the amino terminated tri-benzamide all lie on the same face 
and also mimic the orientation in space of the i, i+4 and i+7 residues of the α-helix. These 
results therefore demonstrate the ability to fabricate an effective mimic. 
 
 
 
 
 
Figure 17– Figure to show the chemical structure of  an oligobenzamide proteomimetic 
inhibitor developed by Plante and co-workers.
25
 
 
As stipulated beforehand, there has been a large amount of interest in the creation of non-
peptidic small molecule α-helical mimics as inhibitors for protein-protein interactions. In 
2011, Lee et al.
26
 reported the synthesis of a novel pyrrolopyrimadine based receptor 13 
(figure 18). The ability of this scaffold to interrupt the p53-MDMX interaction was 
monitored, so as to determine its ability as an α-helical mimic. Initially, the scaffold was 
screened against a library of 900 compounds and primary amines which contained 
hydrophobic groups were selected. The hydrophobic groups were essential in mimicking the 
side chains of the three amino acids found in p53. This particular scaffold exhibits 
conformational rigidity, good aqueous solubility and cell permeability. Moreover, the 
synthetic route is relatively easy and as a result, the synthetic procedure will comply with the 
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construction of large libraries and high throughput screening. Consequently, this scaffold 
could be useful in the discovery of a range of inhibitors of this nature.  
 
 
 
 
Figure 18 – The pyrrolopyramidine based α-helix mimic developed by Lee et al.26 
 
This section is not an exhaustive account; therefore, for more information regarding 
disruption of protein-protein interactions with non-peptidic small molecule α-helix mimetics, 
the reader is directed to the following review by Hamilton and Cummings.
27
 
 
2.2.3 Porphyrin and calixarene based receptors 
Due to the difficulty in the design of small molecule inhibitors, large scaffold molecules have 
also been investigated as potential protein binding agents. As previously stated, the design of 
synthetic agents to bind to an active site has been investigated extensively. However, an 
alternative approach to the disruption of protein-protein association is by binding to the 
surface of a protein in the proximity of, but not directly within, the protein active site.
8
 The 
peripheral surface is distinctive and characteristic to each individual protein and comprises of 
hydrophobic, hydrophilic and charged regions. In addition to electrostatic interactions, 
hydrogen bonding and π- π stacking interactions also feature at the interface between two 
connecting proteins.
12 
 
The greater part of molecules investigated disrupt interactions by binding inside active 
cavities on proteins; meaning synthetic molecules which intervene the function of a protein 
through binding to the outer surface, are comparatively uncharted. Not only could this expose 
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new drug candidates, but it will assist in the comprehension of the periphery of proteins and 
the understanding of surface recognition.
28
 
 
In 1985, Fischer et al. provided evidence that a tetracarboxyphenyl porphyrin (figure 19) 
proved to be a corresponding topographical mimic for cytochrome-c binding with a Kd of 
5µM.
29
 Cytochrome-c is an electron transport protein found in horse heart and is questionably 
one of the most studied proteins. It is considered an attractive target as it plays an important 
role in both electron transfer and aptosis. The surface of the heme edge is bordered by a series 
of arrangements of cationic lysine residues and hydrophobic domains, signifying a strong 
dependence, in particular, on electrostatic interactions.
12
 
 
 
Figure 19- Figure to show the chemical structure of tetracarboxyphenyl porphyrin. 
 
Hamilton et al. continued work in this area investigating both tetraphenyl porphyrin 
scaffolds
28,30-32
 and calix[4]arene scaffolds
33,34
 using a range of techniques, including 
fluorescence spectroscopy. In 1997, Hamilton et al.
33
 developed the strategy of using a 
macrocyclic scaffold, to which peptide loops could be covalently attached. Subsequently, an 
antibody mimic, based upon calix[4]arene linked to four constrained peptide loops, was 
fabricated (figure 20)
35
. Calix[4]arene was selected as it is not only easily obtainable but it 
can be locked into a cone conformation, which results in para substituents being propelled 
onto the same edge of the ring, thereby forming a binding domain.
33
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Figure 20 – Figure to show the chemical structure for an antibody mimics based upon a 
calix[4]arene scaffold and covalently attached to four peptide loops of the sequence (Gly-
Asp-Gly-Asp). This mimic was used for the surface recognition of cytochrome-c and 
designed by Hamilton and co-workers.
i
 Reprinted with permission from [Lin, Q.; Hamilton, 
A. D. C. R. Chim. 2002, 5, 441-450]. Copyright [2002] Elsevier Masson SAS. All rights 
reserved 
 
The initial target protein used was cytochtome-c. It is both well studied and well 
characterised and is known to have a positively charged surface. The peptide loops are 
comprised of negatively charged (Gly-Asp-Gly-Asp) sequence. Negatively charged peptide 
loops are required in order to complement the positively charged surface of the target protein. 
Subsequent X-ray studies showed that four peptide loops could interact with four lysine 
residues present, thereby meaning that the synthetic receptor will cover a large area of the 
surface of the protein. The receptor was shown to disrupt cytochrome c/cytochrome c 
peroxidase complex formation, consistent with the X-ray studies.
35
 Further work by this 
research group demonstrated that an antibody mimic of this nature was also able to interact 
with the surface of chymotrypsin, disrupting serine protease-proteinaceous inhibitor 
interactions.
36 
Calixarene receptors proved disadvantageous as a result of the arduous 
synthetic procedures involved, and the low yields obtained. For further information on 
15 
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supramolecular scaffold based receptors, similar to those mentioned above, the reader is 
directed to the following literature.
37-39
 
 
 In 2000, this research group demonstrated that the surface of cytochrome-c could be 
recognised by receptors based on a tetraphenyl porphyrin scaffold with a variety of amino 
acid and peptide derivatives around the outside edge (figure 21).
28
 The results showed that 
the relative affinity of a receptor to the protein surface was dependent upon the amount of 
hydrophobic and anionic groups present. These receptors bound with a high affinity in an 
aqueous medium with receptor 19 showing the highest affinity for the surface of cytochrome-
c exhibiting a Kd of 20 nM.  In addition to protein surface recognition, these results have 
unearthed a potential medicinal property for receptor 19. Previous reports have confirmed 
that cytochrome-c can interact with the apoptopic protease activating factor, APAF1.
40
 This 
interaction can result in the activation of aptosis. Therefore, receptors of this nature could 
prove useful in the disruption of this particular protein-protein interaction.
28
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Figure 21- Figure to show the chemical structures for a series of tetraphenyl Porphyrin 
scaffolds for the recognition of the peripheral surface of Cytochrome-C designed by 
Hamilton and co-workers.
28 
 
As previously mentioned, the peripheral surface of a protein is crucial in mediating protein-
protein binding in numerous biological processes, such as cell proliferation and cell growth. 
Therefore, synthetic molecules which complement the structural features of the protein 
periphery are expected to bind, thereby disrupting surface, as opposed to the enzyme active 
site. In 2003, Hamilton et al.
37
 reported a series of tetrabiphenyl porphyrin-based receptors, 
one of which, 20 (figure 22), shows a particularly high affinity towards the surface of cyt-c 
(Kd = 0.6 nM). Circular dichroism was employed to investigate the effect of coordination of 
this receptor on the protein. In the absence of the receptor, the melting temperature of 
cytochrome-c was 85 ºC. However, in the presence of the porphyrin receptor, the melting 
50 
 
temperature was reduced to 35ºC. These results provide a platform for the subsequent 
development of other porphyrin-based receptors for protein surface recognition and protein 
denaturation. In relation to this work, Hamilton and co-workers have also developed various 
metalloporphyrin dimers which have resulted in accelerated proteolysis of cytochrome-c.
38, 39
 
 
 
Figure 22– Figure to show the chemical structure of a tetrabiphenyl porphyrin-based receptor 
for the surface recognition and enhanced unfolding of cytochrome-c.
37
 
 
In 2003, Trauner et al.
41
 developed a class of porphyrin based ligands for surface recognition 
of potassium channels. The four-fold symmetrical molecules act as mimics of peptide toxins, 
and subsequently bind to the four subunits of the channel. These ligands bind to the Kv1x 
class of potassium channels, partially obstructing conductance. Potassium channels regulate 
membrane potential and play a part in a range of cellular processes. As a result, they have 
become a target for drug design. Synthetic inhibitors could provide therapeutic solutions to 
numerous conditions, such as various autoimmune disorders and cardiac related illnesses.
42
 
The series of porphyrin ligands were used for competitive binding assays with 
125
I-hongo-
toxin1-A19Y/Y37Ff. This toxin coordinates to the outer vestibule of Kv1.3 channels. This 
particular voltage-gated potassium channel is crucial in human T-lymphocyte activation. 
Results have shown that the cationic ligands 21, 22 and 23 (figure 23) displayed the strongest 
interaction with the Kv1.3 channel. The cationic side chains could form salt bridges to 
aspartate residues, explaining the high affinity shown. The geometry of ligands 21, 22 and 23 
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was also correct for sufficient binding. Ultimately, the development of this class of 
compounds could unearth novel therapeutic agents for a wide range of ailments.
41
 
 
 
 
Figure 23– Figure to show the chemical structures for a series of cationic porphyrin-based 
ligands for the surface recognition of potassium channels developed by Trauner et al.
41
 
 
Notwithstanding these intimidating challenges, there have been many advances in this area of 
research and there are numerous examples of synthetic low molecular weight ligands able to 
inhibit two protein partners. For more information on this area of research, the reader is 
directed to the following literature reviews.
12-14, 44-48
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2.3 Aims and Objectives 
As discussed earlier, protein-protein associations play a fundamental role in numerous 
biological processes. Furthermore,  unwanted interactions can also occur, leading to 
numerous diseases such as sickle cell anaemia.
49
 Therefore, being able to understand the 
manner by which proteins interact with each other is crucial for the development of potential 
novel inhibitors and drug molecules.
50
 Due to the large interfacial areas proteins possess, 
discovering small drug like molecules as inhibitors has been difficult.
2
 As can be seen from 
the introduction and highlighted literature, there have been some intriguing developments 
which show that small molecule inhibitors are becoming closer to realistic use in this area of 
research. There have been numerous successful reports of small molecules interfering with 
protein-protein interactions, and thus behaving as competent inhibitors to binding.
14
 In nature, 
proteins bind large molecules, such as other proteins. Figure 24 is a plot of known protein-
protein complexes found in the literature.
9
 The number of complexes with similar binding 
areas are grouped together and then these groups are plotted (i.e. number of protein-protein 
complexes with a particular interfacial area vs. the size of the interfacial area).  
 
 
Figure 24- A graph to represent the distribution of interfacial areas from common protein-
protein complexes.
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This plot shows that protein complexes cover a wide range of areas, which has triggered 
interest in the research of higher molecular weight molecules as potential synthetic inhibitors 
to protein-protein binding. Owing to the large interfacial area of proteins, the ability to 
synthesise a succession of macromolecular structures able to interact over a range of areas is 
an important target. As identified earlier, size is not the only factor to consider. The 
mechanism for protein-protein interactions also involves the three dimensional shape, 
functionality and the specific location of this functionality within the interacting area. 
Therefore, the aim of this research is to synthesise a succession of macromolecular structures 
which fit these fundamental criteria.  
 
There are several large molecules to consider, the first being linear polymers. There have 
been numerous studies involving the interaction between linear polymers and proteins. 
Bruening et al.
51
 demonstrated the high capacity binding of proteins by poly (acrylic acid) 
brushes; whereby thick polymer brushes were developed to immobilise multiple monolayers 
of proteins. The PAA brushes were derivatised with a nitro triacetate/copper complex 
((NTA)-Cu
2+
) and exhibited the ability to bind a wide variety of proteins. The capability of 
the interaction of proteins with a surface could prove irrefutably valuable in the area of 
protein purification. Another example can be seen in the work by Wowk et al. It was shown 
that the inhibition of bacterial ice nucleation could be achieved using simple linear polymers; 
namely polyglycerol and polyvinyl alcohol. It was shown to bind, and thus inhibit the ice 
nucleating activity of proteins from Pseudomonas syringae (an ice nucleating bacterium). 
This bacterium can be located on the surface of certain bacteria. Both polyglycerol and 
polyvinyl alcohol were investigated, with polyglycerol proving to be the more potent and 
specific inhibitor of the two, however, the combination of the two linear polymers exhibited 
more efficacy than either agent individually.
52
  
 
For the purpose of this research specificity is crucial; therefore, linear polymers are far too 
dynamic and flexible. The interaction between proteins and linear polymers arises because of 
polyvalent effects. That is to say, the more charges present, the stronger the binding. As a 
result, there is no size specificity, as a linear polymer can freely change its shape to maximise 
binding. As a result, their interactions with proteins is predominantly referred to as ‘non-
specific’.53 
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The next class of molecule we took into consideration were dendritic polymers; namely 
hyperbranched polymers and dendrimers. As previously mentioned in chapter 1 of this report, 
dendritic polymers differ from conventionally branched polymers, due to the potential for 
branching at each and every monomer repeat unit, thereby resulting in a large quantity of 
functionalised terminal groups. Due to the surface of proteins possessing regions of high 
charge, dendritic polymers seem a viable option for this research. 
 
Hyperbranched polymers have imperfectly branched irregular architectures in comparison to 
dendrimers, meaning they display a higher level of flexibility. Although not as flexible as 
linear polymers, we felt they may still be too flexible; as a result, they may not execute the 
desired level of specificity for the main target of this work. Dendrimers consist of a series of 
regular branching throughout their globular like structure surrounding a core. They are 
symmetrical and monodisperse, and exhibit an elevated degree of molecular uniformity and 
an element of rigidity compared to linear and hyperbranched polymers. Dendrimers have 
regular structures and exhibit a quantised size effect. Consequently, their maximum 
addressable area is quantifiable and is equal to their diameter squared. The peripheral surface 
of a dendrimer can also be easily functionalised. This is beneficial as the mechanism of 
protein-protein binding involves matching size, shape, terminal functionality and the position 
of this functionality. These specific qualities therefore make dendrimers an attractive option 
for application as large molecule inhibitors for protein-protein binding. 
 
Other work within the Twyman group has demonstrated the presence of a size effect of 
dendrimers, which can be developed towards a size selective binding mechanism for the 
inhibition of protein-protein interactions. That is to say, for a particular protein, the dendrimer 
which binds the best is effectively the one whose addressable area is closest in size to the 
interfacial area of the target protein. When a large ligand interacts with the active site of an 
enzyme, it is effectively blocked-up, thereby hindering the function of the enzyme. Therefore, 
the dendrimer which binds the best will also be the most potent inhibitor.
50, 54
 The dendrimers 
used were a series of PAMAM dendrimers, which are illustrated schematically overleaf in 
figure 25. 
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Figure 25 – Figure to show a series of PAMAM dendrimers (and their corresponding 
addressable areas), which were investigated as size selective inhibitors for protein-protein 
binding. Reprinted with permission from [Chiba, F.; Hu, T.-C.; Twyman, L. J.; Wagstaff, M. 
Chem. Commun. (Cambridge, U. K.) 2008, 4351]. Copyright [2010]  WILEY-VCH Verlag 
GmbH & Co. KGaA, Weinheim. 
 
Although previous work has demonstrated this principle, the location for dendrimer 
interaction remains unknown, be it at the active site entrance or another location. For 
instance, it is possible that the dendrimer is binding to another location on the protein surface. 
This would cause a conformational change to the structure of the protein, rendering it 
denatured, which would result in the same inhibition data ascertained. In order to determine 
the effect that interaction with a dendrimer has upon the structure and stability of a protein, 
the technique of circular dichroism will be employed, due to its sensitivity towards protein 
secondary structure. Therefore, the principal aims of this aspect of the project are (i) to 
establish that binding is possible and (ii) to determine whether the protein is denatured upon 
interaction with a dendrimer. 
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2.4 Results and discussion 
2.4.1 Dendritic macromolecules as inhibitors to protein-protein binding interactions 
In order to carry out the aims outlined beforehand, the initial step was the synthesis of a range 
of different generation PAMAM dendrimers. The physical and chemical properties of this 
family of macromolecules are well known and the synthetic procedures behind them are 
recognised, 
55, 56
 making them a viable option for these studies. Figure 26 represents a series 
of acid terminated PAMAM dendrimers to be synthesised and their corresponding 
addressable areas calculated from their diameter squared. The synthetic procedure of half and 
whole generation PAMAM dendrimers consists of two iterative steps; Michael addition and 
amidation. The addition process is required to generate half generation dendrimers with ester 
terminal groups and the amidation step gives rise to whole generation dendrimers with amine 
terminal groups. 
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Figure 26 – Series of acid terminated PAMAM dendrimers and their corresponding maximum addressable areas. 
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In general, Michael addition (scheme 4) involves alpha-beta unsaturated carbonyl 
compounds. The carbonyl substituent has an electron withdrawing effect, generating a delta 
positive charge on the alpha carbon. Due to resonance stabilisation, the beta carbon is 
rendered electropositive and is therefore susceptible to nucleophilic attack. In this reaction, 
the alpha beta unsaturated carbonyl system is methyl acrylate and the NH2 groups on ethylene 
diamine acts as a difunctionalised nucleophile. 
 
 
 
Scheme 4 – Reaction mechanism for the Michael addition step in PAMAM dendrimer 
synthesis. 
 
In the amidation step (scheme 5), the nucleophilic nitrogen from ethylene diamine attacks the 
electropositive carbonyl carbon of the methoxy group. 
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Scheme 5 –Reaction mechanism for the amidation step of PAMAM dendrimer synthesis. 
 
2.4.2 Synthesis of PAMAM dendrimers  
2.4.2.1 Synthesis of PAMAM dendrimers with ether terminal functionality 
In order to synthesise half generation dendrimers possessing ester terminal substituents, 
ethylene diamine was dissolved in methanol and an excess of methyl acrylate was added drop 
wise. For instance, with generation -0.5 (PAMAM dendrimer possessing four terminal ester 
groups) five molar equivalents of methyl acrylate was added to ethylene diamine and left to 
react at room temperature over a period of 24 hours to ensure the reaction reached 
completion. Excess methyl acrylate was removed via rotary evaporation and, to ensure 
complete eradication, the product was monitored by 
1
HNMR. The solution altered from a 
colourless solution to viscous yellow oil after purification and isolation. As the generation of 
dendrimer increases, the viscosity of the product also increases. 
 
2.4.2.2 Synthesis of PAMAM dendrimers with amine terminal functionality 
With the amidation stage, a large excess of ethylene diamine is required. If the amine in 
question is not added in excess, defects will arise within the structure of the dendrimer. This 
will then result in the loss of molecular uniformity and monodispersity of the dendrimer. 
With the case of generation 0 (4 terminal amine groups), 0.017 moles of the ester terminated 
G-0.5 PAMAM dendrimer was reacted with 0.82 moles of ethylene diamine, which equated 
to 48 molar equivalents. The reaction time required for the amidation step varied with respect 
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to dendrimer generation. Longer reaction times were required for larger dendrimers due to the 
increase in terminal groups. G0 required a reaction of time of 5 days to reach completion 
while G1 and G2 required a reaction time of 7 days. 
 
2.4.2.3 Characterisation 
To ensure purity of product, a variety of characterisation techniques were implemented. The 
techniques employed were 
1
HNMR and 
13
CNMR spectroscopy, mass spectrometry and IR 
spectroscopy. Figure 27 represents the proton NMR spectrum of G-0.5. It shows the methoxy 
peak at 3.68 (a signal characteristic to each ester terminated dendrimer). As the generation 
increases, the integral of this signal increases accordingly, due to the augmentation in 
methoxy groups. There are two triplets which can be seen at 2.48ppm and 2.78ppm, which 
correspond to the two methylene proton environments present. The methylene protons 
neighbouring the ester functional group will be more shielded in comparison to their 
neighbours, accounting for the difference in chemical shift. Finally, the singlet at 2.54ppm is 
indicative of the core protons of ethylene diamine. The 
1
HNMR spectrum of G-0.5 is 
relatively clear-cut giving sharp signals. However, as the generation increases, many proton 
environments become comparable. This leads to considerable overlap, not to mention 
broadened triplets and multiplets. Although the spectra produced for larger generations is not 
quite as straight forward in comparison to smaller generations, classification can still be 
achieved with a sufficient level of accuracy.  
 
Owing to their molecular uniformity and monodispersity, dendrimers have exact molar 
masses, meaning that mass spectrometry is an invaluable tool in dendrimer characterisation. 
From the results acquired, each whole and half generation displayed a molecular ion peak in 
the position corresponding to the exact molecular weight predetermined from ideal structures, 
consequently providing confidence in the synthetic procedure employed. IR data provided 
additional information, confirming correct functional groups inherent to both whole and half 
generation dendrimers. Although not an appropriate tool alone for characterisation, it is 
useful when combined with other techniques. 
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Figure 27 – Figure to show the 1HNMR spectrum of a G-0.5 PAMAM dendrimer with an 
ethylene diamine core. 
 
2.4.2.4 Purification 
The purification of each generation is a crucial stage in the synthetic procedure. If 
purification is not thorough, the outcome will be unwanted by-products and defects within the 
dendrimer architecture.  Excess methyl acrylate in each Michael addition was easy to remove, 
owing to the high volatility of the compound. As a result, rotary evaporation was sufficient in 
the eradication of excess methyl acrylate present, meaning that each half generation PAMAM 
dendrimer could be purified without complications. Purification is essential after each 
amidation step as major problems arise if ethylene diamine is not totally removed. Excess 
ethylene diamine can behave as a new initiator centre, meaning a new dendrimer will also be 
synthesised. In addition, structural flaws and undesired by-products can also occur.  Ethylene 
diamine is difficult to remove as it is able to form strong hydrogen bonds between the internal 
amide of the dendrimer and the peripheral amine groups. Both 
1
HNMR and
 13
CNMR can be 
utilised to verify the efficacy of purification. If ethylene diamine is present, a signal will be 
seen at 45 ppm in the 
13
CNMR spectrum and 2.65 ppm in the 
1
1HNMR spectrum, indicating 
purification is incomplete.  
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In order to completely eliminate ethylene diamine, the product must be washed repeatedly 
with an azeotropic mixture of toluene and methanol in a 9:1 ratio. The solvent is then 
removed by rotary evaporation. Due to the strong hydrogen bonds formed between ethylene 
diamine and the dendrimer, something must be incorporated which competes for the 
hydrogen bonding sites. Methanol is able to compete; however, it has a lower boiling point 
than EDA. Therefore, upon evaporation, the concentration will diminish, meaning ethylene 
diamine will occupy the newly available sites. By using an azeotropic mixture of toluene and 
methanol, the overall boiling point increases, thereby facilitating the removal of ethylene 
diamine. 
 
An alternative method to the use of an azeotropic mixture of methanol and toluene is by 
washing with butanol. This method is more appropriate for higher whole generation 
dendrimers, owing to its ability to compete for hydrogen bonding sites. A hindrance to this is 
the difficulty in the removal of butanol from the product, as it has a very high boiling point of 
11 -11  C. As a result, it is extremely difficult to fully remove.  
  
2.4.3 Hydrolysis of half generation PAMAM dendrimers 
2.4.3.1 Hydrolysis of half generation PAMAM dendrimers in water 
In order to bind to a protein which has positively charged areas around the periphery, each 
half generation dendrimer requires hydrolysing. Hydrolysis allows the conversion of ester 
groups to negatively charged carboxylic acid groups. An ester, when exposed to excess water, 
can hydrolyse without the formation of any unwanted side products. This reaction is 
extremely slow and rarely used for small aliphatic and aromatic compounds. Within the 
group, we have noticed that ester terminated dendrimers are not stable over time and appear 
to hydrolyse very quickly. It can be postulated that a different hydrolysis mechanism may be 
observed for dendrimers compared to aliphatic and aromatic compounds. We thought that 
dendrimer hydrolysis may occur by an autocatalytic reaction, where the rate of hydrolysis 
appeared to be faster for larger dendrimers (due to tighter more dense structures). It is 
probably no accident that ester terminated dendrimers are not commercially available. 
Therefore, adding ester terminated dendrimers to water may be the simplest way of obtaining 
the desired carboxylic acid terminated dendrimers, without any by-products (after freeze-
drying). To test this theory, a series of ester terminated dendrimers (G-0.5 to G3.5) were 
dissolved in deuterium oxide in an NMR tube. The 
1
HNMR spectrum for each generation 
was recorded at time intervals, and the depletion of the methoxy signal was recorded. Figure 
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28 provides a graphical representation of the hydrolysis of G3.5 PAMAM dendrimer. As this 
is the largest dendrimer involved in the study, it was predicted to hydrolyse the fastest. The 
graph below shows that after 156 hours the dendrimer is only 28% hydrolysed. The time 
required for hydrolysis to reach completion is extensive and thus inappropriate for synthetic 
use. As a result, a different synthetic approach is utilised for successful hydrolysis of ester 
terminated dendrimers. 
 
  
Figure 28 – Graphical representation of hydrolysis of G3.5 PAMAM dendrimer, possessing 
64 terminal ester groups, in deuterium oxide. The data shows that hydrolysis is 28% complete 
after 156 hours. 
 
2.4.3.2 Hydrolysis of half generation PAMAM dendrimers using sodium hydroxide and 
ammonium chloride  
Each ester terminated PAMAM dendrimer was hydrolysed (scheme 6) in a basic solution 
followed by neutralisation with ammonium chloride. Hydrolysis was achieved by adding two 
equivalents of sodium hydroxide to a solution of each half generation dendrimer in a solution 
of methanol and water in the ratio 4:1. Ammonium chloride is able to react with sodium 
hydroxide, generating ammonia, sodium chloride and water. Ammonia gas is expelled in the 
process and the other by-products do not interfere, meaning no further purification is 
required. 
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Scheme 6- Hydrolysis of a G-0.5 PAMAM dendrimer and equation, showing the role of 
ammonium chloride. 
 
2.4.4 Assay of the binding activity of PAMAM dendrimers to Proteins 
2.4.4.1 Chymotrypsin and Cytochrome-c 
In this project, the two proteins studied were cytochrome c and chymotrypsin. Both proteins 
have been well documented and the chemistry of each, along with both the chemical and 
physical properties, has been reported in the literature.
34,57-68
 
 
Cytochrome-c (figure 29) is a small heme protein involved in the mitochondrial 
transportation of electrons of the respiratory system, with an interfacial area of approximately 
1100Å
2
. It transports electrons in an assortment of electron transport chains in eukaryotes and 
prokaryotes via collision reliant processes.
63
 The heme moiety is linked covalently to the 
protein via thioether groups and the iron present functions as either an electron donor or an 
electron acceptor by interchanging between the ferrous and ferric oxidation states (Fe
2+ 
and 
Fe
3+
). The changeability between these two states is facilitated by coupling between the heme 
iron electronic orbital and the porphyrin π system.66 The heme edge, which is exposed, is 
bordered by lysine, arginine and numerous other hydrophobic residues, creating an overall 
positively charged domain. This surface is regarded as the site for electron transfer to and 
from the heme moiety, meaning it is the area which interacts with a complementary protein 
partner. The corresponding protein partner will therefore possess anionic domains, allowing 
interaction to take place.
65
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Figure 29 – Figure to show the ribbon structure of human cytochrome-c with heme moiety 
(PDB ID: 3NWV). 
 
Chymotrypsin (figure 30) is arguably one of the most studied and characterised proteins and 
has an interfacial area of approximately 2400Å. The entrance to the active site of the protein 
lies within this area. It is a member of the serine protease protein family, which collectively 
play crucial roles in medicinal chemistry, deeming them an appealing target for protein 
surface recognition. Not to mention, there is also a large family of natural protein inhibitors 
which have been known to bind to the peripheral regions and the active sites of a variety of 
serine proteases. The peripheral surface of α-Chymotrypsin possesses both lysine and 
arginine residues and is therefore essentially cationic, meaning that a complementary binding 
partner would contain anionic residues.
34, 57
 Chymotrypsin is an important biological catalyst; 
it is a digestive enzyme which carries out proteolysis (the digestion of proteins).
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Chymotrypsin comprises of a polypeptide chain of 245 amino acids. The biological role of 
chymotrypsin is to catalyse the hydrolysis of peptide bonds in proteins and polypeptides.  
Chymotrypsin has a high specificity; the carboxylic side of an amino acid, bearing aromatic 
side groups such as tyrosine, tryptophan and phenylalanine, are primarily targeted. The 
common feature of the aromatic ring in the side chain accounts for the substrate specificity.
69
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Figure 30 – Figure to show the ribbon structure of native bovine α-chymotrypsin (PDB ID: 
1YPH) 
 
2.4.4.2 Assay of the use of PAMAM dendrimers as potential inhibitors of α-
Chymotrypsin by UV spectroscopy 
Other members of the group have obtained initial results based on the size selectivity of these 
dendritic systems. However, work cannot progress until it has been established that when a 
dendrimer interacts, it binds to the active site entrance and does not denature the protein. 
Firstly, an investigation into the inhibition of chymotrypsin by a PAMAM dendrimer of 
comparable addressable area will be carried out. It is important to establish that they bind and 
that the concentration employed allows sufficient interaction between protein and dendrimer. 
This will ensure that the concentration is correct for subsequent CD studies. 
 
As previously mentioned, α-Chymotrypsin is a member of the serine protease family and its 
role is to catalyse hydrolysis of peptide bonds. It also exhibits a preference for large 
hydrophobic side chains belonging to aromatic amino acids, with cleavage predominantly 
occurring at the carboxyl end of the aromatic side group. In this section of the project, the 
catalytic efficacy of α-chymotrypsin can be kinetically examined by the hydrolysis of N-
benzoyltyrosine-p-nitroanilide (BTNA), as the resulting product of hydrolysis is a UV active 
species (scheme 7). There is a colour change associated with this reaction. Upon generation 
of p-nitroaniline, the initial colourless solution becomes yellow in colour. Therefore, this 
reaction can be used to demonstrate whether or not PAMAM dendrimers are able to inhibit 
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the rate of hydrolysis catalysed by Chymotrypsin. The dendrimer which binds best to the 
protein in question will therefore be the superlative inhibitor for that particular protein, 
meaning that relative binding and efficacy of inhibition can be directly linked to one another. 
 
 
 
Scheme 7– Hydrolysis of N-benzoyltyrosine-p-nitroanilide (BTNA) by α-Chymotrypsin, 
generating UV active p-nitroaniline. 
 
Prior to these studies, it is important to ensure that a reduced rate in hydrolysis is brought 
about by protein inhibition, and not interaction between the dendrimer and BTNA substrate 
(30). Therefore, a control reaction in the absence of chymotrypsin is required. If the 
dendrimer can coordinate to BTNA, a slower rate of hydrolysis would be observed. This 
would be due to a lower concentration of BTNA available for digestion by chymotrypsin, 
meaning a lower concentration of p-nitroaniline would be generated. To verify whether this 
interaction occurs, a UV cuvette was charged with dendrimer/buffer solution and BTNA 
substrate (in methanol), and identical conditions to protein catalysed hydrolysis, mentioned 
beforehand, were used. After 20 minutes the cuvette was removed and a colourless solution 
with a white precipitate was observed. The precipitate formed resulted in scatter within the 
spectrum. The precipitate formed is, in fact, BTNA precipitating out of solution, due to its 
insolubility in water. The result of this control reaction confirms that the dendrimer does not 
interact with the substrate, meaning inhibition observed is a result of interaction between the 
protein and the dendrimer. 
 
The hydrolysis reaction can be monitored by UV spectroscopy by measuring the rate of 
production of the UV active species p-nitroaniline. Firstly, a control experiment was 
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performed (figure 31), by which a solution of the BTNA substrate in methanol was added to 
an aqueous solution of α-chymotrypsin (final concentrations were 1x10-4M and 1x10-6M 
respectively) at room temperature. From this experiment, it was possible to visualise when 
the hydrolysis reaction terminated and no further production of p-nitroaniline occurred. 
 
 
Figure 31 - A graph to show the hydrolysis of N-benzoyltyrosine-p-nitroanilide catalysed by 
α-Chymotrypsin producing UV active p-nitroaniline. 
 
 Previous work within the group has demonstrated that there is a size selective based 
mechanism involved in the inhibition of protein-protein binding.
50,70
 Results showed that 
G2.5 bound the best as it has a comparable interfacial area to α-chymotrypsin. Therefore, 
G2.5 PAMAM dendrimer baring 32 terminal carboxylic acid groups was used. A time scan 
experiment was set up to record the UV absorption at 410 nm (the UV absorption wavelength 
for p-nitroaniline) at 10 second intervals for a period of 600 seconds after the addition of 
BTNA, α-chymotrypsin and one equivalent of G2.5 PAMAM dendrimer (figure 32). The 
experiment was carried out in a neutral phosphate buffer solution of concentration 0.1M and 
pH 7.4. The pH of the mixture was checked and exhibited no change after each run. 
Therefore, this ensures that any change in enzyme activity was not a conformational change 
induced by an alteration in pH. As previously stated, chymotrypsin displays a preference for 
large hydrophobic aromatic side chains. As a PAMAM dendrimer does not possess these, it 
will not compete for the protein active site entrance, meaning that the inhibition mechanism 
could possibly arise from hydrogen bonds or electrostatic interactions between the negatively 
charged peripheral carboxylic acid groups and the cationic residues present on the exterior 
surface of the enzyme. This mechanism would impede the BTNA substrate reaching the 
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active site, or potentially alter the conformation of chymotrypsin, which would also inhibit 
catalysis.
 
 
 
Figure 32 – A graph to show the relationship between the intensity of UV absorption 
concentration of the catalysed hydrolysis of BTNA by α-Chymotrypsin in the (i) absence and 
(ii) presence of a G2.5PAMAM dendrimer. 
 
For the control reaction, where no dendrimer is present during hydrolysis, a conventional 
reaction profile was noted and an initial reaction rate of 3.23x10
-8
Ms
-1
 was observed. The 
reaction was then repeated in the presence of an equimolar amount of G2.5 PAMAM 
dendrimer and chymotrypsin. From observing the reaction profiles of both experiments, the 
initial rate was lower when compared to the control reaction, giving a result of 9.46x10
-9 
Ms
-
1
. The results obtained indicate that, at 1x10
-6 
M, 70% is bound. If at this concentration 70% 
binding takes place, then at 5x10
-6 
M 100% interaction would be expected. As G2.5 PAMAM 
dendrimer has a comparable interfacial area to chymotrypsin (2250 Å and 2400 Å 
respectively), it can be assumed that this dendrimer can fit the interfacial area of the protein, 
thereby exposing all of the anionic carboxylic acid peripheral groups to the cationic exterior 
of the enzyme, and bind effectively. These results confirm that dendrimers can function as 
potent inhibitors; however, it has not been ascertained whether or not the dendrimer is 
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interacting with the protein, and subsequently altering the structure, which would render the 
target protein denatured.  
 
2.4.5 Effect of binding upon protein structure and stability 
There are numerous theories which could explain the outcome of the previous results. Firstly, 
the ideal situation could occur and the dendrimer could bind to the hotspot region of the 
protein. This would block the active site, but retain the structure of the protein. There is also 
the possibility that binding causes the enzyme to change shape, so as to maximise binding. As 
a result, the protein would denature, thereby losing its function. Finally, the dendrimer could 
bind to an alternative site on the protein surface. The occurrence of this could result in a 
protein altering its shape to accommodate the dendritic ligand. Change in shape could cause 
denaturation. Each one of these options is a plausible mechanism for the inhibition of enzyme 
activity reported in the earlier section. Figure 33 is a schematic representation of these 
contrasting binding mechanisms. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33 - Schematic representation of the probable binding mechanisms which could 
account for inhibition of enzyme function: a) a hotspot mechanism where the dendrimer 
interacts with the enzyme hotspot, blocking the active site whilst retaining the enzyme 
structure b) a hotspot mechanism where the enzyme distorts in structure to maximise 
interaction, thereby, causing denaturation c) an interaction mechanism where the dendrimer 
binds to an alternative site on the enzyme triggering a structural change which renders the 
enzyme inactive.
1
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2.4.5.1 Circular Dichroism (CD) spectroscopy 
In order to carry out the next part of this research an analytical technique known as circular 
dichroism (CD) spectroscopy will be employed. The area of structural biology has evolved 
enormously from as early as the late 19 0’s; with the protein data bank increasing in volume 
with more than 2000 high resolution protein structures being added annually. A tool with the 
ability to investigate protein structures and to measure the rate of alterations to protein 
structure would be of vital importance. Subsequently, CD spectroscopy has become a reliable 
and valued technique for examination and analysis of protein secondary structure. It can be 
viewed as a version of light absorption spectroscopy which involves plane polarised light. 
Circularly plane polarised light can be seen as being composed of two polarised components, 
each of matching magnitude; and circular dichroism is the disparity in absorption between 
these two components. The phenomenon of CD is highly sensitive to polypeptide and protein 
secondary structure. Therefore, it is important to take special care in experimental design and 
instrument calibration, due to the sensitivity of this technique.
71
 For additional information 
about the intricacies of this technique and its involvement in protein structural determination 
the reader is directed to the literature. 
  
2.4.5.2 Effect of binding upon protein structure 
In order to calculate the probability or degree of denaturation, circular dichroism 
spectroscopy was utilised. By comparing the structure of the protein/dendrimer complex with 
that of the native protein it will be possible to ascertain any structural changes. CD spectra of 
each protein, in the presence and absence of a variety of different generation of dendrimers 
(G0.5, 1.5, 2.5 and 3.5), was carried out. The studies were performed initially by using 1x10
-
6
M of dendrimer for both cytochrome-c and chymotrypsin. Solutions of both proteins were 
made up with each generation of dendrimer in order that the final concentrations were 
initially 1x10
-6 
M of protein and 1x10
-6 
M of each dendrimer. As a control and base line 
experiment, solutions of cytochrome-c and chymotrypsin were made up with pH7.4 
phosphate buffer of final concentration 1x10
-6
M and a CD spectrum for each protein was 
generated. All experiments were carried out in phosphate buffer (concentration 0.1 M, pH7.4) 
at 37 C (physiological temperature). Figure 34 displays the spectra of both chymotrypsin 
and cytochrome-c and the spectra corresponding to the protein/dendrimer complexes. The 
experiments were repeated where the dendrimer concentration was 5x10
-6 
M and the results 
produced were identical for each dendrimer. Future work will involve the calculation of the 
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percentage inhibition for the other generations of dendrimer to determine whether sufficient 
binding will occur at the given concentration 1x10
-6 
M. 
    (a)                      
          
 
(b)                             
 
Figure 34 – Figure to show the CD Spectra of native (a) Cytochrome-c and (b) 
Chymotrypsin and when bound to different generations of PAMAM dendrimers of 
concentration 1x10
-6
M (results at 5x10
-6
M produced results which were superimposable). 
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The spectra are the same before and after complexation with a dendrimer, confirming that 
binding does not result in conformational change to the native protein. If there was a variation 
in the structure of the proteins upon complexation then, as a result of the high sensitivity of 
this analytical technique, the spectra obtained would have displayed a notable change. From 
the results, there is little or no change in the protein structure when bound to the dendrimer 
compared to its native state, suggesting that there is slight or no change in conformation upon 
binding and inhibition. This could possibly be a result of the sufficient flexibility exhibited by 
the macromolecule. When a protein binds, it changes shape to maximise binding where the 
loss of structure is compensated by energy gain. The flexibility of the dendritic ligand means 
that it can change its shape with minimal loss in energy, meaning diminutive to no 
conformational change to the protein is required to maximise interaction. This can be referred 
to as the induced fit mechanism. Therefore, this provides confidence in the fact that, upon 
complexation, the proteins studied do not denature.  
 
2.4.6 Effect of binding upon protein stability 
A protein usually denatures under high temperatures or in the presence of a high 
concentration of a denaturant. Hamilton and co-workers focussed much of their research on 
molecules which are able to interact with protein peripheries by electrostatic or hydrophobic 
interactions over a large area of the protein in question. Some of their work involved the 
interaction of tetraphenyl porphyrin derivatives with the surface of Cytochrome-C which 
demonstrated strong binding.
38
 This group of substituted porphyrin derivatives were not only 
found to bind effectively to the surface of Cytochrome-C, but were also discovered to induce 
unfolding of Cytochrome-C under conditions bordering physiological (pH of 7.4 and 50mM 
NaCl).
39 
Hamilton et al. also carried out thermal denaturation research which established that 
Cytochrome-C, in the presence of two equivalents of a metalloporphyrin dimer that contained 
Cu(II), was nearly completely denatured over the entire temperature range.
38
 Work within the 
Hamilton group has therefore illustrated a selection of macromolecules which are able to 
promote denaturation. The results obtained from CD spectroscopy mentioned previously 
showed that different generation PAMAM dendrimers had no effect upon the structure of 
either cytochrome-c or chymotrypsin under physiological conditions, thus suggesting that 
denaturation did not occur upon interaction. 
 
Continuing on from this research, the thermal stability of both cytochrome-c and 
chymotrypsin, upon complexation to a dendrimer, was investigated at raised temperatures. A 
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control experiment for both cytochrome-c and chymotrypsin was essential, where each 
protein was dissolved in a neutral phosphate buffer solution with a final concentration of 
1x10
-6 
M and heated by 1C a minute from an initial temperature of 37 C. A CD spectrum 
for each was subsequently generated so that the point at which both proteins fully unfold 
could be visualised. This process was repeated for each dendrimer (G0.5, 1.5, 2.5 and 3.5) to 
identify whether or not complexation to a dendrimer had an effect on the stability of the 
protein. Each protein/dendrimer complex was made up to identical concentrations as used for 
the previous CD studies. Two solutions for each protein/dendrimer complex were required; 
the first solution comprised of equimolar quantities of both dendrimer and protein (each at 10
-
6
M), and the second comprised of 10
-6 
M of protein and 5x10
-6 
M of dendrimer. The 
dendrimer/protein complexes were subsequently heated up from 37C by 1C a minute and a 
CD spectrum was generated for each, examining the intensity of the peak at 230 nm and 224 
nm for cytochrome-c and chymotrypsin respectively. Figure 35 is a plot depicting the 
percentage of unfolding of chymotrypsin when in its native state and when bound to G2.5  
PAMAM dendrimer.  
 
 
 
Figure 35 –Figure to show the CD spectra of the percentage unfolding in relation to 
temperature of chymotrypsin when in its native state and when bound to a G2.5PAMAM 
dendrimer. 
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As can be seen from the results shown above, the plots for chymotrypsin in the presence and 
absence of a G2.5 PAMAM dendrimer are identical. The results obtained for the other 
generations of dendrimer bound to chymotrypsin were also comparable to the plot of the 
native protein. In the case of cytochrome-c, the results also indicate that denaturation is 
neither induced nor prolonged upon interaction with a dendritic polymer. 
  
There are two possible explanations for the results obtained. Firstly, coordination to a 
dendrimer does not induce or prolong unfolding of the protein, meaning thermal stability is 
unaffected by complexation to a macromolecule of this nature. An alternative explanation of 
the results obtained is that the strength of interaction could potentially be dependent upon 
temperature. This presumption signifies that, above a specific temperature, the dendrimer 
may fully dissociate from the peripheral surface of the protein. This would effectively result 
in the temperature of denaturation remaining the same, thereby generating indistinguishable 
CD spectra. In order to verify which explanation is correct, additional studies are required. To 
determine the temperature which binding stops, future work will involve repeating hydrolysis 
of BTNA substrate by chymotrypsin, complexed to a dendrimer, over a temperature range of 
35 ºC to 45 ºC. This analysis would result in the identification of the point at which binding is 
no longer possible. It is hypothesised that, as the temperature is raised, the difference in rate 
of hydrolysis between the control reaction (in the absence of a dendrimer) and hydrolysis in 
the presence of a dendrimer will decrease as the temperature is raised. The point at which 
unfolding commences will result in the inability of chymotrypsin to digest the substrate. In 
conclusion, the results obtained from circular dichroism spectroscopy provide confidence that 
dendrimer/protein association, under physiological conditions, does not bring about any 
structural changes for cytochrome-c or chymotrypsin. That is to say, neither protein was 
denatured upon complexation. However, the effect upon thermal stability remains unclear 
and further research is required. Further work would include using a much stronger 
concentration of dendrimer to check for weak binding. For instance, at 10
-4 
M, the higher 
concentration of dendrimer would mean more would be bound and it might be possible to 
detect induced denaturation with an increase in temperature. 
 
2.4.7 Direct binding assay of chymotrypsin with fluorescent labelled PAMAM dendrons 
Whilst other members of the group were investigating the use of dendrimers as size selective 
inhibitors to protein-protein interactions, we continued to investigate binding. Specifically, 
we wanted to measure direct binding. This was done using fluorescence spectroscopy in 
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collaboration with Professor Neil Mckeown of Cardiff University. Direct binding between 
cytochrome-c and fluorescent labelled PAMAM dendrons, of varying generation, was 
assessed using the technique of fluorescence titrations. G1.5 and G2.5 fluorescent labelled 
dendrons were provided by Cardiff University and the chemical structure of both dendrons 
are found overleaf in figure 36. 
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Figure 36 – Figure to show the chemical structure of (a) G1.5 and (b) G2.5 fluorescent 
labelled PAMAM dendrons. 
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2.4.7.1 Fluorescence titration assay 
Fluorescence results were obtained using a HORIBA Scientific Fluoromax-4 
spectrofluorometer using its attached software (FluorEssence V3). In order to perform the 
titration experiments, the appropriate concentration of each dendron needed to be established. 
This was achieved by measuring the emission spectrum, of both dendrons, at a variety of 
different concentrations. A concentration of 10
-6 
M, for each dendron, was found to give the 
clearest emission spectrum. G1.5 and G2.5 were each titrated against cytochrome-c (from 
equine heart) and the quenching of the emission spectrum was recorded. Each 10
-6 
M solution 
of the fluorescence labelled dendrimers was prepared using ultra-pure water. A solution 
containing a large excess (5x10
-3 
M) of the guest, cytochrome-c, was then prepared using the 
corresponding dendrimer solution to ensure constant concentration of dendrimer throughout 
the titration. The dendrimer solution was accurately measured (3 mL) into a quartz cuvette 
and aliquots of ligand solution (between 10 μL and 50 μL) were added. Fluorescence 
emission scans were taken after each addition, monitoring the quenching of the emission 
spectrum of the labelled dendrimer (508 nm for each generation). Solutions were made up 
fresh and used immediately after preparation to ensure no damage to the protein. Repeats of 
each titration were performed to ensure accuracy of results. The titration data for each run can 
be found in appendix A of chapter 6.  
 
As mentioned previously, the active site of cytochrome-c contains a porphyrin moiety and 
this is able to quench any appropriate chromophore. Therefore, upon addition of cytochrome-
c, the emission spectrum for each labelled dendron is quenched. Quenching is therefore a 
result of direct interaction. This effect can be visualised in figure 37. 
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Figure 37  – A representative graph to show the titration of fluorescent labelled G1.5 (1x10-
6
M) titrated against cytochrome-c (0.5x10
-2
M). 
 
Binding software 14AllMaster, developed by Professor Chris Hunter from the University of 
Sheffield, was used to deduce the binding constant associated for cytochrome-c and each 
generation of dendron analysed. G1.5 and G2.5 both showed strong interaction, giving 
association constants of 4.2x10
4
 (±2.5%) and 3.2x10
4
 (±2%) respectively. The binding 
software assumes a 1:1 fit and binding can be presumed to be specific. The software gave a 
good fit, which can be seen from the low percentage errors calculated. Results show the 
smaller dendron to bind the strongest, which is not in accordance with initial predictions 
regarding size selectivity. This could be a result of the number of terminal groups able to 
interact with the protein surface. The smaller dendron may be able to use all terminal groups 
in binding, whereas the larger dendron is unable to use all terminal groups. Fewer terminal 
groups able to interact would result in fewer interactions per dendron, giving a lower 
association constant. The binding curves can be seen overleaf in figure 38. 
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Figure 38 – A graph to show the binding curves for G1.5 and G2.5 fluorescent labelled 
dendrons, when quenched with cytochrome-c.  
In addition to an estimate of an association constant, the software program also generates a 
Job plot from the input data. The Job plots obtained from the software program are not in 
accordance with a 1:1 binding stoichiometry as they show a high stoichiometry for each 
dendron, where multiple dendrimers coordinate to a protein. A representative Job plot for 
G1.5 can be seen overleaf in figure 39. It could be that the stoichiometry is high, or the 
software is not providing an accurate representation of binding. The results obtained lead us 
to believe that binding is non-specific. However, future work would include a separate Job 
plot analysis in order to determine whether direct binding is specific or non-specific. 
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Figure 39 – Figure to show the Job plot, generated using 14AllMaster binding software, for 
the titration of G1.5 fluorescent labelled dendron against cytochrome-c. 
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2.5 Future Work 
The next phase of this research will involve the construction of a biological column for 
chromatographic use, where the column resin is doped with the target protein (figure 40), 
such as Chymotrypsin. A mix of a smaller generation dendrimer (i.e. G0.5) and a larger 
generation dendrimer with a comparable addressable area to the interfacial area of the target 
protein (i.e. G3.5 for Chymotrypsin), will be loaded onto the column. A GPC trace of the first 
and final fraction will be ascertained and, theoretically, the lower generation dendrimer will 
be eluted first. As binding to the protein will not be as strong compared to the larger 
generation dendrimer, the smaller dendrimer will not stick as well to the bio-column. 
Therefore, in the case of Chymotrypsin, the first fraction should solely contain G0.5 
PAMAM dendrimer and the final fraction should solely contain G3.5 PAMAM dendrimer. 
This will continue on from work involving the demonstration of a size selective binding 
mechanism for protein-protein binding inhibition. 
 
 
  
Figure 40 – Figure to illustrate the doping of the column resin with the target protein. 
 
As mentioned previously, Bogan and Thorn looked into amino acid preferences within the 
hot spot region. Results showed that hot spots are enriched with three amino acids with a 
frequency higher than 10% (tryptophan, tyrosine and arginine).
5
 These amino acids can be 
considered ‘good’ amino acids as they show a high affinity towards the hot spot area. Those 
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which do not contribute productively to binding can be regarded as ‘bad’ amino acids. 
Therefore, another use for the bio-column is to load it with a series of dendrimers 
functionalised with different amino acids; some possessing a high affinity towards the hot 
spot region and others which do not. In theory, the dendrimer functionalised with ‘good’ 
amino acids will elute last as it will be expected to interact more powerfully with the protein, 
meaning dendrimers functionalised with ‘bad’ amino acids will elute first. 
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Chapter 3 – Anion Receptor Chemistry 
 
3.1 Introduction to anion receptor chemistry 
Anion coordination is a relatively new area in comparison to cation coordination. 
Nevertheless, anion recognition is an area which continues to grow.
1-5
 The first synthetic 
receptor was established by Park and Simmons in 1968. A macrobicyclic receptor, which 
showed an affinity towards halide ions, was developed. This receptor utilised both 
electrostatic and hydrogen bond interactions, retaining a halide ion within the hydrocarbon 
cavity in an aqueous media.
6 
Despite early pioneering work, anion receptor chemistry was 
essentially not investigated in depth until the mid-1970’s.7 
 
The rationale behind the newfound and widespread interest in this particular area is largely 
due to the important roles anions play. Anions are ubiquitous in numerous biological systems, 
as a huge majority of enzymes, co-factors and substrates are anionic in nature. Adenosine 
triophosphate (ATP) is a tetra ion, Deoxyribonucleic acid (DNA) is an important polyanion 
and another good example is Carboxypeptidase A. The function of Carboxypeptidase A is the 
hydrolysis of the C-terminal amino acids from polypeptide substrates. This enzyme displays a 
preference for substrates having large hydrophobic terminal side chains, such as 
phenylalanine. The mechanism of Carboxypeptidase A is a proteolytic mechanism involving 
the generation of an arginine-aspartate salt bridge.
8
 Binding, involving a salt bridge, can also 
be seen in Ribonucleic acid (RNA) stem-loop structure- protein interactions
9
 and zinc finger 
/DNA complexes.
10
 An example of the crucial role anions play is apparent in maintaining the 
phosphorylation state of proteins, which is critical for a broad range of cellular processes. The 
two families of enzymes responsible are kinases and phosphatases. Alkaline Phosphatase 
(AP), a member of the Phosphatase group, possesses a shallow cationic active site. This 
positive charge enables the binding of anionic phosphate moieties which, in turn, leads to 
activation of the substrate for nucleophilic attack from serine residue.
11
  
 
These are but a few examples portraying the crucial role anions play in numerous diverse 
biological systems. Although the previous examples outline some positive roles which anions 
play, it is also important to note that anions can also have deleterious effects. Anions can take 
a negative role in some diseases. Epilepsy, Myotonia and Cystic fibrosis are all examples of 
diseases that arise from the misregulation of chloride ion flux.
12-15
  Anions can also be 
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potentially threatening to the environment; for instance, nitrate anions, present in fertilisers, 
run off the land and pollute the water supplies which brings about excessive algae production, 
thereby damaging aquatic life.
16
 Therefore, the successful and specific coordination of anions 
has both therapeutic and environmental importance. 
 
The properties of anions produce many challenges when designing a suitable receptor. The 
main attribute of an anion is its negative charge, meaning electrostatic forces can be 
considered when designing a suitable host. Anions are also considerably larger than their 
isoelectronic cations, resulting in a lower charge to radius ratio. As a result, electrostatic 
interactions are considerably less efficient when compared to smaller cations.
1
 In addition to 
this; a receptor must possess a cavity of adequate size for sufficient encapsulation. The 
sensitivity of anions to pH should also be considered; this is due to the fact that anions are 
easily protonated at low pH levels, resulting in the loss of the negative charge. All these 
factors contribute to the rate of solvation of anions, thereby stressing their importance. 
Solvents can also affect the potency and selectivity of binding. For instance, polar protic 
solvents can form hydrogen bonds with an anionic species, thus meaning that there is added 
competition for the synthetic receptor to overcome. Anions can also display an assortment of 
geometries, presenting yet another challenge in receptor design as the cavity must correspond 
to the geometric structure of the anion.  The variety of geometries which anions can adopt, 
along with numerous examples, can be visualised overleaf in figure 41. 
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Figure 41– Figure to illustrate the variety of geometries which anions can adopt. 
 
The area of anion receptor chemistry has generated a large level of interest within the field of 
supramolecular chemistry, which is attributable to the potential applications in the fields of 
medicine
17-19
, the environment
20
 and numerous chemical processes. This has led to the the 
fabrication of a wide array of synthetic receptors. There is a range of non-covalent 
interactions which can be utilised when designing a host. Firstly, given the nature of the 
charge of an anion, electrostatic interactions can be employed. These attractive forces can be 
in the form of ion pairing, ion-dipoles or dipole-dipoles. Any anion can be considered as an 
electron pair donor meaning interaction with an electron pair acceptor is a certainty. The most 
basic existing electron pair acceptor is an electropositive hydrogen atom which results in the 
formation of a hydrogen bond upon interaction with an electron pair donor. Hydrogen 
bonding is widely used in a variety of organic frameworks. They are naturally occurring in 
numerous biological systems, such as DNA base pairs and a wide variety of proteins. Despite 
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being weaker than electrostatic forces, they are directional, which is one reason they feature 
in a large number of synthetic receptors. In addition to these forces, hydrophobicity, π-π 
stacking interactions and Van der Waals forces can also be utilised to maximise affinity 
towards a guest molecule. 
 
3.1.1 Ammonium and Guanidinium based receptors 
As stated beforehand, electrostatic interactions are high in strength, making them an attractive 
option for synthetic supramolecular systems. The elementary synthetic methods by Park and 
Simmons, for the development of anion receptors, utilised the ammonium motif.
6 
Protonated 
amines possess both electrostatic interactions and hydrogen bonds, which is the main 
rationale for the use of this group in synthetic receptors. Lehn et al. focussed initial research 
on the ammonium group and reported the fabrication of cryptand receptor systems which 
incorporated this motif. Upon protonation, complex formation with halide ions was 
accomplished, with a particularly high affinity towards chloride.
21
 Lehn et al. then went on to 
synthesise a protonated cryptand which, unlike previous studies, was shape selective and 
demonstrated a high affinity towards the linear azide ion in aqueous media. The linear 
triatomic anion is retained within the cavity by two pyramidal arrangements of three ‘+N-
H
…
N
-’ hydrogen bonds, holding the terminal nitrogen sites in place.22 Based on the early 
studies which demonstrate the ability of the ammonium group to coordinate anionic species, 
research has continued to grow with regards to this binding motif. 
 
Felix et al.
23
 have focussed research on polyammonium macrocyclic receptors. In 2007, the 
synthesis of a receptor system, 35,  which includes two phenanthroline units, was reported.
24
 
This macrocyclic structure is illustrated overleaf in figure 42. 
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Figure 42– Figure to show a macrocyclic receptor which incorporates two phenanthroline 
units.
24 
This Macrocyclic system selectively bound 1,3,5 benzene tricarboxylate (the anionic 
form of  trimesic acid) and pyrene carboxylate. These anionic species were bound from a 
mixture containing a wide array of different carboxylate substrates. 
 
More recently, Burns et al. have developed a family of bis-ammonium receptors to function 
as potential cationic peptide mimics. These receptor systems have been based on a scaffold, 
comprising of two bis linked phenol rings. Studies have demonstrated that a receptor, which 
contains preorganised ammonium groups, can coordinate to both dihydrogen phosphate and 
phosphatidyglycerol (PG). The synthetic procedure for the initial receptor salts fabricated can 
be seen overleaf in scheme 8.
25
 This research illustrates the potential of receptors of this 
nature in the area of antimicrobial therapeutics. 
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Scheme 8 – Representation of the preparation of initial receptor salts: Reagents and 
conditions (a) Br(CH2)zBr, 18-crown-6, K2CO3, THF; (b) (CH2)6N4, TFA, reflux; (c) (i) 
H2N(CH2)xNH2, EtOH, reflux, (ii) triethylsilane, Pd-C, MeOH; (d) HCL/MeOH then 
NH4PF6, CH2Cl2, H2O. Adapted with permission from [Koralegedara, M. B.; Aw, H. W.; 
Burns, D. H. J. Org. Chem. 2011, 76, 1930]. Copyright 2011 American Chemical Society. 
 
Another cationic motif that has received a great deal of attention is the guanidinium ion. This 
binding motif plays an important role in nature; namely in the identification of anionic 
substrates by enzymes and anti-bodies.
26
 The guanidinium cation is the conjugate acid of 
guanidine and has a pKa of 13.5
26
, meaning it remains protonated over a larger pH range than 
the ammonium motif.
3
 In addition, It is also capable of forming several zwitterionic hydrogen 
bonds.
26
 It is the combination of these characteristics which deem the guanidinium cation a 
suitable site for anion recognition. Preliminary work with this cationic species was carried out 
by Lehn et al.
26
 Studies showed the development of a series of guanidinium based 
macrocycles 36 to 38 (figure 43). These receptor systems illustrated the promise of this 
binding motif, showing selectivity of complexation for phosphate, dihydrogen phosphate and 
triphosphate. 
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Figure 43  – Figure to show the chemical structures for a series of cationic guanidinium 
macrocycles developed by Lehn et al.
26
 
 
One function of the guanidinium moiety has been the coordination of oxo-anions. Pioneering 
work by Schmuck et al. has involved the development of guanidinicarbonylpyrroles, based 
upon the role of the guanidinium cation in nature. For instance, specific non-covalent binding 
can be seen with lactate digestion by lactate dehydrogenase and base pairing within nucleic 
acids. Guanidinicarbonylpyrrole receptors showed a significant improvement on the binding 
affinity of the guanidinium cation itself as it contains additional hydrogen bond donors within 
the binding site.
27
 Schmuck and co-workers continued work in this particular area and 
developed novel receptors (39 to 43), which comprise of an ammonium cation connected to a 
guanidinicarbonylpyrrole motif by linkers of differing length.
28
 Receptors 39  to  43 are 
illustrated overleaf in figure 44. 
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Figure 44 – Figure to show the chemical structures of anionic receptors that comprise of an 
ammonium cation connected to a guanidinicarbonylpyrrole motif by linkers of differing 
length.
28
 
 
For more information, regarding recent studies involving guanidinium based anion receptors, 
the reader is directed to the following literature by Schmuck et al.
29
 This work examines 
nucleotide recognition in water using guanidinium based receptors. As this section reveals, 
cationic moieties, incorporated within both acyclic and Macrocyclic receptors, has shown 
promising results and utilised both electrostatic and hydrogen bonding, accounting for strong 
affinities in binding. In addition to ammonium and guanidinium based receptors; 
pyridinium
30-33
, imidazole
34, 35
 and triazole
12,36-38
 based receptors have also utilised both 
hydrogen bonds and electrostatic interactions which have recently been explored. However, it 
is important to note that the pH dependence of charged receptors can restrict their use; 
therefore, neutral anionic receptors, which utilise hydrogen bonding, π-π stacking interactions 
and Van der Waals forces, have received a great deal of interest. 
 
3.1.2 Neutral anion receptor systems 
Owing to the drawbacks of charged host molecules, neutral molecules have featured heavily 
in anion receptor chemistry. A large majority of synthetic hosts incorporate a functional 
group which can coordinate an anionic guest using hydrogen bonds. Some examples of 
functional groups which feature in a vast majority of neutral receptors can be seen in figure 
45. Multiple hydrogen bond motifs can be included within a supramolecular receptor system, 
which is one advantage to this type of interaction. Furthermore, a hydrogen bond is 
directional, which results in the feasibility of designing shape specific anion receptors. Shape 
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specificity allows the distinction between anions of contrasting geometry and certain 
hydrogen bonding conditions in a non-polar solvent.
1
 Therefore; it is evident why hydrogen 
bonding is a dominant non-covalent interaction within the area of anion recognition. 
 
 
 
Figure 45  – Figure to illustrate the common hydrogen bond donor groups and their anion 
binding motif that are frequently used in synthetic neutral anion receptors. 
 
The main objective of this chapter is to supply the reader with the necessary information 
required to grasp the subjects’ specific concepts, which will be employed in this area of 
research. This chapter will look at selected hydrogen bond donor groups that can be found in 
synthetic neutral anion receptors. Therefore, it is not an extensive account and, for this, the 
reader is directed to a number of recommended reviews in the literature.
3-5
 
 
3.1.2.1 Amide based receptors 
Amide NH groups have been utilised as hydrogen bond donor groups to generate a wide 
array of anion binding receptors. One of the first synthetic amide anion binding receptors was 
discovered by Pascal et al.
39
 X-ray data of the sulphate binding protein salmonella 
typhimurium shows that sulphate is held via seven hydrogen bonds, five of which involve 
amide NH protons from the polypeptide backbone. This led to the synthesis of a synthetic 
organic macrocycle possessing seven inwardly-facing amide protons to encapsulate an 
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inorganic anionic species sufficiently. The macrocycle synthesised, 44, was given the name 2, 
15, 28-trioxo-3, 16, 29-triaza-6, 19, 32-trithial [7.7.7] (1, 3, 5- cyclophane) (figure 46).  
 
 
Figure 46 -  Figure to show the chemical structure of 2, 15, 28-trioxo-3, 16, 29-triaza-6, 19, 
32-trithial [7.7.7] (1, 3, 5- cyclophane)
39
 
 
In 2007, Lin et al.
40
 reported the synthesis of a tetraamide Macrocyclic receptor 45 (figure 
47). UV/Vis and 
1
HNMR titration studies showed a high selectivity towards fluoride from a 
mixture of fluoride, chloride, bromide, acetate and dihydrogen phosphate ions. The affinity 
towards fluoride is thought to be a result of size complementarity between the guest and the 
cavity. In addition, upon interaction between the receptor and fluoride, a visible colour 
change was observed, attributable to hydrogen bond formation. This could result in the 
potential use of said macrocycle as a colourimetric sensor. 
 
 
 
Figure 47 – Figure to show the chemical structure of the Macrocyclic tetraamide (3’-
nitrobenzo)[2,3-d]-(3’’-nitrobenzo)[9,10-d]-1,4,8,11-tetraazacyclotetradecane-5,7,12,14-
tetraone.
40 
 
The use of amide bonds within a furyl-cyclopeptide receptor has been demonstrated by 
Robina and co-workers.
41
 From a combination of ESI-MS and 
1
HNMR titration studies, the 
cyclopeptide receptor fabricated (figure 48) formed 1:1 complexes with chloride, acetate and 
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cyanide anions, with a particularly high binding affinity towards chloride. Kubick et al.
42
 
have also researched the anion recognition properties of cyclopeptide based cage receptors. 
 
 
Figure 48 – Figure to show the chemical structure of C3-symmetric furyl-cyclopeptide 
receptor developed by Robina et al.
41
 
 
3.1.2.2 Isophthalamide based receptors 
As illustrated in figure 45, the isophthalamide unit can be used to coordinate an anionic 
guest. It has two amide NH groups which can assemble in a ‘cleft-like’ structure, thus 
creating a cavity to coordinate an anionic species. In 1996, the initial use of this particular 
functional group was reported by Kim et al. An anion templated macrocycle (scheme 9), 
incorporating isophthalamide groups, was documented.
43
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Scheme 9 – Synthetic procedure of  an anion templated macrocycle developed by Kim et al. 
Adapted with permission from [Kim, Y. H.; Calabrese, J.; McEwen, C. J. Am. Chem. Soc. 
1996, 118, 1545]. Copyright 1996 American Chemical Society. 
 
Following this, numerous research was carried out involving this hydrogen bonding 
moiety.
44-46
 The simplicity of synthesis in conjunction with a high affinity towards anionic 
species has triggered interest regarding this particular functional group.  
 
In 2007, Gale et al. synthesised a range of receptors which incorporate the isophthalamide 
skeleton (figure 49). With receptor 51, the inclusion of hydroxyl functional groups result in 
the formation of intramolecular hydrogen bonds, thus stabilising the syn-syn confirmation. 
The intramolecular hydrogen bonds not only make this receptor effective at anion 
coordination, but also competent in transportation of chloride.
19
 However, Receptor 52 did 
not bind significantly to anionic guests.  
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Figure 49 – Figure to show a series of isophthalamide based anion receptors for 
transmembrane chloride transport.
19
 
 
In 2009, Bernier and co-workers
47
 reported the synthesis of a Macrobicyclic anion receptor 
53  that comprised of a tetraoxadiaza macrocycle, accommodating both a dibenzofuran spacer 
and an isophthalamide head unit. The chemical structure can be seen below in figure 50. 
 
 
Figure 50– Figure to show the macrobicyclic anion receptor developed by Bernier et al. 
based on an isophthalamide head unit and tetraoxadiaza macrocycle.
47
 
 
The macrocycle was able to remove halide salts from aqueous solutions in organic media. 
The capability to bind halides was monitored by 
1
HNMR titrations in deuterated chloroform, 
deuterated dimethyl sulphoxide and acidified deuterium oxide. The highest association 
constant was observed for chloride with the protonated macrocycle. The results from these 
studies show the potential of receptors of this nature in the area of chloride transport. 
 
The isophthalamide group has continued to receive a high level of interest in the area of 
supramolecular chemistry, not just in the area of anion coordination but also in the area of 
ion-pair recognition. Beer et al.
48
 have developed a heteroditopic calix[4]diquinone triazole 
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receptor, which contains an isophthalamide cavity (figure 51). From analysis by UV/Vis and 
1
HNMR, a monovalent cation-anion pair cooperatively binds in a polar solvent mixture of 2% 
water/acetonitrile. Studies have shown that cation interaction by the triazole nitrogen donor 
groups and the calix [4] diquinone oxygen donor groups improves the strength in 
coordination of the halide anion at the isophthalamide cavity. 
 
 
 
 
Figure 51 – Figure to show the heteroditopic ion-pair receptor 1. The triazole groups act as 
(a) Lewis bases for coordination of a metal cation and (b) hydrogen bond donors for anion 
coordination. Reprinted with permission from [Picot, S. C.; Mullaney, B. R.; Beer, P. D. 
Chem.--Eur. J. 2012, 18, 6230]. Copyright 2012 WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim. 
 
3.1.2.3 Pyrrole and Indole based receptors 
An important feature of pyrrole and indole is that they can only behave as a hydrogen bond 
donor. This eliminates the possibility of intramolecular hydrogen bonding, which could 
hinder anion recognition. With receptors possessing hydrogen bond donor and acceptor 
groups, there is added internal competition for a hydrogen bond donor. This is a key issue 
that requires forethought when designing a receptor of this nature.
49
 Pyrroles are relatively 
uncomplicated to functionalise and can be included within both acyclic and cyclic structures. 
As a result, pyrrole has been researched in great depth for use in a wide variety of synthetic 
receptors. The incorporation of pyrrole within anionic receptors was first pioneered by 
    54                                                55 
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Sessler et al. In 1992, the fabrication of a pentapyrrolic sapphyrin structure was documented. 
This macrocyclic structure, when protonated, formed a 1:1 complex with halide anions, with 
a particularly high affinity towards fluoride. Selectivity towards fluoride was around >10
3
 
stronger than both chloride and bromide.
50
 Sessler et al. expanded this work by developing 
protonated sapphyrins, which behave as effective phosphate receptors.
51
 In 2007, Sessler et 
al. reported the fabrication of a series of acyclic pyrrole anion receptors. The receptors 
synthesised contain a central pyridine ring connected to pyrrole units via 2-aminopyrrole-
derived amide bonds (56 and 57). The central pyridine ring was also replaced by a phenyl 
ring giving receptor 58. Furthermore, the amide linkages were reversed, generating the 
acyclic receptor 59 (figure 52). Results show that, by having a central pyridine ring, anion 
coordination is stabilised. In addition, reversing the configuration of amide bonds alters the 
selectivity of the receptor. Receptor 56 is selective towards benzoate and 57 towards acetate, 
whereas 59 is selective towards chloride.
52
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Figure 52– Figure to show the chemical structure of a series of acyclic Pyrrole based 
receptors developed by Sessler and co-workers.
52
 
 
There have not only been advances in acyclic pyrrole based receptors; Mani and co-workers 
have developed pyrrolic macrocycles which incorporate amine linkages by using the 
Mannich reaction (figure 53). The larger macrocyclic receptor displayed a considerable 
affinity to halide coordination.
53
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Figure 53– Figure to show the chemical structures of both an azatripyrrolic and an 
azatetrapyrrolic macrocycle, synthesised via the mannich reaction.
53 
 
Indole is an aromatic heterocyclic organic compound which contains a pyrrole ring fused to a 
benzene ring and, like pyrrole, contains a single hydrogen bond donor. Indole is also more 
acidic in comparison to pyrrole as a result of supplementary inductive and resonance effects 
from the adjacent benzene ring. The small rise in acidity means that indole is able to form 
stronger hydrogen bonds with an anionic guest when compared to the pyrrole unit.
54
  
 
While pyrrole has received a great deal of attention in the area of anion receptor chemistry, 
indole has been relatively unexplored. In 2005, Beer et al. generated indolocarbazole 
receptors 62 to 65 (figure 54) by modifying the Fischer indolisation reaction with 1, 2 
cyclohexanedione and a suitable aryl functionalised hydrazine. Each receptor showed the 
highest affinity towards benzoate after analysis by UV/Vis spectroscopy. The simplicity of 
functionalisation of the indolocarbazole skeleton and the efficiency in anion coordination 
deems preorganised receptors of this nature highly useful in anion supramolecular 
chemistry.
55
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Figure 54 – Figure to show the chemical structures of a series of indolocarbazole receptors 
developed by Beer et al.
55
 
 
Jeong et al. have looked at both acyclic
56
 and macrocyclic
57,58
 indole receptors. In 2007
58
, the 
synthesis of two indocarbozole macrocycles was reported (figure 55). The macrocyclic 
receptors have anion binding cavities of differing size and are both rigid in structure, thus 
limiting conformational flexibility. 
 
Figure 55 – Figure to show the chemical structures for two macrocyclic indole based 
receptors, which have been developed by Jeong et al.
58 
 
In the case of the smaller macrocycle, azide coordinated in an ‘end-on’ fashion with the NH 
groups forming hydrogen bonds to a terminal nitrogen atom in the azide ion. For the larger 
cavity, a more stable mode is adopted. Each indolocarbozole unit forms a hydrogen bond to 
the azide terminal nitrogen atoms in an ‘end-to-end’ fashion. Coordination properties with 
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other anions were investigated with interesting results. With the halides, in the smaller 
macrocycle, the relative order of binding is Cl
- 
> Br
- 
> I
-
, which is in accordance with the 
hydrogen bond accessibility of halide anions. With the larger macrocycle, iodide is 
coordinated with the highest affinity showing that the size of the cavity is the deciding factor 
in coordination; the iodide ion and cavity are equivalent in size.
58
 
  
In 2010, Gale and co-workers
59
 developed a range of diindolyurea receptors (figure 56) and 
analysed the relative binding affinities of each receptor towards a range of oxo-anions. 
Receptors 68 and 69 formed 1:1 complexes with sulphate ions; however, upon addition of 
added equivalents of sulphate, the result was the generation of higher order complexes. 
Regardless of possessing fewer hydrogen bond donor groups, receptor 70 still binds sulphate 
strongly. Furthermore, upon complexation of dihydrogen phosphate and bicarbonate anions 
to the receptors containing 8 hydrogen bond donors (68  and 69), the pKa of the bound 
species are altered to the extent that they are deprotonated by free anions in solution. 
 
 
Figure 56 – Figure to show the chemical structures for a series of diindolurea receptors 
developed by Gale et al.
59
 
 
3.1.2.4 Urea and thiourea based receptors 
Urea and thiourea receptors were first established by Wilcox
60
 and Hamilton.
61
 These 
particular functional groups have since received a high level of interest for their potential in 
anion coordination. Urea and thiourea based receptors provide a good environment for ‘y-
shaped’ anions, such as oxo-anions (carboxylate, benzoate and acetate).62 Urea and thiourea 
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groups have two –NH donor groups; they can either coordinate a singular spherical anionic 
species by creating a 6-membered ring, or neighbouring oxygen atoms on an oxo-anion to 
create an 8-membered ring (figure 57).
63
 
 
Figure 57 – Figure to show the two distinct ways in which (thio)urea based receptors 
coordinate to an anionic guest: (a) Both NH donor groups coordinate to a spherical anion, 
producing a 6-membered ring (b) each NH donor group coordinates to two adjacent oxygen 
atoms present in an oxo-anion, producing an 8-membered ring. 
 
Work by Pfeffer et al.
64
 has demonstrated the inclusion of both urea and thiourea groups in 
combination with amide groups in a variety of indole based receptors (figure 58). A flexible 
carbon linker of varying length was used to connect the indole group to a thiourea/urea group, 
allowing some level of flexibility. By the inclusion of a spacer, the groups can cooperate 
when coordinating an anionic guest. From utilisation of 
1
HNMR titration techniques, each 
receptor was shown to coordinate a series of anionic guests. With dihydrogen phosphate, it 
was apparent that every NH donor present was involved in coordination. 
 
 
Figure 58 – Figure to show the chemical structure for a series of indole based receptors by 
Pfeffer and co-workers, which contain thiourea and urea groups.
64
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In 2009, Gale and co-workers developed a series of urea based receptors (figure 59). Studies 
demonstrated that the higher the number of NH donor groups within the receptor, the larger 
the shift of the urea NH protons. In order to achieve successful coordination with an 
alkylcarbamate anion, the receptor must compete with the ammonium cation that forms upon 
complexation. Previous results indicate that the higher the number of donor groups, the more 
likely it is that stabilisation of the alkylcarbamate will occur. Therefore, diindolyurea and 
carbazolyl urea should display the greatest strength of interaction with carbamate anions.
65
 
 
 
Figure 59 – Figure to show the chemical structures for a series of urea based receptors 
developed by Gale et al.
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This research group then went on to demonstrate that the alkyl ammonium cation could itself 
be stabilised by a crown ether structure, which is illustrated in figure 60 overleaf. 
Stabilisation of the cation by a crown ether resulted in an enrichment in the hydrogen 
bonding interaction between the receptor and the alkylcarbamate anion.
65
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Figure 60 – Figure to represent the interaction between an alkylammonium-alkylcarbamate 
salt (formed from 1, 3-diaminopropane and carbon dioxide) with a urea based receptor and 
18-crown-6.
66
 
 
An area of chemistry, which urea and thiourea based receptors can feature, is the area of 
colourimetric sensing. In 2011, work by Bhardwaj et al.
67
 showed the development of a series 
of neutral tripodal and bipodal receptors which contain thiourea/urea groups for coordination 
and a p-nitrobenzene unit for signalling. These receptors have been reported to behave as 
selective colourimetric sensors. The chemical structures of the neutral receptors are shown 
overleaf in figure 61.  
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Figure 61 – Figure to show the chemical structures for a series of neutral tripodal and 
bipodal thiourea/urea based receptors developed by Bhardwaj et al.
67
 
 
Results show that the thiourea derivatives are highly selective towards fluoride. With the urea 
derivatives, complexation is dependent upon the reversible acid-base reaction which takes 
place between the acidic urea NH donor groups and the basic fluoride anion. Despite being 
selective towards fluoride, urea derivatives only show low sensitivity in comparison to their 
thiourea counterparts. As a result, sensing only takes place at high fluoride concentrations. 
The difference in the activity of the urea and thiourea receptors is attributable to the intrinsic 
acidity. Thiourea displays a higher intrinsic acidity in comparison to urea, meaning it is 
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capable of forming stronger hydrogen bonds. Work by Yatsimirsky and co-workers
68
 
compared the strength of binding of thiacalix[4]arenes functionalised with both urea and 
thiourea moieties. Studies showed stronger binding for the urea based receptors in 
comparison to thiourea analogues, despite the elevated intrinsic acidity. 
 
It is evident that there have been numerous advances with respect to neutral anion receptors, 
which incorporate a variety of hydrogen bond donor groups. However, this research will 
focus on the isophthalamide moiety and this particular group will be explored in more detail 
at a later point in this chapter. 
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3.2 Aims and Objectives 
3.2.1 The importance of anion receptor chemistry in nature 
The chemistry of anion coordination is continuing to attract attention within the area of 
supramolecular chemistry. Anions play crucial roles in numerous areas, such as biology, 
medicine and the environment.
16, 69-71
 Therefore, being able to design synthetic receptors has 
been at the forefront of numerous research within this area. There have been numerous 
contrasting designs for synthetic receptors, the majority of which showing a preference for 
harder anions, such as fluoride, over bulkier softer anions, such as carboxylate. Therefore, the 
ability to bind hydrophobic anions in aqueous media still remains a challenge synthetically.  
 
Anion receptors within nature overcome all synthetic obstacles, as the binding site is tailored 
to a specific anionic substrate in aqueous media, regardless of the nature of the anion. As 
previously mentioned in the introductory section to this chapter, an example of the crucial 
role anions play is evident in sustaining the phosphorylation state of proteins, which is 
significant for a wide variety of cellular processes. Both kinases and phosphatases are the 
collective groups of protein responsible for this procedure. Alkaline Phosphatase (AP), a 
member of the Phosphatase family, is an example of an anion receptor found in nature. As 
stated earlier, it possesses a shallow active site containing an arginine residue, a magnesium 
ion and two zinc ions, rendering it positively charged (figure 62). This positive charge is 
responsible for the binding of anionic phosphate moieties and, due to the shallow nature of 
the active site, only the phosphate moiety of the substrate will interact with the enzyme.
11
 
Numerous studies have taken place on examining the structure of protein anion binding sites. 
More enzymes are known to contain arginine in comparison to other amino acids, which is 
due to the fact that arginine operates as an anion binding site, showing a preference for 
hydrophobic substrates in particular.
72
 Amino acids tend to be non-polar in nature, meaning 
that alkaline phosphatase is a water soluble protein that has a hydrophobic cavity, therefore, it 
is a notable example of how nature can preferentially bind soft hydrophobic anions in an 
aqueous medium. Therefore, it can be seen from the literature that, in nature, hydrophobic 
receptors can be located within a water soluble environment. Therefore, nature uses the 
principle of encapsulation to coordinate a hydrophobic anion within a water soluble 
environment. The main aim of this part of the project is to mimic this principle and design an 
anion receptor which is encapsulated within a water soluble environment. 
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Figure 62- Figure to show a phosphate monoester binding to the active site of Alkaline 
Phosphatase (AP).
11
 
 
3.2.2 Approach and consideration 
In order to design a water soluble molecule comparable to nature it is important to consider 
the various components required. Firstly, an appropriate anion receptor site which is able to 
favour binding of hydrophobic anion substrates is required. Secondly, an appropriate water 
soluble molecule is required to encapsulate the receptor within a hydrophilic environment. 
 
3.2.2.1 Design principles of the anion binding receptor 
As mentioned beforehand, the most palpable method for anion binding is by utilising 
electrostatic interactions, for instance, using a positive charge will generate a strong ionic 
bond. A potential hindrance to a cationic receptor is the presence of a counter ion which 
could potentially compete with the anionic substrate in question. As discussed in the 
introductory section of this chapter, another intermolecular force that could be used for anion 
recognition is the hydrogen bond. An anion can alternatively be considered as an electron 
pair donor, meaning interaction with an electropositive H atom (electron pair acceptor) will 
result in a strong interaction. More electron pair acceptor groups present within the receptor 
will enhance binding strength due to cooperative effects. However, the alignment of 
hydrogen bonds must be convergent as it is essentially a dipole, thereby unearthing a 
potential obstacle for design. Finally, when engineering a binding site to show a preference 
towards hydrophobic anions, the site must itself be hydrophobic and organic in nature. This 
will lead to hydrophobic effects being utilised in retaining the anion within the cavity. The 
addition of aromatic rings could also encourage cooperative π-π stacking interactions. A 
hydrophobic binding site would enhance specificity to the desired anionic substrates so the 
site must itself be non-polar. 
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3.2.2.2 Encapsulation of the binding site within a water soluble environment 
The next step in the design process is to decide upon a molecule by which to encapsulate the 
binding site within, so that it is encased within a hydrophilic environment. Linear polymers 
were initially considered but were considered too dynamic and flexible for this purpose, 
therefore, dendritic polymers were also explored. Dendrimers are an innovative type of 
macromolecule. They are monodisperse and both their molecular uniformity and structurally 
perfect architectures has made them desirable for a variety of diverse applications. There 
have been numerous studies involving the utilisation of dendrimers for encapsulation, 
employing both a non-covalent and covalent approach. Due to the perfectly branched nature 
of these polymeric molecules, they are able to trap organic molecules inside. This non 
covalent approach makes use of intermolecular interactions and hydrophobic effects to retain 
the target molecule. The Twyman group reported a modified PAMAM synthesis generating a 
water soluble dendrimer which is able to solubilise small hydrophobic molecules within the 
interior as illustrated in figure 63.73 Another example is the dendritic box reported by Meijer 
et al., which demonstrates a dendrimers ability to exhibit non-covalent encapsulation. The 
dendritic box allows the possibility for molecules to be held in place by chemically closing 
off the periphery, and thus blocking an escape pathway. This allows enveloped guest 
molecules to be selectively ejected, depending on their size/volume, by modifying the nature 
of the peripheral surface.
74, 75
 The possibility for non-covalent encapsulation of small 
molecules within  a dendritic structure allows potential for the use of these macromolecules 
in drug delivery and catalysis.
76
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Figure 63- Figure to show a water soluble PAMAM dendrimer solubilising hydrophobic 
organic molecules within the interior of the architecture.
73
 
 
With dendrimers, there is an exponential growth in molecular weight for a numerical 
enlargement in volume. This has pointed towards a theory, by which there will be a critical 
molecular weight where the core is effectively encapsulated by the sterically hindered and 
densely packed dendritic architecture.
76
 The dendrimer core is a unique environment and can 
sometimes be described as a microenvironment.
75
 Functionalisation of the core will mean the 
dendritic structure will be able to control the microenvironment around an active site. An 
example of this can be seen in the work by Diederich et al., involving the generation of 
porphyrin cored dendrimers to function as synthetic models for globular proteins. To achieve 
this, a dendrimer was constructed around a porphyrin core using a divergent method (figure 
115 
 
64). Electrochemical studies have uncovered that the redox potential of the metalloporphyrin 
core was not influenced by the exterior solvent, but was controlled by the nature of the 
dendritic generation and branching, thus revealing, that as generation increased, the more 
electron rich the environment around the core became. Essentially, the dendrimer acts as a 
solvent as it shelters the core from the surrounding chemical environment.
77
 
 
 
Figure 64 – Figure to show the chemical structure of the skeleton of a metalloporphyrin 
cored dendrimer as a synthetic model for globular heme proteins.
77
 
 
There is an important drawback to consider when contemplating utilising dendrimers for a 
specific application. The multistep synthetic procedure that is required is exhaustive, complex 
and is expensive to accomplish, not to mention the difficulty in purification. Therefore, 
hyperbranched polymers were considered as a potential substitute. Hyperbranched polymers, 
with nearly indistinguishable properties to dendrimers, can be easily synthesised in a one-step 
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synthesis, thereby showing potential as materials for large scale industrial use.
78
 Despite their 
structural defects when compared to dendrimers, they can still uphold a three dimensional 
globular configuration which is comparable to that of a dendrimer. Therefore, covalent and 
non-covalent encapsulation is a potential application for these macromolecules. Frey et al. 
exploited the properties of these macromolecules to demonstrate non-covalent encapsulation 
of hydrophilic pincer-platinum (II) complexes by synthesising amphiphilic hyperbranched 
polyglycerol nanocapsules. Figure 65 represents a sulfonate functionalised pincer platinum 
(II) complex 85, which was successfully encapsulated. These nano reactors showed potential 
in homogenous catalysis, as they enabled double Michael addition reactions to take place. 
The synthetic procedure for a molecular hyperbranched nanocapsule is illustrated in scheme 
10. The synthesis involves the incomplete esterification of hyperbranched polyglycerols. 
Encapsulation was carried out by shaking solutions of the nano capsules in dichloromethane 
with aqueous solutions of the hydrophobic square planar platinum (II) complexes and 
monitored using UV-Vis spectroscopy. The encapsulated platinum (II) complexes exhibit 
catalytic activity regarding double Michael addition. Conversely, this occurred to a lesser 
extent than when compared to the free platinum (II) complexes. Nevertheless, it is a 
successful example for the generation of a hyperbranched polymer microenvironment for a 
homogenous catalyst, via a non-covalent approach.
78, 79
 
 
 
Figure 65 – Figure to show the chemical structure of a sulfonate pincer platinum (II) 
complex. This complex was used by Frey and co-workers to exploit the properties of 
hyperbranched polyglycerols and was encapsulated successfully via non-covalent 
interactions.
78, 79 
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Scheme 10- Synthesis of a molecular hyperbranched nanocapsule involving incomplete 
esterification of hyperbranched polyglycerols.
79
 
 
3.2.2.3 Design of an anion receptor based on a hyperbranched polymer 
Due to the expensive preparative method and protracted procedures involved in dendrimer 
synthesis, hyperbranched polymers were considered. Even though they are relatively 
unexplored in comparison, they appear to be a viable option for this research. Both covalent 
and non-covalent encapsulation methods have been well established. However, the covalent 
approach was selected as it ensures site selectivity of the binding site, so this will be the 
approach selected. A final consideration which is imperative to the covalent incorporation of 
the anion receptor is the compatibility with the polymerisation method selected, in order to 
achieve successful incorporation. The principal aim of this work is to covalently incorporate 
an organic soluble anion receptor within a water soluble hyperbranched polymer environment 
and compare the relative binding affinity of various hard and soft anions between the 
covalently encapsulated receptor and free receptor. Scheme 11 is a simplified schematic 
representation of this aim. 
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Scheme 11 - Schematic representation of the principal aim of this research project. 
 
3.2.2.4 Encapsulation of a receptor within an organic soluble environment 
Despite the overall aim being the encapsulation of an anion receptor within a water-soluble 
environment, it is important to determine if there is any effect of covalent encapsulation 
within a polymeric environment upon anion coordination and relative binding trends. 
Therefore, prior to encapsulation within a water-soluble environment, covalent incorporation 
within an organic soluble polymer system must be attempted as a proof of principle. Due to 
the synthetic obstacles of encapsulation within a water soluble system, an organic soluble 
system provides an easier synthetic approach, in addition to allowing a proof of principle of 
the effect of encapsulation of an anion binding core within a polymeric structure. The 
addition of a new electronic environment surrounding a receptor could result in two potential 
outcomes. Firstly, the trend in which anions would ordinarily interact to the native receptor 
could be modified as the new surrounding environment could provide an optimum 
environment for a specific anion, thus resulting in a difference in selectivity. It is also 
possible that there are no changes in relative binding trends (compared to the native receptor). 
Furthermore, as a result of the new steric barrier in place, there could potentially be a 
reduction in the binding affinity of an anionic guest. Therefore, the determination of the 
effect of covalent incorporation inside an organic polymer is the initial task of this project. 
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3.3 Results and Discussion 
 
3.3.1 Core functionalisation polymerisation – synthetic considerations 
As previously mentioned in the aims and objectives section of this chapter, the covalent 
approach was initially chosen due to the site selectivity it ensures. Consequently, the initial 
stage of this research was the selection of an appropriate polymer and anion receptor core.  
 
3.3.1.1 Selection of the polymer for organic soluble core Functionalisation 
As described beforehand, the ultimate goal for this research is to produce an anion receptor 
incorporated within a water soluble polymer. However, it was initially decided that the 
covalent incorporation of a binding core within an organic soluble polymer would be 
investigated. As discussed earlier, the motive behind this was for proof of principle that an 
anion binding site can be covalently incorporated within a hyperbranched polymer. An 
organic soluble system would be synthetically simpler, generating a more robust system 
compared to covalent incorporation within a water soluble polymer. The generation of an 
organic soluble system will also provide information upon the effect upon anion 
coordination, compared to the receptor in its native state. There is currently an effective 
polymer system in-house within the group. The Twyman group has demonstrated complete 
core incorporation for nitrophenyl acetate and the simple AB2 monomer 3, 5- 
diacetoxybenzoic acid. The synthesis involved a reversible esterification mechanism
80
 and 
will be discussed further in section 3.3.5. Therefore, it was hypothesised, that this process 
could be exercised to synthesise an anion receptor system possessing a binding site with high 
levels of core incorporation.  The chemistry of this monomer is not only well known within 
the Twyman research group, but has also been the focus of research outside,
81
making it an 
appropriate choice for this work. The monomer 3, 5-diacetoxybenzoic acid has an aromatic 
ring. It is therefore hypothesised that benzoate would bind more favourably within the 
polymeric anion receptor, due to cooperative π-π stacking effects. 
 
3.3.1.2 Synthesis of 3, 5 diacetoxybenzoic acid 
The monomer 3, 5 diacetoxybenzoic acid was produced using a single step reaction between 
3, 5 dihydroxybenzoic acid and acetic anhydride (scheme 12). This synthetic procedure was 
based upon a methodology outlined in the work by Turner et al.
82
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Scheme 12 – Synthesis of 3, 5 diacetoxybenzoic acid. 
 
The monomer was refluxed with excess acetic anhydride, generating a yellow solution.  The 
acetic anhydride was then subsequently removed via vacuum distillation. Care was required 
not to exceed a temperature of 80C to avoid self-polymerisation from occurring. After 
dissolution in refluxing chloroform the product was filtered hot and upon addition of 
petroleum ether 40:60, a white solid precipitated out of solution. After filtration, the product 
was dried thoroughly and characterised. The 
1
HNMR data obtained was in accordance with 
the literature displaying a broad singlet at 10.32 ppm, indicative of the carboxylate proton. A 
doublet and triplet at 7.75 and 7.20ppm respectively were observed for the aromatic ortho and 
para protons and, finally, a singlet was observed at 2.32ppm which was characteristic of the 
methyl protons present on the acetate groups. The mass spectra showed an ion peak at 237 
Daltons, indicative of the MH
-
 peak and the melting point determined was in accordance with 
the literature. Elemental analysis gave results within 0.5% of the expected values giving 
confidence in the purity of the sample. Infra-red spectroscopy and X-ray crystallography 
(appendix B) were also employed to provide additional analytical information, confirming 
the synthetic procedure was successful. 
 
3.3.1.3 Design of the anion receptor 
When contemplating a suitable anion binding receptor there are certain necessary 
requirements to consider. The requirements are, firstly, that the core is stable under the 
conditions required for polymerization. Furthermore, it is crucial that the core is compatible 
with the mechanism involved. Finally, the third requirement is that the core is analytically 
visible in the final product. Therefore, the nature and the functionality of the receptor are 
important. There are two types of receptor to deliberate, a cyclic receptor and a cleft receptor. 
A cyclic receptor is a pre-organised system where the anion receptor site is fixed both in the 
bound and unbound state; however, it is synthetically challenging. On the other hand, a cleft 
receptor is not preorganised as free rotation is allowed about the bonds, it only becomes fixed 
when the anion is held in place by interactions; however, this type of receptor is less of a 
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challenge to prepare. Furthermore, by synthesising a receptor which exhibits little 
preorganisation, allows the manufacture of receptors which are not only efficient, but can be 
fabricated on a multi gram scale from commercially available and economically priced 
starting materials.
45
 As a result, the cleft seemed an appropriate choice of receptor to begin 
with.  
 
When considering the structure of the cleft it was decided that a difunctionalised symmetrical 
molecule would be appropriate. This type of molecule would allow simultaneous 
polymerisation to both ends so the cleft will be efficiently encapsulated within the 
hyperbranched polymer. The terminal functionality is extremely important and is solely 
dependent upon the monomer in question and the mechanism of polymerisation. The 
monomer in question is an AB2 monomer; this means that it is a requirement for the core unit 
chosen to contain B functionality. When a B group of a core unit interacts with the A group 
of a monomer unit, additional B groups will propagate as a result. As no interaction can occur 
between like functional groups, the only feasible reactions are propagation and termination. A 
schematic representation of this idea can be seen in scheme 13. 
 
 
Scheme 13 – Schematic representation of the interaction of a core unit and an AB2 monomer 
unit. 
 
 For the organic soluble 3, 5-diacetoxybenzoic acid monomer and resulting polymer, an 
acetoxy group is imperative in the correct place, in order to propagate the polymer by 
coupling to the acid functional group present on the monomer. 
 
 As mentioned in the introductory section of this chapter, there has been a great deal of 
interest regarding anion receptors which possess an isophthalamide moiety (figure 66). 
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Receptors of this nature have been reported to be effective H bond donors; therefore, a 
decision was made to incorporate this functional group, due to past success. 
 
 
 
Figure 66 – Figure to show the chemical structure of isophthalamide. 
 
3.3.2 Synthesis of N
1
, N
3
-bis (4-hydroxyphenyl) isophthalamide 
A di-functional, symmetrical, isophthalamide based receptor was designed. The receptor 
requires two acetoxy functional groups to propagate the polymer; the chemical structure for 
the desired final product can be seen in figure 67.  
 
 
 
Figure 67– Chemical structure of N, N – bis (4-acetoxyphenyl) isophthalamide. 
 
With the design in place the next step was to determine the synthetic route to attain said 
structure. From retrosynthetic analysis it was deduced that the simplest route to the desired 
product was the synthesis of N, N – bis (4-hydroxyphenyl) isophthalamide, followed by the 
acetylation of the terminal hydroxyl groups (scheme 14). 
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Scheme 14 – Retrosynthetic analysis of N, N – bis (4-acetoxyphenyl) isophthalamide. The 
red dotted lines indicate the points of disconnection where bonds could be broken into the 
corresponding synthons. 
 
As seen in scheme 14, the synthons used to generate the amide bond are an amine and an 
acid chloride. In the literature, a preparative method for a para substituted structure 96 (figure 
68) similar to the designed receptor was reported.
83
 Amide synthesis was achieved by 
acylation and the Schotten-Baumann reaction was employed. This type of acylation reaction 
involves the use of a base, which can drive the equilibrium to generate an amide.  
 
 
 
Figure 68 – Figure to show the chemical structure of N1,N4-bis(4-hydroxyphenyl) 
terephthalamide.
83
 
 
A reaction flask containing 4-aminophenol was degassed and triethylamine (distilled in the 
presence of a drying agent) and anhydrous 1-methyl-2-pyrrolidinone (NMP) were added via a 
syringe. The reaction mixture was heated to 60ºC and a solution of isophthaloyl chloride (in 
NMP) was added drop wise and stirring was continued for a period of 30 minutes. The 
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temperature was then raised to 80 ºC and stirring was continued for an additional 20 minutes. 
The salt by-product, triethylammonium chloride, was removed by vacuum filtration and the 
reaction mixture was concentrated by rotary evaporation yielding the dark purple crude 
product. The next obstacle of the synthetic procedure was purification of the crude material 
and recrystalisation was the technique selected. However, after solubility investigations 
involving an array of different solvents, upon addition of methanol, the purple/brown solid 
became white in colour. It appeared that methanol was dissolving the impurities responsible 
for the apparent discoloration of the product. In order to determine the effect of addition of 
methanol, the white solid obtained was filtered, dried thoroughly and characterised using a 
variety of analytical tools. From analysis of the 
1
HNMR both the integration and coupling are 
indicative of the signals expected, as shown in figure 69. The peaks corresponding to the OH 
protons and NH protons can also be visualised as two singlets, both with an integral of two 
protons at 10.20 ppm and 9.34 ppm respectively.  
 
 
Figure 69 – Figure to show the 1HNMR spectrum for N, N-bis (4-acetoxyphenyl) 
isophthalamide. 
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The mass spectrum showed a signal at 349 which is indicative of the MH
+
 ion peak. Infra-red 
spectroscopy and 
13
C NMR were also used to confirm the chemical structure of the product 
and ensure that synthesis and purification were successful. 
 
3.3.3 Synthesis of N, N-bis (4-acetoxybenzaldehyde) 
The next stage of the synthetic procedure is the acetylation of the hydroxyl terminal groups. 
An oven dried flask was charged with N, N – bis (4-hydroxyphenyl) isophthalamide and 
anhydrous pyridine before being degassed with a vacuum and argon gas. Acetyl chloride was 
added drop wise and the reaction mixture was left to stir at room temperature for a period of 4 
hours. Pyridine was removed via rotary evaporation and the crude product was purified by 
column chromatography, eluted with ethyl acetate. Acetylation of a hydroxyl group is 
frequently carried out in the presence of an organic base. In this case, the organic base 
utilised is pyridine. Pyridine not only functions as the solvent in this reaction, but also has 
numerous other important roles in this reaction. The first of these is to neutralise acidic 
protons which are generated, ensuring that a high acid concentration does not develop. The 
second role is that of a nucleophilic catalyst, whereby it has direct involvement in the 
reaction.
85
  
 
A variety of analytical tools were used to determine the success of the experimental 
procedure. From analysis of the proton NMR spectrum it was apparent that acetylation was 
successful as the –OH signal, present in the spectrum for N, N – bis (4-hydroxyphenyl) 
isophthalamide, was no longer present. A signal at 2.28 ppm could now be visualised, which 
is specific to the methyl protons of the acetate groups now present. The mass spectrum gave a 
signal at 433, indicative of the MH
+
 ion. Furthermore, elemental analysis also showed results 
within 0.5% of the theoretical values expected. Infra-red spectroscopy and 
13
CNMR were 
tools also used in the determination of the chemical structure of N, N – bis (4-acetoxyphenyl) 
isophthalamide. The combination of all the analytical techniques used provides confidence in 
the purity of the final product, thereby meaning it was of sufficient quality for core 
incorporation within a hyperbranched polymer.  
 
3.3.4 Polymerisation of 3, 5 diacetoxybenzoic acid 
Initially, the polymerisation was executed in the absence of a core as a control reaction to use 
as a reference. The polymer was synthesised in a solution phase where diphenyl ether was the 
acting solvent. The reaction mixture was added to a round bottom flask which was fitted with 
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a one-piece distillation kit. Care was taken to ensure the reaction was carried out in the 
absence of air, meaning the reaction mixture needed to be repeatedly evacuated and flushed 
with nitrogen to ensure the maintenance of the appropriate reaction conditions. The reaction 
was executed using a two-stage procedure involving two different temperatures. Firstly, the 
reaction was heated to 225 C for a period of 45 minutes, ensuring complete dissolution of 
the monomer. The temperature was then lowered to 180 C and the system was placed under 
low vacuum for a period of 4 hours, so as to initiate equilibrium. This allowed removal of 
acetic acid by-product generated, thus steering the reaction to completion (scheme 15). After 
the vacuum was removed, the polymer was dissolved in hot THF and precipitated into cold 
methanol. The product was then isolated, washed with methanol and dried thoroughly prior to 
analysis. 
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Scheme 15 – Representation for the polymerisation of 3, 5 Diacetoxybenzoic acid. 
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Confirmation that the reaction had taken place was ascertained using 
1
HNMR spectroscopy. 
It confirmed the absence of the carboxylic acid proton at 10.32 ppm, which was present in the 
spectrum for the monomer. Further confirmation can be seen in the diminution of the 
intensity of the peak at 2.32 ppm, corresponding to the methyl protons. With each 
propagation step of the polymerisation reaction, an acetoxy functional group is used up and, 
subsequently, two are added to the developing polymer. Therefore, as the polymer increases 
in size, the ratio of the terminal acetoxy groups to the level of internal groups decreases; this 
results in a decline in the integral size corresponding to the methyl protons.  
 
3.3.5 Total core incorporation 
As mentioned earlier, this monomer has received a great deal of attention within the group, 
therefore, the chemistry of polymerisation is well known. As discussed earlier, Twyman et 
al.
80
 exploited this polymerisation and reported total core incorporation for a hyperbranched 
polymeric system. The polymerisation occurs through a reversible transesterification reaction 
mechanism, which is directed by thermodynamics. The reversible nature of the reaction 
ensures that core units will be evenly distributed and incorporated during the course of 
polymerisation. The polymerisation involved a one-step synthetic procedure with p-
Nitrophenyl acetate as the core molecule. Provided that the core unit is more reactive than the 
monomer, the core will continually be involved. This will ensure that there will be an even 
distribution across the complete molecular weight range. Another advantage to a reversible 
polymerisation is the ability for the system to self-correct until equilibrium is attained, thus 
giving rise to a statistical distribution of core units.  
 
3.3.5.1 Core incorporation of N, N – bis (4-acetoxyphenyl) isophthalamide 
The synthesis was modified to include N, N – bis (4-acetoxyphenyl) isophthalamide as a core 
molecule. The core/monomer mixture (1:20 mole ratio) was heated with an equal weight of 
diphenyl ether and a method equivalent to that followed for unmodified poly 3, 5- 
diacetoxybenzoic acid was employed. After removal of the vacuum, the next step was the 
isolation and purification of the polymer. The product formed was a thick brown, glass-like 
solid which, unlike the unmodified polymer, was only partially soluble in THF. The slight 
amount which dissolved was precipitated in excess methanol, and the white solid which 
emerged was washed thoroughly with ice cold methanol and dried thoroughly prior to 
analysis. From the proton NMR spectrum, small broad signals could be observed at 8.52 and 
8.89 ppm, which indicate core incorporation. However, the integrals of these values are 
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extremely low in comparison to the acetoxy proton signal, suggesting minimal core 
incorporation. Only a small amount of polymer was obtained, and subsequently used up in 
characterisation, therefore the procedure was repeated. When reattempting the synthetic 
procedure with this core molecule, the brown, glass-like solid produced was insoluble in 
refluxing THF.  Poly 3, 5 diacetoxybenzoic acid is soluble in THF, regardless of what core 
has been incorporated; therefore, the insolubility of the polymer produced indicates another 
process is taking place, which differs from the process expected. It has been postulated that 
trans-etherification could be taking place, as opposed to desired trans-esterification 
mechanism. This could lead to cross linking, which could explain the difficulty in dissolution. 
However, how this occurs exactly still remains unknown to us. In order to confirm that this 
undesired effect is a result of the chemistry and not the chemist, it is important to verify that 
the method for core incorporation is viable and the monomer synthesised is suitable. In order 
to show this, a known successful reaction, which involves p-nitrophenyl acetate as a core 
unit, was attempted. 
 
3.3.5.2 Polymerisation of 3, 5 diacetoxybenzoic acid with 4-Nitrophenyl acetate core 
The synthesis was modified to include 4-nitrophenyl acetate as a core unit. The 
core/monomer mix (1:20 mole ratio) was heated with an equal weight of diphenyl ether using 
the same procedure mentioned prior. After the period under low vacuum was complete, the 
polymer was dissolved in refluxing THF and precipitated in excess methanol. There were no 
issues experienced with the dissolution of the product with use of this particular core unit. 
The polymer was washed repeatedly with ice cold methanol so that any trace amounts of 
unreacted 4-nitrophenyl acetate could be eradicated. The product was subsequently isolated 
by vacuum filtration. By using 
1
HNMR, it was possible to verify the presence of the core 
molecule. A signal can be seen at 8.39 ppm, which is absent in unmodified poly 3, 5-
diacetoxybenzoic acid (figure 70). This additional peak is indicative of the aromatic beta 
protons from the 4-nitrophenyl ester. To validate physical incorporation of the core within the 
polymeric structure, 4-nitrophenyl acetate was added to the NMR sample. A peak 
corresponding to free 4-nitrophenyl acetate was observed at a lower chemical shift of 
8.31ppm, thus confirming core incorporation (figure 70 c) 
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a) 
 
b) 
  
c) 
 
 
Figure 70 – Figure to show the 1HNMR spectrum of a) unmodified poly 3, 5 
diacetoxybenzoic acid  b)  poly 3, 5 diacetoxybenzoic acid with 4-nitrophenyl acetate core 
and c) poly 3, 5 diacetoxybenzoic acid with 4-nitrophenyl acetate core that has been doped 
with 4-nitrophenyl acetate. The marked signals are representative of resolved chloroform in 
deuterated chloroform.     
 
3.3.5.3 Purification of N, N – bis (4-acetoxyphenyl) isophthalamide 
As core incorporation was successful with 4-nitrophenyl acetate, the synthetic procedure can 
be deemed suitable. Therefore, the cross linking must involve the core molecule alone. 
Although analytical data showed the core to be of high purity, it is important to acknowledge 
6.76.86.97.07.17.27.37.47.57.67.77.87.98.08.18.2 ppm
6.86.97.07.17.27.37.47.57.67.77.87.98.08.18.28.38.48.5 ppm
6.86.97.07.17.27.37.47.57.67.77.87.98.08.18.28.38.48.5 ppm
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that there could still potentially be slight impurities present, which are interfering with the 
reaction. It was therefore postulated that rigorous purification of N, N – bis (4-
acetoxyphenyl) isophthalamide was the next course of action. The core underwent a hot 
filtration by dissolution in methanol and the brown solid turned grey in colour. The grey solid 
generated was dried meticulously prior to analysis. From examining the 
1
HNMR, it was 
apparent that the core hydrolysed during the hot filtration process, generating isophthalic acid 
(figure 71). This would usually be difficult due to resonance effects. 
 
 
Figure 71 – Figure to show the 1HNMR spectrum for isophthalic acid. 
 
The resonance of an amide bond usually proceeds by movement of the lone pair on the 
Nitrogen atom, thus generating a C-O
-
 moiety (scheme a). However, from analysis of the 
1
HNMR spectrum, there appears to be an alternative resonance mechanism involved. It has 
been hypothesised that this involves the movement of the lone pair in the opposite direction 
to that predicted, thereby triggering the collapse of the molecule. In the predicted mechanism 
(scheme 16 a) the carbonyl carbon is not susceptible to nucleophilic attack. The mechanism 
proposed in scheme 16 b involves the role of the electron withdrawing acetate group para to 
the amide group, rendering the carbonyl carbon electrophilic. As a result, the carbonyl group 
is now susceptible to nucleophilic attack. As a result, the amide bond can now be broken, 
explaining the formation of isophthalic acid.   
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(a) 
 
(b) 
 
 
Scheme 16 - Representation of the (a) resonance within an amide bond (b) resonance 
mechanism for the collapse of (isophthaloylbis (azanediyl) bis (4, 1-phenylene) diacetate to 
isophthalic acid. 
 
Analysis from attempted purification demonstrates that the core is unstable to elevated 
temperatures, resulting in the formation of isophthalic acid. As the temperature required for 
polymerisation is considerably higher than the temperature reached during hot filtration, the 
core is evidently too unstable for covalent incorporation. The collapse of N, N – bis (4-
acetoxyphenyl) isophthalamide to the di-acid therefore explains the cross-linking observed in 
the original attempt at core incorporation. The synthesis of poly 3, 5 diacetoxybenzoic acid 
with an N, N – bis (4-acetoxyphenyl) isophthalamide core can be visualised in scheme 17. 
Consequently, this specific receptor is incompatible for incorporation. The acetate group is 
located in the para position, leads to movement of electrons between the 1 and 4 positions. If 
the position of the acetate groups were changed to the meta position, this movement of 
electrons would no longer be possible. Restricting this movement could result in the 
generation of a receptor which could withstand the polymerisation conditions and potentially 
solve this problem. It was postulated to make this necessary change, thus fabricating N, N – 
bis (3-acetoxyphenyl) isophthalamide. 
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Scheme 17 - Synthesis of poly 3, 5 diacetoxybenzoic acid with N, N – bis (4-
acetoxyphenyl) isophthalamide core 
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3.3.6 Synthesis of N, N – bis (3-hydroxyphenyl) isophthalamide 
The retrosynthetic analysis for N, N – bis (3-acetoxyphenyl) isophthalamide followed a 
similar route to that of N, N – bis – (4-acetoxyphenyl) isophthalamide, whereby the hydroxyl 
terminated receptor was synthesised first, followed by acetylation of the terminal hydroxyl 
groups (scheme 18). 
 
 
Scheme 18- Retrosynthetic analysis of N, N – bis (4-acetoxyphenyl) isophthalamide. The red 
dotted lines indicate the points of disconnection where bonds could be broken into the 
corresponding synthons. 
 
A reaction flask was charged with 3-aminophenol and anhydrous N, N’-Dimethylacetamide 
and then degassed and flushed with argon. The reaction flask was subsequently cooled to 0ºC 
and then isophthaloyl chloride was added drop-wise by a syringe. The reaction flask was then 
stirred for a period of 6 hours and allowed to return to room temperature. After completion, 
the reaction mixture was then poured into 1L of ice cold distilled water and the white solid 
obtained was isolated by filtration. The crude product was purified by dissolution in refluxing 
ethanol followed by a hot filtration, the filtrate was then poured into excess distilled water 
and the precipitate was isolated by vacuum filtration. The experimental procedure was 
adapted from the literature
85
, with the addition of an alternative purification process. 
 
A variety of analytical tools were implemented to determine the chemical structure. From 
analysis of the 
1
HNMR both the integration and coupling is representative of the signals 
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expected, as shown in figure 72. The peaks corresponding to the OH protons and NH protons 
can also be visualised as two singlets, both with an integral of two protons at 10.31ppm and 
9.47ppm respectively. 
 
 
Figure 72 – Figure to show the1HNMR spectrum for N, N – bis (3-hydroxyphenyl) 
isophthalamide. 
 
Elemental analysis gave results within 0.5% of the theoretical values deduced and the mass 
spectrum showed a signal at 349, indicative of the MH
+
 ion. X-ray crystallography 
(appendix B), 
13
CNMR and Infra-red spectroscopy were also tools used. The combination of 
this array of analytical techniques demonstrated that the synthetic procedure and purification 
was a success. As a result, N, N – bis (3-hydroxyphenyl) isophthalamide obtained, was of 
sufficient purity to be carried forward to the next stage of synthesis. 
 
3.3.7 Synthesis of N, N – bis (3-acetoxyphenyl) isophthalamide 
The next stage of the synthetic procedure was to acetylate the hydroxyl terminal groups. A 
similar procedure to the acetylation of N, N – bis (4-hydroxyphenyl) isophthalamide was 
adopted. An oven dried flask was charged with N, N – bis (3-hydroxyphenyl) isophthalamide 
and anhydrous pyridine before being degassed with vacuum and argon gas. Acetyl chloride 
6.57.07.58.08.59.09.510.0 ppm
1
.9
7
3
.9
0
2
.0
8
1
.0
4
2
.0
0
1
.0
0
1
.9
9
2
.0
0
O
NH
O
HN
OHOH
Hf
He
Hg
Ha
Hb
Hc
Hb
Hd
He
HfHg
Hd
a b c 
d & e 
f 
g 
136 
 
was added drop wise and the reaction mixture was left to stir at room temperature for a period 
of 4 hours. After removal of pyridine via vacuum distillation, the crude product was dissolved 
in dichloromethane and washed with saturated sodium hydrogen carbonate solution and 
distilled water three times each to ensure any acid present is removed. The organic layer was 
collected and reduced down and dissolved in chloroform. The cream precipitate formed was 
filtered by gravity filtration and purified by recrystalisation. The crude material was dissolved 
in a minimum of hot dichloromethane and petroleum ether (40:60) was added drop wise until 
the solution remained cloudy. The crystals were isolated by gravity filtration after slow 
evaporation. From analysis of the proton NMR spectrum it was apparent that acetylation was 
successful as the –OH signal, present in the spectrum for N, N – bis (4-hydroxyphenyl) 
isophthalamide, was no longer present. A signal at 2.30 could now be visualised, which is 
specific to the methyl protons of the acetate groups now present. An accurate mass spectrum 
gave a signal at 433.1406, indicative of the MH
+
 ion and also confirming the chemical 
formula. Furthermore, 
13
CNMR and Infra-red spectroscopy were also employed to provide 
additional analytical information, confirming the synthetic procedure was successful.  
 
The crystals generated from recrystalisation were allowed to evaporate slowly so as to ensure 
adequate crystals for X-ray crystallography were obtained. As mentioned previously, cleft-
like receptors are freely rotating in solution and not fixed in binding confirmation; a variety 
of different confirmations can thus be adopted (figure 73)
45
, with only syn-syn allowing for 
binding.  
 
Figure 73 – Figure to show the different conformations of N, N – bis (3-acetoxyphenyl) 
isophthalamide.
45 
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When the crystals were analysed it was apparent that they crystallised in the binding 
confirmation. It is pleasing to note that the crystals obtained are in the correct conformation 
for coordination. However, in solution, there is rapid rotation about bonds in the absence of a 
guest resulting in equilibrium between numerous potential confirmations as seen in figure 73. 
The crystal structure obtained can be visualised in figure 74. In the work by Kavallieratos et 
al.
45
 it has been demonstrated that, in the absence of an anionic guest, isophthalamide based 
receptors show syn-anti or anti-anti confirmations, as opposed to the syn-syn confirmation, 
which is optimal for anion interaction. The syn-syn confirmation is usually adopted when an 
anionic guest is introduced; the two linear hydrogen bonds formed drive this confirmation. It 
was therefore unexpected that X-ray crystallography showed crystals adopting the syn-syn 
confirmation. 
 
Figure 74 – Figure to show the X-ray crystal structure of N, N – bis (4-hydroxyphenyl) 
isophthalamide. 
 
3.4 Determination of the optimum molecular weight for anionic interaction 
Previous work by Dr. Adam Ellis
86, 87
 of the Twyman group† has involved the effect of 
molecular weight of a zinc porphyrin cored hyperbranched poly 3, 5 diacetoxybenzoic acid 
system upon interaction with a variety of pyridyl ligands (pyridine, 3, 5 – lutidine and 3-
phenyl pyridine). The purpose of this work was to probe the concept of dense packing. The 
two main forces which direct an interaction can be categorised as electronic and steric effects. 
A core unit will possess a different electronic environment to that of the bulk solvent and can 
provide an optimum environment for a guest species. Steric effects also play a crucial role in 
binding. If there is a steric barrier present between the core unit and the ligand, binding will 
be hindered. In the work carried out by Dr Ellis, the HOMO-LUMO interaction is optimum 
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when the pyridyl ligand in question is coordinated perpendicular to the plane of the zinc 
porphyrin, thus permitting maximal orbital overlap. Therefore, if sterics play a part in the 
disturbance of optimal orbital overlap, then the association constant, Ka, would diminish. The 
predictions were that, as molecular weight increased, dense packing will undoubtedly occur. 
At the molecular weight that the onset of dense packing occurs, the ligand will no longer be 
able to access the core unit. As a result, there will be a large drop in the association constant 
observed. Results have shown that, as the size increases the value of Ka also increases as a 
result of positive electronic effects provided by the polymeric structure. This increase 
occurred up to a point (~6000-8000 for each ligand), and for molecular weights beyond this 
value, there was a sharp decrease in the association constant. These results suggest that steric 
effects have overcome any positive electronic effects and the onset of dense packing occurs 
around this molecular weight, thwarting access of ligand to core. The graphical data for 
pyridine, showing this effect, is reported below in figure 75. 
 
 
Figure 75 – A graph to show the binding data for interaction of zinc porphyrin cored 
hyperbranched poly 3, 5-diacetoxybenzoic acid, of varying molecular weight, with a pyridine 
ligand. 
 
†For previous work in the Twyman group regarding dense packing and dendritic systems, the 
reader is directed to the following literature.
88-90
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From analysis of the experimental data obtained for poly 3, 5 diacetoxybenzoic acid with a 
Nitrophenyl acetate core, using a 1:20 core to monomer ratio afforded a polymer of 
approximately 9000 molecular weight. Taking into account past studies, it was hypothesised 
that, this molecular weight would be beyond the point of dense packing; the core would be 
too sterically hindered from an anionic guest species. Therefore, a smaller core to monomer 
ratio will be employed to, hopefully, generate an anion receptor polymer of adequate size for 
optimal binding. An ideal size would range between 4000-5000 molecular weights to 
optimise electronic effects. 
 
3.4.1 Polymerisation of 3, 5-diacetoxybenzoic acid with N, N’- Bis-(3-acetoxy-phenyl)-
isophthalamide core using a 1:5 ratio 
In the reaction flask, N, N’- Bis-(3-acetoxy-phenyl)-isophthalamide and monomer were 
introduced (1:5) along with diphenyl ether solvent. The general procedure for polymerisation 
of 3, 5 diacetoxybenzoic acid, as discussed in section 3.3.4, was subsequently followed. 
Contradictory to N, N’- Bis-(4-acetoxy-phenyl)-isophthalamide, the crude mixture dissolved 
readily in refluxing THF. The polymer solution was then precipitated into excess ice cold 
methanol and left in a freezer overnight, so as to maximise precipitation. The product was 
then isolated, washed with methanol and dried thoroughly prior to analysis. The most crucial 
tool in determining whether core incorporation is successful is proton NMR spectroscopy. 
From analysis of the 
1
HNMR spectrum (figure 76), broad signals from the core can be seen 
to both the right and left of the polymer signals. The broadness of the signals generated 
provides confidence that they represent incorporated core as opposed to free unreacted core. 
A broad multiplet can be seen at 8.55-8.67 ppm which is indicative of the NH signal which is 
the most deshielded. There is also a broad multiplet at 8.20-8.33 ppm. This signal arises from 
the two equivalent protons on the central aromatic ring and the proton (on the same ring) 
which does not neighbour another proton. There is a considerable amount of overlap between 
the polymer signals and remaining core signals due to the similarity in chemical shift and 
complicated coupling patterns formed. Therefore, direct assignment of these particular 
signals is extremely difficult. To the right of the dominant polymer signals, there is a broad 
multiplet at 6.72-6.90 ppm. This is representative of the protons para to the –CNH group, 
which are the most shielded core protons present. 
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Figure 76 – Figure to show the 1HNMR expansion (6.5 ppm to 8.7 ppm) of poly 3, 5 
diacetoxybenzoic acid with N, N’- Bis-(3-acetoxy-phenyl)-isophthalamide core (1:5). The 
marked signal is resolved chloroform in deuterated chloroform. 
 
Two techniques are used in molecular weight determination, the first being GPC analysis. 
GPC illustrated a molecular weight of 4000. It is important to note that GPC provides an 
underestimation for the molecular weight of dendritic polymers as it is calibrated against 
linear polystyrene. This is a result of the branched architecture of a dendritic polymer; the 
nature of the structure means that they adopt a more compact arrangement in solution when 
compared with an equivalent linear polymer. The other technique used was 
1
NMR estimation 
by analysis of the core signals. This is achieved through the comparison of the –NH core 
protons compared to the signal at 2.25 ppm (not shown) from the acetoxy terminal groups. 
The monomer, 3, 5-diacetoxybenzoic acid, is of type AB2, meaning that the number of B 
functionalities (acetoxy) is equivalent to one less than the number of monomer units. Upon 
each addition of monomer, one B group is expended, but two are subsequently contributed. 
Molecular weight estimation from an HNMR spectrum is therefore an overestimation and 
presumes total core incorporation, not taking into account any polymeric impurities. The 
value obtained from proton NMR estimation was 4670; the discrepancy between the two 
techniques is slight, giving confidence that there is a high level of core incorporation. With a 
molecular weight of approximately 4000 molecular weight, it falls in the molecular weight 
region prior to dense packing, so it is an appropriate size to use for binding studies. The 
6.76.86.97.07.17.27.37.47.57.67.77.87.98.08.18.28.38.48.58.6 ppm
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proton spectrum can also be used to estimate the number of monomer units present, meaning 
an estimated structure can be devised. In the case of this particular ratio the number of 
monomer units was estimated as 20 (figure 77). IR analysis of the polymer also provided 
confidence in the reaction. Aromatic C-H stretches could be seen between 2009 and 2158 cm
-
1
, the ester carbonyl functionality gave a strong signal at 1741cm
-1
 and a signal at 1286 cm
-1
 
was representative of an ester (OC (O) R) stretch.  
 
 
Figure 77– Figure to show the proposed chemical structure for poly 3, 5 diacetoxybenzoic 
acid with N, N’- Bis-(3-acetoxy-phenyl)-isophthalamide core (1:5). 
 
3.4.2 Anion binding assay  
With successful synthesis of an isophthalamide based anion receptor, and the subsequent 
effective incorporation of said core within a hyperbranched polymer, the next step was to 
analyse the binding efficacy of both. The majority of research in the area of anion receptor 
chemistry has utilised the technique of 
1
HNMR titrations to analyse anion coordination to a 
hydrogen bond donor. Due to past success of this technique, it was the appropriate choice for 
analysis. As mentioned in the introductory section of this chapter, certain properties anions 
possess can hinder receptor design. Two important properties mentioned previously are the 
size and various geometric shapes that they can adopt. In the selection of anions to use for the 
binding assay, it was decided that a contrasting range would provide a more in-depth set of 
results. Benzoate, acetate and dihydrogen phosphate were selected as they are organic in 
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nature and possess geometric limitations, therefore, it will be interesting to see the effect of 
binding when access to the core is restricted by the polymer. The halides were also selected; 
unlike the previous anions stated, they are spherical in nature so the relative size of each 
should be a dominant factor in the efficacy of interaction to the host. As both the core and 
polymer are organic soluble, the NMR solvent required for the titration experiments is 
deuterated chloroform. The anions were therefore purchased from Sigma Aldrich as 
tetrabutylammonium salts.  
 
3.4.2.1 
1
HNMR Titration analysis 
Both N, N’- Bis-(3-acetoxy-phenyl)-isophthalamide and the core-functionalised 
hyperbranched polymer were each titrated against the various anionic guests. Each titration 
began with 0.7 mL of the host species at the correct concentration in deuterated chloroform in 
an NMR tube. The anionic guest, at the correct concentration in deuterated chloroform, was 
added in aliquots (10-25 μL) to the host. NMR scans (32) were run following each addition 
and the position of the NH chemical shift (ppm) was monitored (figure 78). Upon addition of 
anionic guest and the resultant coordination to the NH protons, a chemical shift downfield is 
observed. This shift downfield continues to the point at which the NMR solution becomes 
saturated with anionic guest, meaning to no further change in the chemical shift of the signal 
is observed.  
 
 
 
143 
 
 
 
Figure 78 – Figure to show 1H NMR spectra depicting the change in NH resonances in 
compound 1 when titrated against tetrabutylammonium benzoate. 
 
 Solutions were made up fresh and used immediately after preparation. Topspin 2.6 software 
was used to process the spectra that was generated, and 14allMaster† was the software used 
to deduce the binding constant and obtain Job plots for each titration. Representative software 
images and the corresponding Job plot for the core receptor and tetrabutylammonium iodide 
can be seen in figure 79 and figure 80. It is important to note that the binding software used 
is extremely sensitive to both the concentration of host and guest; therefore, numerous 
concentrations were tested in order to deduce an appropriate concentration of both species for 
the binding assay. This was complex as it involved striking a balance between minimal error 
of fit to the binding curve as well as an appropriate concentration for visualisation. 
789101112 ppm
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†14allMaster software was designed by Professor Chris Hunter and permission to use the 
Excel program was granted. Assistance on the use of this software was kindly provided by 
John Albaya and Simon Turega of the Hunter group. 
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Figure 79 – Figure to show the print screen of a 14allMaster NMR titration software output which illustrates the binding curve, 
association constant and associated error of fit for the anion core titrated against tetrabutylammonium iodide. 
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Figure 80 – Figure to show the Job plot obtained from 14allMaster software for the anion 
core titrated against tetrabutylammonium. 
 
From the Job plot shown in figure 80, it is apparent that binding is one to one; this binding 
motif was seen for both the core and polymer with each anionic guest. The binding constants 
obtained are tabulated overleaf in table 1. 
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 Core 1:5 HBP 
(Mn – 4000) 
 
 
F
-
 
I)  9670 
II) 8130 
8900 ± 1690 
I) 1800 
II) 1910 
1855 ± 328 
 
 
Cl
- 
I) 66800 
II) 67100 
66950 ± 20100 
I) 1783 
II) 1580 
1682 ± 572 
 
 
Br
-
 
I) 6250 
II) 5530 
5890 ± 360 
I) 11000 
I) 9820 
10410 ± 2600 
 
 
I
- 
I) 894 
II) 672 
783 ± 111 
I) 3570 
II) 3740 
3655 ± 391 
 
 
C6H5CO2
- 
I) 6740 
II) 8620 
7680 ± 940 
I) 7500 
II) 7240 
7370 ± 884 
 
 
CH3CO2
- 
I) 4920 
II) 5530 
5225 ± 605 
I) 6210 
II) 6550 
6380 ± 702 
 
 
H2PO4
- 
I) 1120 
II) 1030 
1075 ± 45 
I) 638 
II) 572 
605 ± 33 
Table 1 – Table to illustrate the binding constants and associated errors obtained for N, N’- 
Bis-(3-acetoxy-phenyl)-isophthalamide and the core-functionalised polymer (1:5). All data 
obtained from a 1:1 fit. All titrations were performed in deuterated chloroform at room 
temperature. 
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From initial analysis of the halides, it is evident that the polymer is having a negative effect 
upon interaction of chloride and fluoride whereas, for the larger, softer bromide and iodide 
ions, binding is significantly increased in the polymeric system. Dihydrogen phosphate 
displays weaker binding in the polymeric system, whereas, benzoate and acetate appear to 
show no significant change, meaning that, at this molecular weight, the steric effects and 
geometric restraints appear to not be having an adverse effect upon binding. 
 
3.4.3 Effect of molecular weight upon anion binding 
As mentioned previously in 3.4, work within the group involved the examination of the effect 
of molecular weight upon binding affinities of pyridyl ligands with zinc porphyrin cored 
hyperbranched polymeric systems. The trend realised for each ligand was that as molecular 
weight increased, the binding constant increased due to positive electronic effects from the 
polymer system. This increase occurred up to a point in which there was a dramatic drop in 
association, this point was the threshold at which the onset of dense packing was realised and 
access to the core restricted. From comparison of binding to the anion receptor and to the 
hyperbranched polymeric system of 4000 molecular weight interesting results were obtained 
for the different anionic species. It appeared that the geometric constraints of the non-
spherical anions were not problematic for a polymer this size. For the smaller halides, the 
polymer had an adverse effect upon binding, whereas, for the softer more diffuse bromide 
and iodide ions, the polymeric system was providing a better environment as a host.  
Therefore, the next stage of this project was to synthesise polymer systems, both higher and 
lower than 4000 molecular weight. The core to monomer ratio was altered to fabricate an 
oligormeric, open structure (1:1) and a larger polymeric system with a molecular weight 
higher than the point of onset of dense packing (1:20). This would provide insight into 
whether steric effects and geometric limitations play an important role in binding.  
 
3.4.3.1 Polymerisation of 3, 5-diacetoxybenzoic acid with N, N’- Bis-(3-acetoxy-phenyl)-
isophthalamide core using a 1:1 ratio to generate an oligormeric system 
For the smaller system a molecular weight between 1000 and 2000 would be an ideal 
polymeric model for an expanded cleft structure. As a 1:5 core to monomer ratio gave a 
molecular weight of 4000, a 1:1 core to monomer ratio was attempted. In the reaction flask, 
N, N’- Bis-(3-acetoxy-phenyl)-isophthalamide and monomer were introduced (1:1) along 
with diphenyl ether solvent. The general procedure for polymerisation of 3, 5 
diacetoxybenzoic acid, as detailed in section 3.3.4, was consequently followed. As identified 
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beforehand, 
1
HNMR is critical in the confirmation that the core has been covalently 
introduced. The 
1
HNMR spectrum can be seen below in figure 81.  
 
 
Figure 81 – Figure to show the 1HNMR expansion (6.4 ppm to 9.1 ppm) of poly 3, 5 
diacetoxybenzoic acid with N, N’- Bis-(3-acetoxy-phenyl)-isophthalamide core (1:1). The 
marked signal is resolved chloroform in deuterated chloroform.  
 
When the core to monomer ratio is reduced, the polymer peaks are not as dominant, resulting 
in a spectrum with more signal overlap in comparison to higher ratios. As a result of this, 
spectral assignment becomes problematic. A broad multiplet can be seen from 8.57 to 8.74 
ppm which houses the NH protons. Infra-red also provided product validation by verifying 
functional groups present. GPC analysis gave a molecular weight of 1554 and the value 
obtained from NMR was 2034. The small margin between both estimations provides 
confidence in a high level of core incorporation. From the NMR spectrum it was calculated 
that approximately 7 monomer units surround a core unit. The estimated chemical structure is 
displayed in figure 82. 
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Figure 82 – Figure to show the chemical structure of poly 3, 5 diacetoxybenzoic acid with N, 
N’- Bis-(3-acetoxy-phenyl)-isophthalamide core (1:1). 
 
3.4.3.2 Polymerisation of 3, 5-diacetoxybenzoic acid with N, N’- Bis-(3-acetoxy-phenyl)-
isophthalamide core using a 1:20 ratio to generate a large polymeric system 
The general procedure for polymerisation was employed with the alteration to the monomer 
mass. For higher amounts of monomer, the polymer signals become more dominant, thereby 
reducing the sharpness of core signals observed. The 
1
HNMR spectrum (figure 83) gives a 
broad multiplet from 8.57 to 8.67 ppm, which is representative of the NH protons from the 
receptor incorporated. As is apparent from the spectra, the polymer signals predominate and, 
as a result, the core signals become thwarted. With a higher core to monomer ratio, 
concentration determination for titration analysis was crucial as the core signals are weaker 
and harder to distinguish; therefore, too low a concentration would lead to a high inaccuracy 
in spectral interpretation.  
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Figure 83  - Figure to show the 
1
HNMR analysis of poly 3, 5 diacetoxybenzoic acid with N, 
N’- Bis-(3-acetoxy-phenyl)-isophthalamide core (1:20). The marked signals are due to 
presence of resolved chloroform and residual diphenyl ether solvent in deuterated chloroform. 
 
GPC analysis gave a molecular weight value of 10, 500 and NMR gave a value of 12, 229. 
The discrepancy between estimations is higher in this case than for polymers with a lower 
core to monomer ratio. In spite of this, the margin between the values is still relatively small, 
meaning that the core incorporation is relatively high. From the proton NMR spectrum it was 
estimated that there were approximately 40 monomer units surrounding the anion receptor, 
generating a more globular polymeric system (figure 84). 
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Figure 84 – Figure to show the estimated chemical structure for of poly 3, 5 
diacetoxybenzoic acid with N, N’- Bis-(3-acetoxy-phenyl)-isophthalamide core (1:20). 
 
3.4.3.3 Effect of molecular weight upon interaction 
With the fabrication of three polymers of contrasting molecular weights, the next stage was 
the investigation into binding of an oligormeric polymer system and a globular polymer 
system, where access to the core is more restricted. After deduction of appropriate 
concentrations, the procedure for analysis by NMR titrations, mentioned in 3.2.4.1, was 
employed. The binding constants for the core and each polymeric system are tabulated 
overleaf in table 2. The data has also been normalised with respect to the core so as to focus 
solely on the effect of polymer size. The normalised data is also tabulated overleaf in table 3 
and also illustrated in a column chart in figure 85. 
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 Core 1:1 HBP 
(Mn – 1600) 
1:5 HBP 
(Mn – 4000) 
1:20 HBP 
(Mn – 10500) 
 
 
 
F
-
 
I)  9670 
II) 8130 
8900 ± 1690 
I) 1930 
II) 2060 
1995 ± 379 
I) 1800 
II) 1910 
1855 ± 328 
I) 2460 
II) 2040 
2250 ± 210 
 
 
Cl
- 
I) 66800 
II) 67100 
66950 ± 20100 
I) 1460 
II) 1510 
1485 ± 178 
I) 1783 
II) 1580 
1682 ± 572 
I) 1180 
I) 1180 
1180 ± 212 
 
 
Br
-
 
I) 6250 
II) 5530 
5890 ± 360 
I) 12300 
I) 13700 
13000 ± 1200 
I) 11000 
I) 9820 
10410 ± 2600 
I) 10300 
II) 11200 
10750 ± 1720 
 
 
I
- 
I) 894 
II) 672 
783 ± 111 
I) 1220 
II) 1030 
1125 ± 95 
I) 3570 
II) 3740 
3655 ± 391 
I) 1410 
II) 1290 
III) 1340 
1347 ± 63 
 
 
C6H5CO2
- 
I) 6740 
II) 8620 
7680 ± 940 
I) 8690 
II) 9440 
9065 ± 688 
I) 7500 
II) 7240 
7370 ± 884 
I) 547 
II) 464 
505 ± 41.5 
 
 
CH3CO2
- 
I) 4920 
II) 5530 
5225 ± 605 
I) 5040 
II) 5590 
5315±275 
I) 6210 
II) 6550 
6380 ± 702 
I) 224 
II) 241 
232.5 ± 8.5 
 
 
H2PO4
- 
I) 1120 
II) 1030 
1075 ± 45 
I) 633 
II) 616 
625 ± 21 
I) 638 
II) 572 
605 ± 33 
I) 81.7 
II) 82.8 
82.25 ±7 
Table 2 –  Table of binding constants and relative errors associated with the binding fit for 
the anion binding core, N, N’- Bis-(3-acetoxy-phenyl)-isophthalamide, and core 
functionalised hyperbranched polymers of varying molecular weights when titrated against a 
range of anionic guests. All titrations were performed in deuterated chloroform at room 
temperature.  
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 Core 1:1 HBP 
(Mn – 1600) 
1:5 HBP 
(Mn – 4000) 
1:20 HBP 
(Mn – 10500) 
 
F
-
 100 22.4 (±4.3) 18.6 (±3.3) 25.3 (±2.4) 
Cl
- 
100 2.2 (±0.3) 2.5 (±0.8) 1.8 (±0.3) 
Br
-
 100 220.7 (±20.0) 176.7 (±44.2) 182.5 (±29.2) 
I
- 
100 143.7 (±12.1) 466.8 (±49.9) 172.0 (±8.1) 
C6H5CO2
- 
100 118.0 (±10.6) 96.0 (±11.5) 6.6 (±0.6) 
CH3CO2
- 
100 101.7 (±5.3) 122.1 (±13.4) 4.4 (±0.2) 
H2PO4
- 
100 58.1 (±2.0) 56.3 (±3.1) 7.7 (±0.6) 
Table 3 – Table to show the relative binding affinities for anions to each polymer. (Relative 
to the core which was normalised to 100%).  
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(a) 
 
(b)
Figure 85 – A column chart to show the binding effects for (a) halides to each polymer 
relative to the core (normalised to 100%) and (b) benzoate, acetate and dihydrogen phosphate 
to each polymer relative to the core (normalised to 100%). The dashed lines are 
representative of the core data; below the line indicates a negative effect upon binding and 
above the line indicates a positive effect upon binding. Individual column charts with error 
bars for each hyperbranched polymer system can be found in appendix D. 
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From analysis of the data concerning the non-spherical anions, similar trends are observed as 
seen with the zinc porphyrin cored system. Past the point of onset of dense packing, the 
added steric barrier results in a dramatic drop in association constant for the 1:20 
hyperbranched polymer system. With the organic ions there is also the added obstacle of 
geometry. With restricted access to the core, the added complication of geometric restraints 
could therefore account for the poor association constants calculated with this monomer to 
core ratio. With acetate and benzoate, binding appears to be as effective in the 1:1 and 1:5 
polymer when compared to association to the native receptor, whereas interaction of 
dihydrogen phosphate, strongest binding is observed for the core.  From analysis of the data 
for the halide ions, a noticeable result is seen for iodide in the 1:5 hyperbranched polymer 
system. The polymer of 4000 molecular weight showed considerably stronger binding 
compared to the free core and other polymer systems. The result appeared irregular but, after 
several repetitions, the observation was confirmed. For bromide, the oligormeric polymer 
provided a more optimum environment compared to larger polymers. Nevertheless, it is still 
evident that bromide is more strongly bound when the receptor is covalently incorporated 
within poly 3, 5 diacetoxybenzoic acid as opposed to its native state. A different scenario is 
observed for the smaller halide anions. By covalent incorporation of the receptor, there is 
depletion in the association constants, effectively meaning both ions are deselected. In order 
to facilitate observation of these trends and see the effect of molecular weight upon each 
anionic guest individually, line graphs have been created for each anion and are found 
overleaf (figure 86 to 92). 
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Figure 86 – A Line graph to show the 
effect of molecular weight upon interaction 
with tetrabutylammonium fluoride. 
 
Figure 87 – A Line graph to show the 
effect of molecular weight upon 
interaction with tetrabutylammonium 
chloride. 
 
Figure 89 – A Line graph to show the 
effect of molecular weight upon 
interaction with tetrabutylammonium 
bromide. 
 
 
Figure 88 – A Line graph to show the 
effect of molecular weight upon 
interaction with tetrabutylammonium 
iodide. 
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Figure 91– A Line graph to show the effect 
of molecular weight upon interaction with 
tetrabutylammonium benzoate. 
 
 
Figure 90 – A Line graph to show the effect 
of molecular weight upon interaction with 
tetrabutylammonium acetate. 
 
Figure 92 – A Line graph to show the effect 
of molecular weight upon interaction with 
tetrabutylammonium phosphate monobasic. 
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From the data obtained, it appears that the incorporation of the isophthalamide based receptor 
within poly 3, 5 diacetoxybenzoic acid results in increased selectivity of larger, softer anions; 
namely bromide and iodide. Kavallieratos et al.
45
 used a plot of Gibbs free energy versus the 
ionic radii for a selection of hard and soft anions in order to clarify any trends observed 
regarding selectivity. Therefore, it was postulated that the inclusion of a plot of this kind, 
relative to the data obtained, would help elucidate the trends experienced for the core and 
range of polymer receptors. In table 4 one can see the data for the ionic radii of the ions 
selected (with the exception of benzoate), experimental hydration free enthalpies (scaled by 
10
-1
)
 91
 and the corresponding ΔG values for the core and polymer systems. This data has also 
been presented as a scatter graph, and can be seen in figure 93. The hydration data of the ions 
provides confirmation that smaller, harder anions are more able acceptors of Hydrogen bonds 
compared to bulkier softer anions.
45
 
 
 
 
 
Anionic 
Guest 
Ionic 
radius 
ΔG (hydration) 
(10
-1
 kJmol
-1
) 
ΔG (core) 
(kJmol
-1
) 
ΔG  
(1:1 HBP) 
(kJmol
-1
) 
ΔG 
(1:5 HBP) 
(kJmol
-1
) 
ΔG 
(1:20 HBP) 
(kJmol
-1
) 
F
-
 0.133 -46.5 -22.53  -18.83 -18.65 -19.12 
Cl
-
 0.181 -34 -27.53 -18.09 -18.40 -17.52 
Br
-
 0.196 -31.5 -21.51 -23.47 -22.92 -22.99 
I
-
 0.22 -27.5 -16.51 -17.41 -20.33 -17.85 
CH3CO2
-
 0.162 -36.5 -21.21 -21.30 -21.71 -13.50 
H2PO4
-
 0.2 -46.5 -17.29 -15.95 -15.87 -10.93 
Table 4 – Table to show the ionic radii of anionic guests and the corresponding experimental 
ΔG values for the core and polymer systems. Experimental hydration free enthalpies (10-1) 
and the ionic radii data has been taken from the literature.
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Figure 93 – A plot to represent ΔG vs. ionic radius for fluoride, acetate, chloride, bromide 
and iodide. 
 
The scatter graphs presented in figure 93 show the relative selectivity for each polymer 
system and the native receptor. From comparison of the hydration data with the experimental 
data, it is apparent that the polymer systems deviate from expected binding results, whereby, 
larger softer anions appear to be selected over small hard anions. From analysis of the scatter 
graphs, the core appears most stable for chloride. Therefore, in geometrical terms, the native 
receptor provides the best geometry for chloride. The scatter graph for the native receptor 
also shows the same gradient as the hydration data for chloride, bromide and iodide. 
However, with the hyperbranched polymer systems, the trend differs. As the anion binding 
site is identical for all receptor systems, the hyperbranched polymer must be involved in 
binding, whereby the polymeric structure is perhaps providing additional stability. It has been 
shown in previous studies that fixed receptors and synthetic anion receptors on the whole 
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have a tendency to bind smaller anions more favourably, whereas selective receptors for 
bulky, softer anionic guests is synthetically more challenging. Therefore, the results observed 
for the hyperbranched polymer systems and their selectivity towards bromide and iodide are 
extremely promising.  
 
Work by Kavallieratos et al.
45
 showed the enhanced binding affinity towards smaller halides 
by the incorporation of a nitrogen atom in close proximity to the anion binding site (scheme 
19). The lone pair is sterically more bulky when compared to an aromatic C-H bond and, as a 
result, the repulsion between the lone pair and negatively charged guest will reduce the 
binding strength. This adverse effect will be more notable for larger more diffuse ions 
(bromide and iodide), thus resulting in a higher selectivity for smaller harder ions (fluoride 
and chloride). Therefore, a possibility for future work could be to implement this synthetic 
approach in order to see whether the poor selectivity towards fluoride and chloride in the 
current isophthalamide polymeric systems could be improved.  
 
 
Scheme 19 – The synthetic procedure, developed by Kavallieratos et al., for an anion 
receptor which possesses a nitrogen atom in close proximity to the binding site, resulting in 
an improvement in affinity towards smaller harder anions.
45
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3.5 Fabrication of a water soluble hyperbranched polymeric anion receptor 
As mentioned previously, developing an organic system was to serve as proofs of principle, 
demonstrating that an anion receptor can be covalently incorporated and still maintain the 
ability to bind anionic species. The ultimate goal, as stated beforehand, is to develop a core 
functionalised water soluble system. An effective organic binding system has been realised; 
therefore, the next stage was development of a core functionalised water soluble polymeric 
system. 
 
3.5.1 Selection of the monomer for a water soluble polymeric system 
Glycidol was decided as the monomer of choice when designing a water soluble dendritic 
polymer. Glycidol is an organic moiety containing both epoxide and alcohol functionality, 
which is able to polymerise to form a water soluble hyperbranched polymer. Polyglycidol has 
been explored in numerous areas of chemistry, including core encapsulation. Frey et al. 
demonstrated the complete incorporation of a photo-sensitiser core within hyperbranched 
poly ether polyols. They used ring opening multi-branching polymerisation (ROMP) of 
glycidol utilising slow addition of monomer, demonstrating the possibility to integrate a 
photoactive core within a hyperbranched polymer.
92
 Kim et al. demonstrated the use of this 
monomer as a reducing and stabilising agent in the synthetic procedure for water soluble, 
multifunctional, metal nanoparticles. The conditions involved in this research were 
completely green in nature, meaning that this polymer exhibits promise for biomedical use.
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Glycidol (87) has been studied extensively within the Twyman group, meaning the chemistry 
of this monomer is well understood. Glycidol is also particularly well established within 
literature, thereby deeming it an appropriate choice for this purpose.  
 
As is the case with the polymerisation of 3, 5 diacetoxybenzoic acid, the terminal 
functionality of the core molecule is crucial for compatibility with the polymerisation 
reaction. For polymerisation with glycidol, a core should ideally possess at least one –OH 
terminal group. Upon addition of base, the hydroxyl group will be deprotonated, resulting in 
generation of a RO
-
 moiety. This species can now attack the epoxide, triggering 
polymerisation (scheme 20). 
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Scheme 20 – Mechanism of the polymerisation of glycidol upon reaction with a hydroxyl 
terminated core. 
 
N, N’ – bis (3-acetoxyphenyl) isophthalamide proved to be a potent anion receptor for the 
organic soluble system and was compatible with polymerisation after repositioning of the 
terminal groups. As a result of this, it was postulated that N, N’ – bis (3-hydroxyphenyl) 
isophthalamide was selected as the core for development of a water soluble polymeric 
system. 
 
The polymerisation of 3, 5 diacetoxybenzoic acid is driven by thermodynamics, whereas, the 
polymerisation of glycidol is an irreversible kinetic reaction. A polymerisation driven by 
kinetics has numerous disadvantages in comparison to a reversible thermodynamic 
polymerisation reaction. It is not possible for core molecules to be distributed in a uniform 
manner within the polymer.  The level of core incorporation is dependent upon the rates of 
individual reactions which occur throughout polymerisation. In theory, there are two routes 
possible, polymerisation via monomer propagation or polymerisation via core propagation 
(scheme 21). Another factor to be considered is the relative reactivity of the core in relation 
to the monomer. This will determine whether core incorporation is favoured towards either 
the high or low molecular weight range. A drawback to this method is the impossibility to 
achieve complete core incorporation, as a result, a high level of core is required 
experimentally. 
164 
 
 
Scheme 21– Representation of the two potential routes in the polymerisation of glycidol in 
the presence of a core molecule. The insert shows a possible receptor interaction with anionic 
species generated during the polymerisation process. 
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3.5.2 Polymerisation of glycidol with a N, N’ bis – (3-hydroxyphenyl) isophthalamide 
core (1:20) 
The molar ratio of core to monomer implemented was 1:20 for this methodology. Firstly, N, 
N’ – bis (3-hydroxyphenyl) isophthalamide was dissolved in diethylene glycol dimethyl ether 
solvent in a 3-neck round bottom flask. The solution was heated to 50C and subsequently 
heated to 90C, upon complete dissolution of the core. After a period of 20 minutes, half an 
equivalent of sodium hydride was added and it was at this point a colour change was 
observed. The colourless solution became pale yellow in colour, upon addition of the base. 
After 90 minutes glycidol was added to the solution slowly over a period of 12 hours via a 
syringe pump. The reaction was left to stir for a further 5 hours before cooling to room 
temperature. Polyglycidol, with or without core incorporation, is insoluble in diethylene 
glycol dimethyl ether, meaning the solvent can be disposed of and the polymer will form an 
adhesive oil film on the inner surface of the reaction flask. However, after disposal of the 
solvent, no polymer appeared to remain. As can be seen from scheme 21, there are numerous 
anionic species generated throughout this polymerisation process. The core is highly capable 
of coordinating anionic guests, thereby preventing monomer propagation. However, the 
initial deprotonation of the phenolic species gave a colour change, indicating free anion was 
present in solution. Unfortunately, the equilibrium must have been shifted extensively in 
favour of the complexed species (effectively meaning any propagating and initiating anions 
are completely bound and unavailable for further reaction). This can be seen in the insert of 
scheme 21. 
 
3.5.3 Polymerisation of glycidol with a 4-Nitrophenol core (1:20) 
In order to confirm that it is the chemistry and not the chemist, polymerisation of glycidol 
was performed using 4-Nitrophenol as a core molecule (scheme 22). This molecule is not 
capable of coordinating anionic guests and has also been well studied within the Twyman 
group.  
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Scheme 22 – Reaction scheme for the incorporation of 4-Nitrophenol in polyglycidol. 
 
The general procedure discussed in section 3.5.2 was employed. However, upon removal of 
the solvent, a thin layer of adhesive oil could be seen lining the reaction flask, giving 
confidence that the polymerisation had been successfully achieved. After removal of solvent, 
the polymer was then dissolved in methanol before precipitation into excess acetone. The 
polymer was washed repeatedly with acetone and dried in a vacuum oven prior to analysis. 
As is the case for the determination of core incorporation within poly 3, 5 diacetoxybenzoic 
acid, proton NMR spectroscopy is also a crucial tool in establishing successful covalent 
incorporation of 4-Nitrophenol within polyglycidol. From implementation of 
1
HNMR, the 
core can be visualised within the polymeric structure. There are two proton environments 
present for 4-nitrophenol; two aromatic protons ortho to the nitro functionality and two 
aromatic protons ortho to the hydroxyl functionality. The two protons ortho to the nitro group 
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can be seen at 8.15 ppm, and the two protons ortho to the hydroxyl group can be seen at 7.05 
ppm. The nitro functionality is more electron withdrawing, in comparison to the hydroxyl 
group, thus explaining why the two protons ortho to the nitro group will be more deshielded. 
An expansion of the 
1
HNMR of the core protons can be seen in figure 94. The final peak of 
interest in the proton NMR spectrum is a broad multiplet occurring between 3.2-4.0 ppm, 
which is representative of the multiple proton environments within the polymer. This 
multiplet corresponds to the methine, methylene and hydroxyl proton environments present 
within the polyglycidol architecture. 
 
 
 
Figure 94 – Figure to show the 1HNMR expansion of the aromatic protons present in 4-
Nitrophenol. Marked signal is indicative of resolved chloroform in deuterated chloroform. 
 
In order to verify that the core has been covalently incorporated, the NMR sample was doped 
with 4-nitrophenol. The spectrum generated possessed two additional doublets at 8.1 ppm and 
6.8 ppm respectively, indicative of unincorporated 4-nitrophenol. An expansion of the doped 
spectrum can be seen in figure 95, the unincorporated4-Nitrophenol gives sharp doublets, 
whereas, core incorporated 4-Nitrophenol gives broader signals. 
 
6.97.07.17.27.37.47.57.67.77.87.98.08.18.2 ppm
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6.16.26.36.46.56.66.76.86.97.07.17.27.37.47.57.67.77.87.98.08.18.2 ppm
Figure 95 –Figure to show the 1HNMR expansion of core functionalised 
polyglycidol doped with 4-Nitrophenol. 
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3.6 Non-covalent encapsulation of an anion receptor 
Unfortunately, due to the nature of the polymerisation, an anion receptor does not appear to 
be suitable for core incorporation within polyglycidol; therefore, an alternative approach must 
be employed so that a fully functioning water soluble anion receptor system can be 
fabricated. Conversion of the terminal groups of the organic soluble hyperbranched 
polymeric system would be synthetically challenging, meaning non-covalent encapsulation 
was considered as a potential solution. Dendritic polymers are not the only materials which 
could be used to create a water soluble anion receptor; another approach could involve the 
use of di-block polymer micelles. Polymeric micelles have been studied extensively and have 
shown potential for use in numerous applications such as nano-bioreactors, viral gene vectors 
and drug delivery agents.
94
 The reasoning behind the growing fascination for block 
copolymers is their ability to self- assemble, both in bulk and solution. Amphiphilic block 
copolymers signify a large series of materials ranging from simple linear di-block structures 
containing a hydrophilic segment and a hydrophobic segment to much more complex multi-
block systems. This type of polymer can spontaneously self-assemble to give a 
supramolecular nanoparticle possessing a hydrophobic core shielded by a hydrophilic 
periphery. As previously mentioned, these polymeric micelles have shown promise in the 
area of medicinal chemistry, namely drug delivery. The drug molecule can be encapsulated 
within the hydrophobic interior, protected from the hydrophilic region of the micelle and be 
transported and distributed where desired. There are numerous examples in the literature 
utilising these micelles for this specific application. Quaglia et al. developed and investigated 
micelles based on amphiphilic poly (-caprolactone) and poly (ethylene oxide) copolymers 
with both linear and star architectures. Results obtained showed that these polymeric micelles 
displayed low toxicity towards red blood cells, thus showing potential as drug delivery agents 
for lipophilic drug molecules.
95
  Zhang et al. have developed a series of monomethoxy poly 
(ethylene glycol)- poly (lactide) (mPEG-PLA) di-block copolymers. These micelles were 
prepared and used to investigate the encapsulation of Cyclosporin, a highly lipophilic 
immunosuppressant drug used in post allogeneic organ transplant and severe cases of 
Ulcerative Colitis. Cyclosporin was encapsulated effectively and results demonstrated that 
the polymeric micelles maintained the release of the drug moiety. The intestinal absorption of 
cyclosporin was improved by these nanocarriers, thus showing promise for enhancing oral 
absorption of weakly absorbed drugs.
96
 More recently, Wang et al. have reported the 
synthesis of PEG-PE micelles and demonstrated their compatibility with drug molecules; 
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namely doxorubicin hydrochloride and vinorelbine tartrate. The loaded micelles not only 
showed sustained release, but an elevated level of stability.
97
 These are merely a few 
examples of the use of these polymeric materials in the area of drug delivery, for more 
information the reader is directed to the following literature.
98-100
 Therefore, for the purpose 
of this research, a linear amphiphilic di-block polymer could be used to encapsulate an anion 
receptor.  
 
In collaboration with Caroline Glover and Dr. Adam Ellis, the synthesis of polymeric 
micelles and the exploitation of encapsulation properties of these vehicles were realised. The 
block polymer chosen was the biocompatible poly (ethylene glycol) methyl ether – block – 
poly (ɛ-caprolactone) (mPEG-b-PCLn). This particular di-block polymer has received a great 
deal of interest in recent years and featured in numerous pieces of literature for its potential in 
the area of therapeutic medicine. For further information regarding the therapeutic potential 
of mPEG-b-PCL micelles, the reader is directed to the following literature.
101-108
 
 
3.6.1 Synthesis of mPEG-b-PCLn di-block copolymer 
The synthesis of a range of di-block copolymers and polymeric micelles was performed, 
under supervision, by Caroline Glover, a master’s student in the Twyman research group. A 
series of di-block copolymers, with varying composition of PCL/mPEG molar ratios, were 
prepared for comparison. The first stage of synthesis involved the addition of oven dried 
mPEG to a 2-neck round bottomed flask and stirred for 60 minutes at 130ºC under vacuum. 
The apparatus was refilled with nitrogen and ɛ-caprolactone was added (varying amounts) via 
a syringe. This was followed by the addition of 0.05% w/w tin (II) 2-ethyl hexanoate catalyst. 
The reaction mixture was then stirred for a period of 24 hours at 130ºC to yield a white solid 
at ambient temperature. The white solid obtained was dissolved in dichloromethane and 
precipitated into petroleum ether 40-60 to yield the di-block copolymer. This synthetic 
procedure proceeds via catalysed ring opening polymerisation of ɛ-caprolactone monomer, 
initiated by mPEG (scheme 23). 
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Scheme 23– Synthesis of mPEG45-b-PCLn (where n = 5, 10, 20 and 60). 
 
Analysis of the polymers was also carried out by Caroline Glover; the experimental data 
obtained from said analysis is recorded in the experimental chapter of this thesis. The 
1
HNMR spectra provided evidence of the structures. The methylene protons of poly (ɛ-
caprolactone) in the product can be found at 2.32, 1.66, 1.39 and 4.07 ppm; these signals are 
indicative of α, β+δ, γ and ɛ positions to the ester carbonyl group respectively. There are also 
two singlets at 3.39 and 3.65 ppm which are characteristic of the mPEG section of the di-
block copolymer. Infra-red spectroscopy also provides structural evidence as it confirms the 
presence of the ester carbonyl functional group with a signal at 1721 cm
-1
. The presence of 
this stretch confirms the success of the ring opening polymerisation. The GPC and NMR 
molecular weight estimations, along with the PDI and the theoretical and experimental chain 
lengths of the poly (ɛ-caprolactone) segment, are tabulated overleaf in table 5. 
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3.6.2 Exploiting the encapsulation properties of polymeric micelles 
Previous results within the group have shown that micelles usually lie within the range of 20 
to 40 nm in diameter, with a hydrophobic cavity of approximately between 10 and 15 nm. 
The size of the structure to be encapsulated can be approximated in angstroms and 
subsequently converted to nanometres, so as to deduce whether it is of adequate size to sit 
within the hydrophobic pocket. The polymer receptor (1:20) was estimated to be 
approximately 1nm is size, meaning each polymeric receptor system are well within range to 
fit comfortably within the internal hydrophobic cavity. To estimate the size in nanometres, 
the 
1
HNMR spectrum was used to calculate the approximate number of monomer units 
present in the polymer. This calculation was then used to deduce a proposed chemical 
structure. The approximate distance between a C1 and C3 in a three carbon chain (propyl 
unit) is approximately 1.5 Å. A carbon chain can be broken down into propyl units and the 
maximum distance of any chain can be estimated by calculating the number of propyl units 
(or 3 atom chains) and multiplying by 1.5 Å. Therefore, using this information, the distance 
from one end of the estimated polymer structure to the other can be estimated in Angstroms. 
It is postulated that, when a species is encapsulated within a micelle structure, the micelle 
will subsequently swell, regardless of the nature of the encapsulated guest. As the anion 
receptor polymer system is not UV active it will be difficult to ascertain whether or not 
encapsulation within a polymeric micelle has occurred. Therefore, encapsulation of a 
porphyrin and porphyrin cored hyperbranched polymers of varying molecular weights were 
to be encapsulated first. This was necessary so as to confirm that the method of encapsulation 
 n = 5 n = 10 n = 20 n = 60 
Molecular weight from GPC 1921 2506 4344 7772 
Molecular weight from NMR 2399 3057 5893 10025 
Theoretical length of poly (ɛ - 
caprolactone) chain 
5 10 20 60 
Experimental length of poly (ɛ - 
caprolactone) chain 
4 10 23 68 
PDI 1.20 1.18 1.23 1.34 
Table 5 – Table to show the molecular weight values obtained from GPC and NMR, the PDI 
and the theoretical and estimated chain lengths of poly (ɛ - caprolactone) segments in each of 
the di-block copolymers synthesised. 
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is sufficient and also show that encapsulation of a hyperbranched poly-3, 5 diacetoxybenzoic 
acid systems could be accomplished. 
 
3.6.3 Synthesis of tetraphenyl porphyrin (TPP) 
 The poly 3, 5 diacetoxybenzoic acid anion receptor system does not possess a UV active 
core, meaning visualisation within the micelle is difficult. In order to first probe the 
encapsulation properties of micelle structures, aromatic porphyrin molecules were chosen. 
Porphyrin structures exhibit high absorption in the visible spectrum and, as the loaded 
compound must be detected in order to confirm encapsulation, a porphyrin seemed an 
appropriate choice. The first porphyrin synthesised is tetraphenyl porphyrin (TPP), which is 
shown in scheme 24. The first stage of synthesis involved the addition of pyrrole and 4-
benzaldehyde to a reaction flask containing propionic acid. The flask was equipped with a 
reflux condenser and the solution was heated to reflux for a period of 30 minutes. The 
product was subsequently isolated by vacuum filtration.  
 
 
 
Scheme 24 – Reaction scheme for the synthesis of TPP. 
 
Validation of the desired product was reached by the use of a range of analytical techniques. 
An important tool used for the characterisation of the macrocycle was 
1
HNMR spectroscopy. 
A singlet can be visualised at 8.90, integrating to 8 protons, which is indicative of the pyrrolic 
methine protons. There are also signals at 8.27 and 7.81 ppm, which correspond to the ortho, 
meta and para Phenylic protons. The porphyrin structure was confirmed by the presence of 
the NH singlet at -2.71 ppm. These protons are found up field as they are located within the 
shielding cone of the porphyrin. Further evidence was given from mass spectrometry; the ES-
MS spectrum gave a signal at 615, which is indicative of the MH
+
 ion. UV/Vis spectroscopy 
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showed the presence of the characteristic high absorption Soret band at 418.5 nm, along with 
four Q bands, which gave weaker absorption at 515.0, 550.0, 590.5 and 645.0 nm 
respectively. The Q bands are much weaker as they correspond to the pseudoparity forbidden 
S0 to S1 transition. The combination of these techniques with IR and 
13
CNMR gives 
confidence in the success of the synthetic procedure and the purity of the product obtained. 
Tetraphenyl porphyrin is simple to synthesise but has zero solubility in water, meaning that 
any improvement in water solubility is difficult to quantify. Furthermore, previous work 
within the group showed that TPP had a tendency to aggregate; meaning encapsulation was 
also challenging to quantify. To overcome these problems, it was decided that a porphyrin 
with higher solubility in water should also be studied.  
 
3.6.4 Synthesis of 3, 5-dihydroxyphenyl porphyrin 
The second porphyrin required for encapsulation studies is 3, 5-dihydroxyphenyl porphyrin. 
The synthetic procedure for this particular macrocycle involved multiple steps; the first stage 
involved the synthesis of 3, 5-dimethoxyphenyl porphyrin and the second stage involved the 
demethylation of said macrocycle, giving 3, 5-dihydroxyphenyl porphyrin. 
 
3.6.4.1 Synthesis of 3, 5-dimethoxyphenyl porphyrin 
The initial step involved the use of the Rothemund
109
 and Adler-Longo
110, 111
 method. This 
method will be discussed in further detail in Chapter 4 (section 4.3.2.2). Equal molar 
quantities of 3, 5-dimethoxybenzaldehyde and pyrrole were refluxed in propionic acid for a 
period of 30 minutes (scheme 25). The product was isolated via vacuum filtration and 
washed meticulously with methanol. 
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Scheme 25– Synthesis of 3, 5-dimethoxyphenyl porphyrin. 
 
The UV/Vis absorption spectrum confirmed the existence of porphyrin by showing the 
presence of the high absorption Soret band at 421 nm and four weaker Q bands at 515, 550, 
589 and 649.5 nm respectively. From analysis of the 
1
HNMR spectrum, there is a signal at 
8.97 ppm, corresponding to the pyrrolic methine protons. There are two multiplets at 7.43 and 
6.93 ppm, which are indicative of the ortho and para Phenylic protons. A singlet signal can 
be seen at 3.99 ppm integrating to 24 protons, corresponding to the methyl protons present on 
the methoxy functional groups. A singlet can also be seen at -2.80 ppm which relates to the 
highly shielded NH protons. ES-MS also displays a signal at 855 for the MH
+
 ion, thereby 
providing additional structural evidence. The next stage of the synthetic procedure was the 
demethylation of the octa-methoxy functionalised porphyrin macrocycle. 
 
3.6.4.2 Demethylation of 3, 5-dimethoxyphenyl porphyrin 
Demethylation was performed by using boron tribromide as the demethylation agent. Boron 
tribromide is widely used in the de-alkylation of methyl aryl ethers.
112
 The synthetic 
procedure is illustrated below in scheme 26. 
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Scheme 26 – Synthesis of 3, 5-dyhydroxyphenyl porphyrin. 
 
A reaction flask was charged with 3, 5-dimethoxyphenyl porphyrin and anhydrous 
dichloromethane solvent and stirred under an atmosphere of nitrogen for a period of 10 
minutes. Boron tribromide was added drop-wise to the reaction mixture via a syringe, 
inducing a green colour change. The Lewis acidic species interacts with oxygen, leading to 
the loss of a bromide ion. This then attacks the methyl group, successively ejecting methyl 
bromide. Hydrolysis subsequently takes place and replaces each bromide with a hydroxyl 
group, whilst boron leaves as boric acid.  
 
The reaction took place at room temperature under nitrogen, followed by careful quenching 
with distilled water. Due to the violence of the interaction between surplus boron tribromide 
and water, stirring was continued for an additional 20 minutes to ensure any excess boron 
tribromide present is removed. Once quenching is complete, the reaction mixture was 
neutralised with sodium hydrogen carbonate in order to remove any acid present, followed by 
the extraction with ethyl acetate. Boric acid generated during the reaction results in the colour 
change. The green colour of the solution, prior to neutralisation, is due to protonated 
porphyrin. Upon neutralisation with sodium hydrogen carbonate, the organic phase becomes 
a more characteristic purple colour and the aqueous phase becomes colourless. Insoluble 
impurities which form at the solvent interface were removed via vacuum filtration. The 
solvent was removed by rotary evaporation, yielding the product. From analysis of the 
1
HNMR spectrum, the peak corresponding to the methyl protons was no longer present. In 
addition to this, the 
13
CNMR spectrum showed a loss of the signal at 55.3 ppm, which was 
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representative of the methoxy carbon. Additional evidence was provided by Infra-red 
spectroscopy, which showed a broad O-H stretch at 3025 cm
-1
. Furthermore, the ES-MS 
spectrum showed a signal at 743, which was specific to the MH
+
 ion. The Soret band and 
four Q bands were visualised in the UV/Vis absorption spectrum; therefore, the combination 
of each analytical tool used gives confidence in the successful demethylation of 3, 5-
dimethoxyphenyl porphyrin.  
 
3.6.5 Poly 3, 5 – diacetoxybenzoic acid with a 3, 5 diacetoxyphenyl porphyrin core 
The polymer was provided by Adam Ellis and was synthesised from 3, 5-dihydroxyphenyl 
porphyrin. The first step involved the acetylation of 3, 5-dihydroxyphenyl porphyrin with 
acetic anhydride to generate 3, 5 diacetoxyphenyl porphyrin. The porphyrin was then reacted 
with the monomer, 3, 5-diacetoxybenzoic acid, to generate the polymer. The synthetic 
procedure and characterisation for both 3, 5-diacetoxyphenyl porphyrin and poly 3, 5 – 
diacetoxybenzoic acid with a 3, 5 diacetoxyphenyl porphyrin core can be found in the 
experimental chapter of the PhD thesis by Dr. Adam Ellis, pages 176 and 177 (compounds 12 
and 13).
86
 
 
3.6.7 Micelle Formation 
Micelle samples of di-block copolymers were prepared, under supervision, by Caroline 
Glover using a direct dissolution method, in which an aqueous solution of polymer (at the 
appropriate concentration for micelle formation) was vigorously stirred for a period of 30 
minutes using a shaker device. 
 
3.6.7.1 Determination of the critical micelle concentration (CMC) 
Prior to encapsulation studies, the appropriate concentration required for analysis needed to 
be determined. For micelles to form in solution, the concentration of polymer must be just 
above the critical micelle concentration (CMC). The determination of appropriate 
concentration is crucial as, if the concentration is too high, larger aggregated species will 
form instead of the desired micelle structure. Similarly, if the concentration is below the 
CMC, unimers will exist and no self-assembly will take place. In order to determine this 
concentration, Caroline Glover examined the changing hydrodynamic diameter with varying 
concentrations of mPEG-b-PCLn polymeric solutions. The data obtained for the PCL chain of 
5 is illustrated in figure 96. 
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Figure 96 - A graph to show the change in hydrodynamic diameter with a range of 
concentrations of mPEG-b-PCL5 polymeric micelles.  
 
The CMC data for chain lengths of 10 and 20 showed similar trends to the CMC line graph 
above. As can be seen from the data, the optimum concentration for micelle formation is 0.3 
mg/mL. Succeeding micelle formation, the hydrodynamic diameter was measured using 
dynamic light scattering (DLS) and the analysis was based upon volume distribution. It is 
important to note that analysis by DLS utilises zeta potentials, thereby generating values that 
are considerably larger than a standard micelle. This is because it is not simply a 
measurement of particle size, but a measurement of the particle size and the associated 
solvent, which in this case is water. 
 
3.6.7.2 Encapsulation studies 
As specified beforehand, in addition to the two porphyrin macrocycles synthesised, two 
different molecular weight hyperbranched polymeric systems were used for encapsulation 
studies and were provided by Dr. Adam Ellis.
86
 It was essential to use a hyperbranched poly 
3, 5-diacetoxybenzoic acid system, as this is the polymer used for anion receptor design and 
will provide the necessary comparison. The polymers each contained a 3, 5 diacetoxyphenyl 
porphyrin core, which enables confirmation of encapsulation through UV/Vis spectroscopy. 
For the porphyrin macrocycles and core functionalised hyperbranched polymeric systems, an 
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absorption signal was observed between 417 and 423 nm, indicating successful encapsulation 
of each species. The hydrodynamic diameter was measured prior to encapsulation and then 
again after encapsulation of each of the compounds. The data obtained can be seen below in 
figure 97. 
 
Figure 97 – A graph to show the hydrodynamic diameter of loaded mPEG-b-PCL5 at 0.3 
mg/mL. The blue columns represent the initial diameter measured prior to encapsulation and 
the red columns show the change to the diameter after encapsulation of a variety of guests. 
 
As can be seen from the column chart, when each porphyrin macrocycle is loaded into a 
polymeric micelle, there is a swelling of diameter observed. This is the postulated effect upon 
loading. However, this is not the case for the core functionalised hyperbranched polymer 
systems. Instead of a swelling observed, the micelle structure appears to shrink when the 
hyperbranched polymer is encapsulated. After repetition of these results, the same effect is 
observed. It can be postulated that the hydrophobic segments appear to be dipping into the 
encapsulated polymer, effectively meaning the hyperbranched polymer is dissolving the 
hydrophobic regions of the di-block copolymer. This could account for the shrinking of the 
micelle diameter after encapsulation. In spite of this, the molecule as a whole is still water 
soluble. In order to gain a better understanding of the chemistry involved, transmission 
electron microscopy (TEM) was used
† 
for visualisation of the micelle structures both before 
and after encapsulation of various molecules (figure 98). 
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†
TEM imaging was performed by Dr. Svetomir Tsokov in the Department of Biomedical Science, 
University of Sheffield.  
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Figure 98 – A figure to show the TEM images for (a) mPEG-b-PCL10 at 0.3mg/mL (b) 3, 5 
dihydroxyphenyl porphyrin macrocycle encapsulated within mPEG-b-PCL10 at 0.3mg/mL 
and (c) 3, 5 dihydroxyorphyrin cored hyperbranched polymer encapsulated within mPEG-b-
PCL10 at 0.3 mg/mL. 
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From the TEM images of the di-block prior to encapsulation, it is evident that there are 
micelles present, ranging between 15 and 25 nm. There is also a larger vesicular structures 
present. This could account for the large particle sizing measurements obtained via DLS. The 
presence of a large vesicle would lead to a high amount of scattering and even the presence of 
only a few larger aggregates, in comparison to smaller micelle structures, would have a 
significant effect upon the particle size measured. This is a potential explanation for the large 
values obtained from DLS analysis.  
 
From examination of the TEM images of the di-block micelle after encapsulation of a 3, 5 
dihydroxyorphyrin macrocycle, the structures visualised are larger in size than the micelles 
obtained prior to encapsulation, explaining the observed swelling. It is also apparent that the 
morphology of the structures has changed after inclusion of a porphyrin macrocycle. The 
observed structures deviate slightly from spherical micelles and appear as ricicle type 
structures, this could be a result of the occurrence of π-π stacking. In addition, there is also 
the presence of larger aggregates such as vesicles. 
 
The images shown for the micelles which contain a 3, 5 dihydroxyorphyrin cored 
hyperbranched polymer deviate from the DLS measurements obtained. As detailed before, 
the micelles appear to shrink in size from analysis of the particle measurements before and 
after encapsulation. However, the TEM images obtained show spherical micelles which are 
larger in size than those without an encapsulated guest. From analysis of the TEM there are 
no larger aggregated species present such as the vesicles shown in figure 98 and 99. As a 
result, there would be less scattering experienced, thus explaining the smaller value obtained 
from DLS spectroscopy. It can therefore be concluded that the polymer is not dissolving the 
hydrophobic regions of the di-block polymer. As originally hypothesised, the micelles are 
behaving as expected and swelling in size due to the presence of the guest. 
 
Following these results, the hyperbranched polymeric anion receptor was encapsulated and 
the hydrodynamic diameter was subsequently recorded. A similar result was observed, 
whereby the micelle structure appeared to shrink in size after introduction of the 
hyperbranched polymeric receptor system. This is the same observation for the porphyrin 
cored hyperbranched polymer guest. For the porphyrin cored system, as mentioned above, the 
TEM images showed that swelling occurred, despite the apparent reduction in particle size, 
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from DLS analysis. Therefore, TEM images were obtained for the hyperbranched polymeric 
anion receptor (figure 99). 
 
 
(a)  
 
 
 
 
 
 
 
 (b)  
 
 
 
 
 
 
 
 
 
 
 
From analysis of the TEM images of the micelles after encapsulation of poly-3, 5-
diacetoxybenzoic acid with an anion receptor core, swelling of the micelles appears to take 
place. Although there is no conclusive evidence that it has been successfully encapsulated 
within the di-block copolymer micelle, similar results to the porphyrin cored hyperbranched 
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Figure 99 – Figure to show the TEM images for (a) mPEG-b-PCL10 at 0.3mg/mL 
and (b) hyperbranched polymeric anion receptor encapsulated within mPEG-b-
PCL10 at 0.3mg/mL. 
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polymer are obtained. Therefore, it can be presumed that encapsulation of the anion receptor 
system has been successful. 
 
3.7 Future work 
A polymeric micelle can be used to successfully encapsulate an organic soluble species, 
deeming it a viable option for generating an anion receptor system. The drawback of the 
designed receptor is difficulty in verifying successful encapsulation within the micelle 
architecture. Work by Gale and Twyman
113
 looked into the use of calix[4]pyrrole-4-
nitrophenolate as a colourimetric anion sensor. The deep characteristic yellow colour of the 
4-nitrophenolate ion (figure 100) ceases upon coordination with a receptor. As a result, this 
complex was used as a halide sensor in a displacement assay, by which the halide displaced 
the 4-nitrophenolate ion, regenerating the intense yellow colour to the solution.  
 
 
Figure 100– Figure to show the chemical structure of the 4-nitrophenolate anion. 
 
It was therefore postulated that the anion receptor synthesised, pre-coordinated to 4-
nitrophenolate, could be encapsulated within a polymeric micelle. Succeeding encapsulation, 
a similar displacement assay could be carried out, whereby an organic soluble halide anion 
could be introduced into the system to investigate the potential sensor capabilities of the 
water soluble anion receptor system. Furthermore, this would provide evidence of successful 
encapsulation of the receptor within the micelle. In addition to developing an effective water 
soluble system, the chemistry of the receptor itself can also be changed in order to develop 
different systems which could exhibit different selectivity. The hydrogen bonding donor 
group used in this research is the isophthalamide group. As discussed in the introductory 
section of this chapter, there are numerous different hydrogen bonding motifs which can be 
exploited. Therefore, structural changes to the receptor could lead to changes in anion 
selectivity. The results showed the hyperbranched anion receptor system (1:20) to show poor 
selectivity towards benzoate and acetate. It has been shown that both urea and thiourea based 
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receptors have been shown to provide an effective binding site for ‘y-shaped’ anions such as 
these.
2
 Therefore, this group could be utilised instead, as a way of developing a 
hyperbranched polymeric system which could be more selective towards benzoate and 
acetate over halide ions.  
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Chapter 4 – Colloidosome microcapsules as potential vehicles for 
catalysis 
 
4.1 Introduction 
My research has predominantly involved dendritic polymers. This chapter, however, will 
focus on a different type of system called a colloidosome. A colloidosome, at the simplest 
level, can resemble an enzyme, as it is able to control a microenvironment. Enzymes can also 
be referred to as biological catalysts and it is the area of catalysis which will be explored in 
this chapter. Although it is a different type of material to those explored in previous chapters, 
the principles of controlling an environment are maintained. This aspect of research was 
carried out in collaboration with Professor Steve Armes and Dr Kate Kirkham and this 
chapter will provide the reader with information about this particular chemical field. The 
reader will also be provided with an understanding into the synthesis and potential use of 
colloidosomes within the area of microencapsulation.  
 
There has been a high level of interest in colloidosomes, attributable to their potential 
relevance in the area of microencapsulation. These microcapsules have the ability to both 
store and release a wide array of different materials, making them novel vehicles for a large 
range of therapeutic and industrial uses. A colloidosome is a type of microcapsule whose 
shell is made up of colloid particles, which have been merged together. The fusing of 
particles within the shell provides a level of control over permeability, not to mention 
additional stability.
1
 Customarily, the synthesis of a colloidosome involves the self-assembly 
of colloidal particles at the interface of two liquids which are immiscible; namely water and 
oil. The preliminary structures formed by self-assembly are known as Pickering
2
 or 
Ramsden
3
 emulsions, and they have been known for over a century. For an amphiphilic 
surfactant at an oil/water interface, the hydrophobic-lipophile balance (HLB) is a key 
parameter in the determination of whether an oil-in-water (o/w) or water-in-oil (w/o) 
emulsion is stabilised.
4
 Colloidal particles, adsorbed at a liquid-liquid interface, behave 
similarly to surfactant molecules and the HLB number is required to determine the oil or 
water susceptibility of a surfactant. The contact angle, formed at the oil/water interface, is 
used to determine the tendency for colloidal particles. The contact angle is a measure of the 
wettability of the particle and can consequently be used in the determination of whether an 
o/w or w/o emulsion will be stabilised. For hydrophilic particles, a contact angle less than 90˚ 
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will be observed, meaning that the greater part of the particle is located in the aqueous phase. 
For hydrophobic particles, the opposite is encountered and a w/o emulsion is preferred.
4
 This 
principle is illustrated below in figure 101.
 
 
 
 
 
 
 
 
 
 
Colloidosome preparation involves additional stabilisation at the interface of a Pickering 
emulsion. The resulting microcapsule is not only more robust, but also less penetrable. 
Figure 102 is a schematic illustration of the formation of a colloidosome from the self-
assembly of colloidal particles. The microcapsule template is upheld when the internal oil 
phase is removed, due to the merging of the colloidal particles.  
 
 
 
 
 
 
 
 
 
Figure 102 – Schematic representation of colloidosome formation via a Pickering emulsion 
step. 
Colloidal 
particles 
Emulsification in oil 
Particle stabilised emulsion 
droplet (Pickering emulsion) 
Stabilisation 
Colloidosome 
 
Oil 
Water 
Oil-in-water (θ<90˚)  Water-in-oil (θ>90˚)  
Figure 101– Representation of the emulsion formed by particles at the interface for contact 
angles both below and above 90˚.4 
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4.1.1 Synthetic approaches to the formation of colloidosome microcapsules 
The primary organic colloidosome-type structures were first described by Velev et al.
5-7
 In 
1996, this group reported the assembly of hollow spherical microstructures. The assembly of 
latex particles was brought about by means of emulsion droplets as templates. These 
microstructures were subsequently entitled ‘supraparticles.’5 Velev et al. showed that 
negatively charged sulphate stabilised polystyrene particles were not competent in the 
stabilisation of emulsion droplets. A solution to this drawback was to sensitise the particle 
surface using lysine. This amino acid provided partial hydrophobicity to the particles. Surface 
modification allowed the particles to adsorb at the interface. A strong coagulant was 
employed to lock the neighbouring particles together, within the microspheres. Introduction 
of a coagulant allowed the aggregation of the latex particles, which in turn provided 
additional stabilisation; this was sufficient to allow endurance of the microcapsules when the 
n-octanol droplets were removed by excess ethanol.
5
 Velev et al. went on to develop an 
emulsion based technique to generate ‘ball-like aggregates’.6 These aggregates arise from 
permeation of particles into the greater part of the oil droplets. This is achieved by increasing 
the hydrophobicity of the particles. Sodium dodecyl sulphate is used to encourage adsorption 
into the body of the droplets. As a result, the droplets are sterically protected from 
coalescence and the particles, assembled within, are secure. This work, combined with the 
scheme for hollow particles
5
, led to the development of composite particles. The cores of 
these particles comprised of ball-like aggregates of amidine latex particles which, were 
enclosed by a shell of negatively charged sulphate latex particles.
5
 To conclude, the final 
paper in this series involved a reverse system, by which latex particles were assembled 
around water droplets; such that water-in-oil microspheres are formed.
7 
 
4.1.1.1 Thermal annealing 
Following on from the pioneering work by Velev et al., there has been a great deal of interest 
in the synthesis of organic latex based colloidosomes; with numerous contrasting synthetic 
techniques having been explored. The label ‘colloidosome’ was first suggested by Dinsmore 
et al.
8
 Dinsmore took a different approach to synthesis. The colloidosomes were generated by 
the process of thermal annealing. The first stage involved the preparation of microcapsules by 
the self-assembly of carboxylate functionalised polystyrene latex particles at the outer layer 
of o/w emulsion droplets. The next stage was the formation of the colloidosome shell. This 
was accomplished by coalescing particles together by a process called sintering. This 
technique involved heating the emulsion at a slightly higher temperature than the Tg of the 
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polystyrene latex particles at approximately 105˚C. Heating resulted in the fusion of the latex 
particles (figure 103). The outcome of sintering led to a colloidosome with a specific 
arrangement of ‘uniform holes.’ The adjustment of the sintering time can also tune the size of 
these interstitial gaps present.
8
 
 
 
Figure 103– A scanning electron micrograph illustrating a 10μm ‘colloidosome’ which has 
been assembled from an o/w emulsion droplet, comprising of 0.9μm polystyrene latex 
particles. The sintering procedure occurred at 105ºC for a period of 5 minutes, sufficiently 
fusing the particles.
8
 Reprinted with permission from [Dinsmore, A. D.; Hsu, M. F.; 
Nikolaides, M. G.; Marquez, M.; Bausch, A. R.; Weitz, D. A., Science, 2002, 298, 1006-
1009]. Copyright [2002] AAAS. 
 
Progressing from this work, Routh et al. examined the potential in the use of copolymer 
colloidal particles in order to reduce the Tg, so as to reduce the sintering temperature 
required. Lowering the temperature would allow the successful encapsulation of sensitive 
materials. The research involved using poly (styrene-co-n-butylacrylate) colloidal particles in 
order to construct water-core colloidosomes under relatively mild conditions; with sintering 
temperatures ranging from 35 to 65ºC.
9
 Following from this work, Routh et al. detailed the 
formation of colloidosomes at room temperature by exploiting colloidal instability. This was 
achieved by the incorporation of ethanol into the continuous oil phase. The latex particles 
used for this study were poly (methyl acrylate-co-n-butyl-acrylate). The addition of ethanol 
into the aqueous latex suspension allowed the latex particles to aggregate together.
10
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4.1.1.2 Gel-trapping 
Another technique which can be employed to assemble colloidosome microcapsules is gel-
trapping. This approach exploits the use of an aqueous gel as the internal phase. The internal 
aqueous phased is gelled in order to produce a solid core. This will go on to provide support 
for the shell, not to mention enhance structural steadfastness and rigidity. Cayre et al. have 
employed this novel technique in the assembly of colloidosome microcapsules. Water-in-oil 
emulsions, stabilised by amine-functionalised polystyrene latex particles, were used to 
generate templates. In the aqueous phase a gelling agent was incorporated (1.5 wt.% agarose) 
and heating provided complete dissolution of the gel. The temperature was then lowered to 
room temperature, so as to set the gel. The gel core proved crucial in allowing the survival of 
the microcapsules during the transferral from diluted oil into water.
11
 Work by Nobel et al. 
involved the same synthetic procedure, making use of agarose as a gelling agent. Research 
involved the synthesis of ‘hairy’ colloidosomes, where the shells were comprised of microrod 
particles.
12
 Duan et al. also exploited the use of gelation of an aqueous phase containing 
agarose in order to produce ‘magnetic´ colloidosomes from the directed self-assembly of 
magnetite (Fe3O4) nanoparticles.
13
 
 
4.1.1.3 Layer-by-layer deposition and polyelectrolyte complexation 
As mentioned previously, Dinsmore et al. used thermal annealing to generate colloidosome 
microcapsules.
8
 Work by this research group also included the use of a different technique, 
polyelectrolyte complexation. This work involved the electrostatic adsorption of an 
oppositely charged polyelectrolyte (poly-L-lysine) onto the anionic colloidosome surface. 
The poly-L-lysine molecules act as a bridge between neighbouring particles, therefore fixing 
them in place. A benefit to this synthetic approach, over sintering, is the improved flexibility 
in the colloidosome shell, leading to the production of microcapsules which are not only 
flexible, but also extremely robust.
8
 
 
A similar approach was explored by Gordon et al., whereby cross-linked polystyrene latex 
particles were dispersed into toluene (the oil phase) and subsequently emulsified with an 
aqueous phase. Cationic poly-L-lysine was located in the aqueous phase and, after self-
assembly of the emulsion droplets, the cationic polyelectrolyte could adsorb onto the 
polystyrene latex, connecting neighbouring particles together. It was then shown that these 
specific capsules could be inflated by osmotic pressure from the polyelectrolyte present in the 
aqueous droplet phase. In order to exploit this property, Gordon et al. used a range of 
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concentrations of sodium chloride solution to determine the concentration which leads to 
complete deflation of the microcapsule. It was shown that addition of 1M NaCl solution led 
to the full deflation of the microcapsules. The addition of salt therefore reduces the osmotic 
pressure of the polyelectrolyte in solution.
14
 
 
There has also been work involving layer-by-layer deposition of enzyme multi-layered shells 
on latex particles, which could prove useful in the area of bio-catalysis.
15
 Work by Fang et al. 
has followed on in this area by synthesising bio/nanoreactors through the incorporation of 
inorganic and magnetic nanoparticles, engulfed by multilayer polymer/enzyme shells. The 
enzyme used in these studies was glucose oxidase and Fang et al discovered that, the 
inclusion of silica layers on latex particles provided a higher surface area. An increase in the 
surface area means that adsorption of the enzyme will be increased, thus improving the 
catalytic activity of the bioreactor.
16
 
 
4.1.1.4 Covalent cross-linking 
The majority of techniques mentioned previously tend to involve the application of heat. 
Thermal annealing requires heat for sufficient stabilisation before emulsification. As stated 
earlier, Routh et al.
9,10
 used copolymer colloidal particles in order to reduce the temperature 
required for sintering. In order for thermally sensitive compounds and biological materials to 
be successfully encapsulated within a colloidosome, without incurring any structural damage, 
heat is not optimal. Colloidosomes can be synthesised by covalent cross-linking which can 
provide sufficient locking of the structure at room temperature, without the need for any heat.  
 
In 2003, Croll et al. reported the synthesis of ‘tectocapsules’, which is one of the first 
reported examples of this method. These microcapsules involved the covalent cross-linking 
of poly (divinylbenzene-alt-maleic anhydride) microspheres with a range of polyamines. The 
amine functionality reacted with the anhydride group in order to generate both amide 
linkages and ammonium-carboxylate ionic linkages (scheme 27).
17
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Scheme 27  – Reaction scheme to illustrate the interaction between the anhydride functional 
group and the amine functional group, resulting in the formation of amide and ionic 
ammonium-carboxylate linkages.
17
 
 
Recent work by Shah et al., involved the fabrication of stimuli-responsive colloidosomes 
made from poly(N-isopropylacrylamide) microgels. Water-in-oil emulsions were prepared 
and were cross-linked by glutaraldehyde molecules. The amine functionalised microgels were 
interconnected by amine-aldehyde condensation reactions, owing to the reactive sites present 
at each end of a glutaraldehyde molecule
18
 (figure 104). 
 
 
Figure 104– Figure to show the chemical structure of glutaraldehyde, which was used to 
cross-link water-in-oil emulsions of poly(N-isopropylacrylamide) microgel based 
colloidosomes developed by Shah and co-workers.
18
 
 
In 2010, Thompson* et al. prepared poly (glycerol monomethacrylate)-based 
macromonomers to prepare sterically stabilised latex particles. These particles exhibited a 
suitable surface wettability to stabilise oil-in-water emulsions.
19
 Colloidosome microcapsules 
were prepared by covalent cross-linking. The hydroxyl groups on the stabiliser chains within 
the oil droplet were cross-linked using an oil soluble cross-linker, polymeric diisocyanate 
(tolylene 2, 4-diisocyanate-terminated poly (propylene glycol) [PPG-TDI].  As the cross-
linker was limited to the interior of the oil droplet, colloidosomes could be prepared at a high 
solid level (50 vol.%), without the occurrence of aggregation.
20
 
 
*This project involved the collaboration with Dr Kate Kirkham (formally Kate Thompson) from the Armes 
research group at the University of Sheffield. These specific particles were utilised in research, therefore, more 
information regarding the preparation of these colloidosomes will be discussed in detail in section 4.3.6.4 of 
this chapter. 
 
196 
 
Walsh et al. continued on from this work by the replacement of the hydroxyl-functionalised 
stabiliser with an amine-functionalised poly (ethylene imine) [PEI] stabiliser. This 
replacement showed that the PEI stabiliser chains could be cross-linked from both within the 
oil droplet (using an oil soluble cross-linker) and from the aqueous continuous phase (using a 
water soluble cross-linker).
21
 As found in the initial study
20
, use of an oil soluble cross-linker 
allowed colloidosome preparation to occur at 50 vol.% without aggregation. When covalent 
cross-linking took place from the aqueous continuous phase, similar results were observed. In 
both cases, colloidosome microcapsules could endure the extraction of the interior oil phase 
by washing with excess alcohol.
21
 This project will focus on the potential novel uses of these 
microcapsules within the area of microencapsulation. 
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4.2 Aims and Objectives 
 
4.2.1 Colloidosomes for Microencapsulation 
As touched upon in the introductory section of this chapter, colloidosome microcapsules have 
attracted a great deal of attention owing to their promise in the area of microencapsulation. 
Microencapsulation is the process by which a core is confined by encircling said core in 
another material, termed the shell. The core can comprise of liquid droplets, solid particles or 
gases.
22
 Microencapsulation is important in everyday life as it allows the controlled release of 
a variety of active ingredients in numerous sectors; some examples of these being medicine, 
agriculture, textiles, food and cosmetics.
23,24
 The use of colloidal drug delivery systems in the 
biomedical field has advanced a great deal regarding diagnostics and treatment. Currently, 
colloidal carriers include liposomes, ethosomes, lipospheres and nanoparticles, which are 
used in a range of areas, such as gene delivery, tumour targeting and oral medication. A 
colloidosome is an alternative example of a vesicular system, offering promise in this area.
25
 
With a colloidosome microcapsule, one has the capability to control numerous factors such as 
size, permeability, mechanical strength and compatibility. The ability to control the size of 
microcapsules affords adaptability in applications, not to mention an option in the material 
which is to be enveloped.  The colloidosome membrane has both an impenetrable phase 
(colloidal particle) and a penetrable phase (interstitial pores between particles). The ability to 
control the permeability of a microcapsule will enable both selective and targeted release of 
an active ingredient. Depending on the block co-polymer building block selected for 
synthesis, the mechanical strength of the colloidosome can also be governed. This will affect 
the mechanical load a microcapsule is able to endure. Finally, there is also the potential to 
manage the compatibility which facilitates the encapsulation of more sensitive entities, 
namely biological material. The ability to control these particular elements allows the design 
of specific release mechanisms, thus explaining why these microcapsules have become a 
prospective tool in this area.
8,25
 
 
Encapsulation of live cells is an area which faces numerous challenges. Live probiotic 
bacteria, such as Lactobacilli and Bifidobacteria, have positive health effects which include 
competition with pathogens located in the intestine and improvement of the microbial 
balance.
26
 In order for people to sustain a sufficient level of probiotic bacteria in the intestine, 
probiotics have been incorporated into food produce. A drawback to this is whether the 
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microorganisms sustain viability when passed through the gastrointestinal tract to the 
intestine, where they are required. If ingested orally, the bacteria need to be protected from 
the acidic conditions of the stomach, in order to have the desired effect.
26, 27
 For this reason 
microencapsulation can be presented as a viable option and has subsequently received a 
considerable amount of attention. Routh et al. reported a method by which viable 
Lactobacillus crispatus could be encapsulated within water-core colloidosomes. The 
colloidosomes are made from poly (methyl methylacrylate-co-butyl acrylate) latex particles. 
These latex particles were fused together to form the microcapsule shell by the inclusion of a 
small amount of ethanol and salt to the oil continuous phase. Though slower than 
unencapsulated bacteria, metabolism of glucose to generate lactic acid did occur within the 
colloidosome. The microcapsule was subjected to conditions comparable to those within the 
stomach. After exposure to pH3 HCl for a period of 2 hours, the colloidosome proved 
effective in the protection of the live bacteria. A larger number of encapsulated bacteria 
remained viable under these conditions in comparison with unencapsulated bacteria.
26
 Routh 
et al. also used this synthetic procedure to encapsulate yeast cells. The encapsulated baker 
yeast cells were able to metabolise glucose. A benefit of the colloidosome preparation, used 
in both cases presented, is that it does not involve high temperatures, meaning it is 
appropriate for encapsulation of biological material.
28
 
 
Another application is the controlled release of active ingredients, such as dye molecules. 
Yow and Routh have described the preparation of colloidosomes from poly (styrene-co-n-
butyl acrylate) latex particles and monitored the release of fluorescein sodium salt that has 
been successfully encapsulated. The sintering times were varied for water-core colloidosomes 
and the results showed that longer sintering times led to the fabrication of less porous shells. 
This gave rise to the slower release of the encapsulated active ingredients from the aqueous 
core. The dye release profiles show that there is not much difference for sintering times of 5 
and 30 minutes. However, when the time is increased to 60 minutes, the dye was released 
within 24 hours, as opposed to merely a few. The dye release profiles for the water-core 
colloidosomes can be seen in figure 105. Though results show a notable improvement, this 
time period is not long enough for commercial applications, where months or even years 
would be desired retention time periods for industry.
22
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Figure 105 – Figure to show the dye release profile for colloidosomes which have been 
prepared from poly (styrene-co-n-butyl acrylate) latex particles sintered at 50ºC for 5, 30 and 
60 minutes. The dotted line for each time frame represents the release model (m) and the data 
points represent the experimental data (e).
22
 Reprinted with permission from [Yow, H. N.; 
Routh, A. F., Langmuir, 2009, 25, 159-166.] Copyright [2009] American Chemical Society. 
 
There has been a high level of interest in using stabilisers that lead to microcapsule 
membranes which exhibit novel properties. For instance, as previously mentioned in the 
introductory section, Duan et al. showed the use of magnetic nanoparticles as stabilisers, 
meaning that colloidosome microcapsules fabricated could be influenced by an external 
magnetic field.
13
 There has been a lot of interest in the development of colloidosome 
microcapsules which provide another possibility for the encapsulation and release of active 
ingredients, based on the chemistry of the microcapsule shell. Cayre et al have used pH as an 
external stimulus and fabricated pH responsive colloidosomes and thus reported the effect of 
pH upon release of actives. Cayre et al. have reported the use of PMMA-pDMAEMA to 
generate a pH responsive shell. At an acidic pH level, the amine groups, present on the 
pDMAEMA polymer, become protonated which subsequently leads to the extension of the 
polymer away from the particle surface. At an alkaline pH level, these groups become 
deprotonated and the chains collapse back onto the exterior of the particle. The particles were 
fused together by covalent cross-linking within the internal oil phase. Washing with alcohol 
allowed the removal of the internal oil phase and the shells were loaded with the 
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fluorescently labelled sugar, dextran. At low pH, as predicted, equilibrium of the sugar 
concentration between the microcapsule core and the continuous phase occurred. Under basic 
conditions, the sugar was held within the core of the microcapsule, with little seepage through 
the shell into the continuous phase taking place.
29
 This technique has proved successful in the 
controlled encapsulation and release of larger molecules. One challenge which remains, 
however, is the retention of small molecules within colloidosome microcapsules.
30
 
 
4.2.2 Colloidosomes in catalysis 
As shown from the examples above, industrial and biomedical applications have received a 
great deal of interest. Another potential application for a colloidosome microcapsule, that is 
yet to be explored in detail, is catalysis. The research in this area predominantly concerns 
enzyme microencapsulation for bio-catalytic purposes. An enzyme is a potent biological 
catalyst and there is a wide variety is in existence with each one crucial to a specific organic 
reaction. Work by Wu et al.
31
 has reported the use of hydrophobic silicon dioxide 
nanoparticles in the emulsification of aqueous solutions of various enzymes. A schematic 
representation of this can be seen in figure 106. 
 
 
 
Figure 106– Schematic representation of a Pickering emulsion which has been stabilised by 
SiO2 nanoparticles for enzyme catalysis. The grid is representative of the agarose gel 
network.
31
 Reprinted with permission from [Wu, C.; Bai, S.; Ansorge-Schumacher, M. B.; 
Wang, D. Adv. Mater. (Weinheim, Ger.) 2011, 23, 5694] Copyright 2011 WILEY-VCH 
Verlag GmbH & Co. KGaA, Weinheim. 
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The catalytic activity of the Pickering emulsions was determined; the enzymes selected for 
inclusion in this study were Lipase A from Candida antarctica (CalA), Lipase B from 
Candida antarctica (CalB) and benzaldehyde lyase from Pseudomonas fluorescens Biovar I 
(BAL). Trimethoxy (octadecyl) silane (TMODS) was used to make the nanoparticles 
hydrophobic in nature so that they could be used to stabilise water-in-oil Pickering emulsions, 
where the aqueous core of the Pickering emulsion contained an enzyme. To facilitate 
fabrication and characterisation, gel-trapping with agarose gel was the synthetic technique 
used. CalB, when incorporated within a Pickering emulsion, showed activity of 
approximately 300 times more elevated than in its native state in a biphasic system. Cal A 
showed an enhanced catalytic performance of around 100 times compared to free enzyme, as 
demonstrated in the literature.
31-33 
The most sensitive enzyme to be analysed, BAL, showed 
an enhancement in catalytic activity of around 4.5 times that of native BAL in a biphasic 
system. Though all enzymes tested display enhanced catalytic performance, the gel-trapping 
method utilised has a drawback.  Though still higher than each enzyme in its native state, 
upon gelling with agarose, catalytic performance dropped, therefore synthetic modifications 
must be made in order to avoid the intraparticle diffusion constraints brought about by the 
agarose network.
31,34
 
 
Wang et al.
35
 continued work in this area by the investigation into stabilising Pickering 
emulsions through the use of hollow nanoparticles. The project involved the use of poly 
(ethylene glycol)-co-b-poly-(styrene-co-3-isopropenyl-α, α-dimethyl benzylisocyanate) 
(figure 107).  
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Figure 107 – Figure to show the chemical structure of the block copolymer building block 
(black) with the isocyanate moiety (red) and the chemical structure of the cross-linking agent 
(red).
35
 
 
This polymer can be cross-linked through the isocyanate functionality present within the 
hydrophobic region. The enzyme selected for this study was CalB, which was encapsulated 
within the central cavity of the colloidosome. The enzyme was not only able to withstand 
purification in between each reaction cycle, but also sustain catalytic activity. An advantage 
to this method is the facilitation in separating the enzyme from both substrates and products, 
not to mention, the evident reusability of the enzyme. Furthermore, due to the particular 
arrangement of a polymersome stabilised Pickering emulsion, a system with different 
chambers is generated. Therefore, it is plausible that an array of different enzymes could be 
encapsulated, giving rise to the potential use of these systems for cascade reactions.
35
 
Previous work within the Twyman group has looked at the use of catalysis as a tool to probe 
encapsulation properties of dendritic polymers and we were interested, following discussions 
with Professor Steve Armes, to use this knowledge and study similar effects in 
colloidosomes. 
 
4.2.3 Project motivation 
Encapsulation has been described previously in chapter 3 and this theme is continued, in 
collaboration with Professor Steve Armes. The majority of research in the area of catalysis 
predominantly involves bio-catalysts; therefore, this project will focus on synthetic catalysts 
and using catalysis as a tool to probe the encapsulation properties of a colloidosome. As the 
control of a microenvironment is integral in a catalytic environment, a colloidosome appears 
to be a suitable tool for this purpose. This project involves the collaboration with Professor 
Steve Armes and Dr Kate Kirkham. Professor Armes works in the area of polymer and 
colloid chemistry at the University of Sheffield and has developed a prestigious reputation 
worldwide within this area of chemistry. Dr Kirkham played an integral role in the Armes 
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research group, specialising in covalently cross-linked colloidosomes.
19-21
 Work within the 
Twyman group has involved the use of metalloporphyrin molecules as catalysts for a variety 
of chemical reactions
36-39 
and so the expertise from both research groups was combined. 
Colloidosomes have proven to be successful in enzyme catalysis within an organic media.
31,35
 
As water is the most abundant solvent available and also non-toxic, it has been proposed to 
attempt catalysis using oil-in-water emulsions. The main objective for this project is to 
perform a reaction whereby the substrate is oil soluble but the product is water soluble, thus 
enabling it to pass out of the colloidosome and into the surrounding bulk water. A schematic 
representation of the ultimate aim of this project can be seen in scheme 28. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Substrate 
 (oil soluble) 
+ Catalyst 
Product 
(water 
soluble) 
Bulk Water Bulk Water 
Scheme 28 – Schematic representation of the generation of a water soluble product from 
an oil soluble substrate, resulting in release of product into bulk water 
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4.3 Results & Discussion   
4.3.1 Identification of a reaction and suitable catalyst 
As identified in the aims and objectives of this research, catalysis will be used to probe 
encapsulation properties of a colloidosome structure. The ultimate goal is the development of 
a system where a substrate is oil soluble and, upon catalysis within the central cavity of the 
colloidosome, a water soluble product is fabricated and released into the aqueous phase. 
 
The initial stage is to identify both a plausible reaction and appropriate catalyst, which fits the 
criteria set out in the aims of this project. As mentioned previously, there is a lot of 
experience in the Twyman group with porphyrin chemistry.
37, 38, 40-44
 A porphyrin is a 
heterocyclic macrocycle, comprising of four pyrrole units. Each pyrrole unit is connected to 
another by the α-carbon atoms, interlinked by a methine bridge. The structure of porphine can 
be seen in figure 108. It depicts the heterocyclic ring structure made up of four pyrrole 
subunits and is the basic unit for a porphyrin macrocycle. Porphyrins possess 18 delocalised 
electrons, therefore obeying Hückels rule for aromaticity. This rule states that a cyclic 
molecule will exhibit aromatic behaviour when the number of Π electrons equates to 4n + 2 
(when n ≥ 0). 
 
 
Figure 108 – Figure to show the chemical structure of Porphine, which is the basic unit of a 
porphyrin macrocycle. 
 
 
Porphyrins have the ability to act as host molecules. This is a direct result of the central 
cavity present, which can accommodate a variety of metal ions. This host-guest potential 
allows metalloporphyrins to be applied as catalysts for a wide range of contrasting chemical 
reactions. There has been a vast level of interest in the area of catalysis using a wide array of 
metalloporphyrins. For further information, the reader is directed to the following pieces of 
literature which explore the recent development in this field.
45-49
 Due to the extensive level of 
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experience and expertise in the synthesis and chemistry of this particular class of molecules, 
it was decided that this type of molecule would be used as a catalyst. Work by Evans and 
Smith showed oxidation of ethylbenzene using an iron porphyrin catalyst to generate a range 
of oxidation products; one of which was benzoic acid, which is water soluble (scheme 29).
50
 
 
 
Scheme 29 – Oxidation of Ethyl benzene, indicating the major and minor oxidation products 
generated.
50
 
 
 
Evans and Smith used a solvent free system, where ethylbenzene behaved as both substrate 
and solvent.
50
 For the purpose of encapsulation within a colloidosome, the solvent needed is 
dodecane. Therefore, the porphyrin catalyst used must be oil soluble. It was hypothesised 
that, by adding long, non-polar alkyl chains to the periphery of a porphyrin, dissolution could 
be achieved. This would improve the lipophilicity, thus improving solubility of the 
macrocycle in oil. The proposed iron porphyrin catalyst is shown in figure 109. 
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Figure 109 – Figure to show the proposed chemical structure of the 5, 10, 15, 20-Tetra(4-
hexadececycloxyphenyl)porphyrin iron catalyst. 
 
4.3.2 Synthesis of 5, 10, 15, 20-Tetra(4-hexadececycloxyphenyl)porphyrin 
4.3.2.1 Synthesis of 4-(hexadecyloxy) benzaldehyde 
The initial stage in the synthesis of the oil soluble porphyrin is the preparation of the 
aldehyde starting material. The introduction of non-polar alkyl chains is accomplished by 
alkylating the aldehyde starting material, prior to porphyrin assembly. A hexadecyl chain is 
attached to 4-hydroxybenzaldehyde via the Williamson reaction. The reaction of an alcohol 
functional group with n alkyl halide to generate an ether bond is widely known as the 
Williamson ether synthesis.51  
 
A mixture of 4-hydroxybenzaldehyde, bromohexadecane and potassium carbonate was 
dissolved in anhydrous acetonitrile and refluxed for a period of 3 days (scheme 30). Upon 
completion of reflux, the reaction mixture was concentrated, via rotary evaporation, and 
dissolved in diethyl ether and water (1:1). The organic layer was washed primarily with 
saturated sodium hydrogen carbonate solution followed by brine solution. The organic layer 
was collected and dried over magnesium sulphate prior to concentration, generating the crude 
product. Purification was accomplished by column chromatography using an eluent of 
petroleum ether 40-60 and ethyl acetate (20: 1).  
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Scheme 30 – Synthesis of 4-(hexadecyloxy) benzaldehyde. 
 
The desired product could be visualised by UV due to the aromatic system present; under UV 
only one spot could be visualised. After staining with anisaldehyde a few impurities could be 
visualised. The desired product had an Rf value of 0.83 and showed good separation from the 
impurities, facilitating purification.  
 
Validation of the desired product was achieved from the use of a variety of analytical 
techniques. Elemental analysis showed results less than 0.5% of the expected values, giving 
confidence in the purity of the sample. 
1
HNMR was an essential tool in proof of the purity of 
the aldehyde (figure 110). The spectrum showed a singlet at 9.87 ppm, specific to an 
aldehyde functional group. Two doublets could be visualised at 6.97 and 7.81 ppm for the 
Phenylic ortho and meta protons respectively, with each doublet showing a coupling constant 
of 9Hz. There is a triplet seen at 4.02 ppm which corresponds to the methylene group, 
neighbouring the oxygen atom on the –OC16H33 chain. The methylene group next to this 
gives a multiplet at 1.80ppm, integrating to 2 protons. The remaining 26 CH2 protons in the 
alkyl chain show a series of multiplets from 1.20 to 1.50 ppm, attributable to the proximity in 
chemical shift of each pair and the coupling patterns generated. A triplet can be seen at 
0.87ppm which integrates to 3 protons. This signal arises from the methyl group present at 
the end of the alkyl chain substituent. 
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Figure 110 – Figure to show the 1HNMR spectrum for 4-(hexadecyloxy) benzaldehyde 
showing the different proton environments present within the compound. Deuterated 
chloroform solvent gives a signal at 7.25ppn, which is highlighted. 
 
In addition, the mass spectrum showed a peak at 347 which was indicative of the MH
+
 ion. 
The combination of these techniques with 
13
C NMR and IR gave confidence in the success of 
the synthetic procedure and the purity of the aldehyde required for porphyrin assembly. 
 
4.3.2.2 Synthesis of 5, 10, 15, 20- tetrakis (4-hexadececycloxyphenyl) porphyrin  
With aldehyde preparation complete, the next step is the construction of the porphyrin 
macrocycle. There are numerous different approaches to porphyrin synthesis; the Lindsey 
method, the Rothemund method and the Adler method. The Rothemund and Adler methods 
will be discussed at a later point in this chapter for the synthesis of different porphyrin 
macrocycles. For this particular macrocycle the Lindsey method was adopted. In 1979, 
Lindsey and co-workers established a synthetic procedure for the assembly of a porphyrin 
under relatively mild reaction conditions. The initial stage of this approach is the acid 
catalysed condensation between the aldehyde in question and pyrrole at room temperature.
52
 
Lindsey investigated a variety of Lewis and Brønsted acid catalysts and discovered that the 
condensation step is highly sensitive to the catalyst used. A survey performed showed that 35 
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out of 45 acids tested produced TPP with a yield ranging from 5-58%.
53
 Lindsey and co-
workers also discovered the potential of co-catalysis with ethanol and Boron trifluoride 
diethyl etherate. Co-catalysis using these reagents showed enhanced yields in porphyrin 
assembly.
54
 For the synthesis of 5, 10, 15, 20 – tetrakis (4-hexedececycloxyphenyl) porphyrin 
the co-catalysis approach was employed. Acid catalysis condensation results in the generation 
of a porphyrinogen intermediate. The next step of the synthetic procedure is the introduction 
of an oxidant. This results in the generation of the porphyrin via 6e
-
/6H
+
 oxidative 
dehydrogenation of the intermediate.
52
 The oxidant employed for the synthesis of the oil 
soluble polymer was 2, 3 – Dichloro-5, 6-dicyano- p-benzoquinone (DDQ). There are both 
advantages and disadvantages to this method. Whilst it gives a higher yield of porphyrin in 
comparison to other methods, it requires dilute concentrations of both aldehyde and pyrrole. 
Dilution is essential as it lessens the competition between the oligomerisation of 
pyrromethanes and cyclisation to yield the porphyrinogen intermediate. The synthetic steps 
for porphyrin formation can be found overleaf in scheme 31.  
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A 3-neck round bottom flask was charged with equal molar quantities of 5, 10, 15, 20 tetrakis 
(4-hexadececycloxyphenyl porphyrin) and pyrrole, dissolved in 300 mL of anhydrous 
dichloromethane at room temperature, under an atmosphere of Argon. Boron trifluoride 
diethyl etherate and a catalytic amount of anhydrous ethanol were added to the solution and 
stirred for 1 hour in an inert gas stream. This was followed by the addition of 2, 3-dichloro-5, 
6-dicyano-p-benzoquinone (DDQ) at room temperature. The reaction mixture was then 
stirred for an additional hour. Purification was accomplished by, firstly, using flash 
chromatography and then column chromatography, eluting with chloroform, to generate the 
desired porphyrin. The synthetic procedure can be visualised in scheme 32a. 
 
Scheme 31– Steps involved in the synthesis of a porphyrin 
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Scheme 32 – (a) synthetic procedure for 5, 10, 15, 20 tetrakis (4-hexadececycloxyphenyl) 
porphyrin (b) synthetic procedure of 5, 10, 15, 20 – tetrakis (4-hexadececycloxyphenyl) – 
porphyrin complex, which is used as the catalyst for the oxidation of cyclooctene in dodecane 
solvent. 
 
Authentication of the product was accomplished by use of a wide array of analytical 
techniques. Elemental analysis gave results less than 0.5% of the expected values, providing 
assurance in the purity of the sample. Another important tool used for the characterisation of 
this macrocycle was 
1
HNMR. The spectrum showed a singlet at 8.80 ppm, representative of 
the pyrrolic protons of the macrocycle. Two doublets can be seen at 7.30 and 8.14 ppm which 
denote the ortho and meta methylene protons present on the phenyl ring substituents. A triplet 
can be seen at 4.30 ppm, which relates to the methylene group, next to the oxygen atom on 
the –OC16H33 chain. The methylene group, neighbouring this methylene unit, gives a 
multiplet at 2.01 ppm, integrating to 2 protons. The remaining CH2 protons in the alkyl chain 
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show a series of multiplets from 1.23 to 1.73 ppm, because of the closeness in chemical shift 
of each pair combined with the coupling patterns generated. A triplet can be seen at 0.91 ppm 
which integrates to 12 protons. This signal is indicative of the methyl groups present at the 
end of the alkyl chain substituent on each of the phenyl rings. Finally, a singlet can be seen at 
-2.72 ppm, representative of the highly shielded NH protons located at the centre of the 
macrocycle. MALDI-TOFF mass spectrometry showed a peak at 1575.4, which represents 
the MH
-
 ion. This analytical data, in combination with a UV/Vis soret band at 423 nm and Q 
bands at 520, 557, 593 and 651 nm, confirms that the product is analytically pure. 
 
4.3.2.3 Synthesis of 5, 10, 15, 20-tetrakis (4-hexadececycloxyphenyl)-porphyrin Iron(III) 
Complex 
 
The porphyrin catalysis required for the epoxidation of cyclooctene requires a central iron 
atom in order to function. The insertion of iron into the porphyrin macrocycle was achieved 
by the reaction of a large excess iron (II) chloride (scheme 32b). The porphyrin, along with 
2, 6-lutidine, were dissolved in anhydrous tetrahydrofuran and a large molar excess of iron 
(II) chloride was added and the reaction mixture was refluxed for a total of four hours. On 
completion, the mixture was exposed to air and cooled. This process allowed oxidation of 
Fe
(II)
 to the desired Fe
(III)
 oxidation state. The crude reaction mixture was filtered to remove 
unreacted iron (II) chloride and reduced via rotary evaporation. Following filtration, the 
mixture was dissolved in dichloromethane and washed repeatedly with 1M hydrochloric acid 
solution. After each wash impurities were formed at the solvent interface, these were 
subsequently removed via vacuum filtration. After performing an acid wash, purification was 
completed using column chromatography. The eluent used was a 3:1 ratio mixture of 
dichloromethane and methanol. The mass spectrum showed a molecular ion peak at 1631 
which was indicative of the MH
+
 ion. The product was validated by UV/Vis spectroscopy. 
The spectrum displayed noteworthy broadening of the soret band, at 412 nm, and a reduction 
in the number of Q bands, from four to two; both effects are anticipated for an iron porphyrin 
macrocycle. These effects can be seen from the UV spectra shown in figure 111. 
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Figure 111 – Figure to show the UV/Vis spectral overlay of the free porphyrin (blue) and the 
porphyrin, after insertion of an iron metal centre (red). 
 
Nuclear magnetic resonance spectroscopy was not possible for both proton and carbon. The 
spectrometer was not capable of locking the solvent, which was a result of the paramagnetic 
nature of the iron centre. The lack of complete characterisation, albeit not desirable, is not 
crucial to product identification. Consequently, the NMR spectra for both proton and carbon 
have been excluded from the experimental chapter. 
 
4.3.3 Oxidation of ethylbenzene  
4.3.3.1 Catalysis Quantification  
As discussed in section 4.3.1, the chemical reaction selected is the oxidation of ethylbenzene 
(scheme 29, page 198). Gas chromatography was the tool used to measure the extent of the 
oxidation reaction. Before the extent of reaction could be quantified, it was first important to 
run standards through the instrument. Highly pure GC grade products, purchased from Sigma 
Aldrich, were obtained. GC plots for each of the oxidation products and ethylbenzene starting 
material were attained at the appropriate concentration. This allowed the yield of each 
oxidation product to be calculated, as the area of each standard GC plot represents 100% of 
the relative product. 
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4.3.3.2 Control reaction in dodecane 
An initial reaction was required to test the efficacy of the porphyrin catalyst and solvent for 
this type of oxidation reaction. A reaction flask was charged with ethylbenzene (20 mg, 2x10
-
4 
mol), the iron porphyrin catalyst (3mg, 2x10
-6 
mol) and dodecane. The reaction was heated 
to 70 ºC and stirred in a constant stream of dioxygen for a period of 7 hours. Upon 
completion, the reaction mixture was filtered through a Whatman
® 
GD/X syringe filter, with 
a pore size of 0.45 µm, directly into a GC vial. The sample was run through the 
chromatogram, where the procedure upheld a temperature of 50 ºC for five minutes. This 
then rose to 250 ºC over a period of 20 minutes.  From analysis of the GC trace generated, the 
reaction did not appear to be successful. Ethylbenzene remained unreacted, suggesting that 
the catalyst and the solvent are not appropriate for this particular type of oxidation reaction. 
 
4.3.4 Oxidation of Cyclooctene 
As the oxidation of ethylbenzene proved unsuccessful, another reaction was required to probe 
the encapsulation properties of colloidosomes. Previous work within the Twyman group has 
involved the use of an Iron porphyrin as a catalyst for the oxidation of cyclooctene
37
, with 
iodosylbenzene as the oxygen source. In this reaction, oxygen is transported from 
iodosylbenzene to the iron porphyrin centre. This process results in the generation of a metal 
porphyrin oxo intermediate. The intermediate then reacts with the alkene substrate to 
generate the epoxide and various other oxidation by-products. The scheme for this reaction 
can be seen in scheme 33. Cyclooctene oxide is one of the oxidation products generated in 
this reaction. This work was based on work by Suslick et al. which involved the shape 
selective epoxidation of alkenes using metalloporphyrin dendrimer catalysts.
55
 Though a 
water soluble product is not generated, there has been success within the Twyman group with 
regards to this reaction. It was decided that, despite the setback, this reaction could be used as 
a proof of principle that catalysis could occur within a colloidosome structure.  
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Scheme 33– Catalytic epoxidation of cyclooctene indicating the mixture of products 
obtained. 
 
4.3.5 Synthesis of Iodosylbenzene  
As the oil soluble catalyst has been prepared, the next stage is the synthesis of 
Iodosylbenzene, which is the oxygen source for the catalytic procedure. Iodosylbenzene was 
prepared by the reaction of iodobenzene diacetate with sodium hydroxide solution (scheme 
34). The procedure involved stirring iodobenzene in a 3M solution of sodium hydroxide for a 
period of 45 minutes. The solution was filtered and the yellow powder obtained was washed 
thoroughly with water, followed by chloroform. Iodosylbenzene is highly sensitive and is 
easily decomposed when exposed to light. Therefore, due to the simplicity of the 
experimental procedure, iodosylbenzene was synthesised prior to each epoxidation reaction 
executed. 
 
 
Scheme 34 – Synthetic procedure of Iodosylbenzene, which is used as the oxygen source for 
the oxidation of cyclooctene. 
 
A variety of analytical techniques were utilised to confirm successful preparation of 
iodosylbenzene. The mass spectrum confirmed the mass peak at 220 and also showed the 
presence of the fragment pattern at 204 and 205, resulting from the loss of the oxygen atom. 
This was in accordance with the Integrated Spectral Database System of Organic Compounds 
(AIST). The melting point showed decomposition at a temperature of 211 ºC, which is in 
agreement with results found in the literature.
56
 Nuclear magnetic resonance for both proton 
and carbon were performed, confirming the identification of the product. The 
1
HNMR 
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spectrum showed a multiplet at 8.05 ppm which was representative of the ortho protons and a 
multiplet at 7.58 ppm which was representative of the para and meta protons.  
 
4.3.6 Catalysis Quantification 
As discussed previously, when GC was first introduced in 4.3, it is first necessary to run 
standards through the instrument. Neat samples of cyclooctene, cyclooctene oxide and 
iodobenzene, at appropriate concentrations, were run through the chromatograph. These 
compounds were purchased from Sigma Aldrich and this step of the procedure was 
imperative for determining the yield of the products obtained, upon completion of the 
reaction. An initial blank experiment was performed, so as to determine whether the alkene 
reacted with iodosylbenzene in the absence of the porphyrin catalyst. The GC traces obtained 
confirmed that there is a slight background reaction, but only to a minor extent. Though 
undesirable, this background reaction is inevitable and will be taken into consideration when 
deducing an accurate yield for cyclooctene oxide and the other oxidation products generated. 
 
4.3.6.1 General Catalytic procedure – Control reaction 
In a typical experiment 0.1 mmol of iodosylbenzene was added to a reaction vial, which was 
sealed and degassed thoroughly using low vacuum/N2. A 2 mL solution of the solvent 
(dodecane) containing both 1 mmol cyclooctene substrate and 2.5 μmol porphyrin containing 
catalyst was then added via syringe. The suspension was then stirred in the dark for a period 
of thirty minutes under an atmosphere of nitrogen. After completion, the suspension was 
filtered using a Whatman
® 
GD/X syringe filter, with a pore size of 0.45 µm, and transferred 
into a GC vial for analysis via manual injection. For the control reaction the yields obtained 
for cyclooctene oxide and all other oxidation products was very low. This procedure was 
repeated and similar results were obtained. As the yields obtained are low, it was advisable to 
test the efficiency of the oxygen source. The Twyman group performed this reaction with 4-
acetoxyphenyl porphyrin and dichloromethane as the solvent and obtained yields of 
approximately 30-50%. In order to test the quality of the iodosylbenzene obtained, the 
reaction involving TAPP and dichloromethane was repeated. 
 
4.3.6.2 Synthesis of 5, 10, 15, 20, tetrakis (4-acetoxyphenyl)-porphyrin (TAPP) 
4.3.6.2.1 Synthesis of 4-acetoxybenzaldehyde 
The initial task at hand, to carry out the repeat reaction, was the synthesis of TAPP. The 
initial step in the synthetic procedure of this porphyrin was the preparation of the 4-
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acetoxybenzaldehyde. Although commercially available, 4-acetoxybenzaldehyde can be 
easily prepared via acetylation of 4-hydroxybenzaldehyde with acetyl chloride in an inert 
atmosphere (scheme 35). 
 
 
Scheme 35 – Synthetic procedure of 4-acetoxybenzaldehyde. 
 
 
A reaction flask, charged with 4-hydroxybenzaldehyde, anhydrous THF and anhydrous 
triethylamine, was degassed with argon and acyl chloride was added drop wise. The reaction 
mixture was stirred for a period of 30 minutes. The role of triethylamine in this reaction is 
that of a catalyst. The first step in the reaction is attack by the lone pair on the phenolic 
hydroxyl oxygen atom on the acyl carbon of acetyl chloride. Triethylamine present is then 
able to deprotonate the charged tetrahedral intermediate formed from the first step. This 
allows chloride to be ejected upon regeneration of the carbonyl double bond, generating the 
acetylated product. The chloride leaving group withdraws the hydrogen from the protonated 
amine species, restoring the catalyst. This mechanism can be visualised in scheme 36.  
 
 
Scheme 36 – Reaction mechanism for the acetylation of 4-hydroxybenzaldehyde, illustrating 
the role of triethylamine in the procedure. 
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Once the reaction is complete, the solid impurities generated were removed via filtration. The 
filtrate was reduced and the resulting brown oil was dissolved in chloroform and purified by 
washings with water and sodium hydrogen carbonate solution. The product was validated 
from the 
1
HNMR spectrum which displayed a singlet at 2.36 ppm integrating to 3 protons, 
indicative of the methyl protons present on the acetoxy functional group. Utilisation of NMR 
and IR spectroscopy combined with mass spectrometry confirmed the product was 
sufficiently pure for the synthesis of 4-acetoxyphenyl porphyrin. 
 
4.3.6.2.2 Assembly of TAPP 
The simplicity of the production of the acetylated aldehyde enabled large quantities to be 
synthesised efficiently. With a sufficient amount of aldehyde, the next part was the 
construction of the porphyrin macrocycle. The porphyrin synthesis involved refluxing equal 
molar quantities of 4-acetoxybenzaldehyde and pyrrole in propionic acid for a period of 30 
minutes (scheme 37a). This particular type of porphyrin synthesis differs to the Lindsey 
method, outlined previously. This alternate synthetic procedure was first considered by 
Rothemund in 1935.
57
 Adler et al. went on to develop this method further towards the end of 
the 19 0’s.58,59 
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Scheme 37 – (a) synthetic procedure of 4-acetoxyphenyl porphyrin (b) synthetic procedure 
for the 5, 10, 15, 20 – tetrakis (4-acetoxyphenyl)-porphyrin Iron (III) complex, which is used 
to catalyse the oxidation of cyclooctene in dichloromethane solvent. 
 
Upon completion of reflux, a dark brown/black suspension remained in the reaction flask. 
This slurry was a mixture of numerous polypyrollic structures, incomplete porphyrin 
structures, other undesirable by-products and the desired porphyrin, 4-acetoxyphenyl 
porphyrin. The desired porphyrin was collected by vacuum filtration and purified by 
numerous washings with methanol. This workup was sufficient in generating analytically 
pure porphyrin. A notable disadvantage to using this specific method is the characteristically 
low yield associated with it. In order to explain this limitation, one must consider the 
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necessary prerequisites for total porphyrin assembly. In order to generate the complete 
macro-cyclic structure of the porphyrin, a succession of reactions must occur. The overall 
yield is inescapably poor, even if each individual successive reaction has a high yield. This is 
a result of accumulative negative effects present in macro-cyclic formation. The yield was 
typically between 15 and 20% for this experimental procedure. 
 
The proton NMR displayed a singlet at 8.93 ppm which is representative of the pyrrolic 
protons on the porphyrin macrocycle. There are also doublets at 8.25 ppm and 7.54 ppm 
which are indicative of the ortho and meta protons of the phenyl ring. There is a singlet 
present at 2.53 ppm which corresponds to the methyl protons present in the acetoxy 
functional groups on the phenyl rings. The inner protons of the porphyrin are extremely 
shielded and therefore show a signal at -2.79 ppm. Electrospray mass spectrometry showed 
the molecular ion peak at 847, which is identical to the theoretical value. This analytical data, 
in combination with a UV/Vis soret band at 418 nm, confirms that the product synthesised is 
analytically pure. 
 
4.3.6.2.3 Synthesis of 5, 10, 15, 20-tetrakis(4-acetoxyphenyl)-porphyrin Iron(III) 
Complex 
As previously identified, the porphyrin catalysis required for the epoxidation of cyclooctene 
needs to have a central iron atom to operate. The insertion of iron into the porphyrin 
macrocycle was achieved using the same synthetic procedure as specified beforehand. The 
reaction scheme for iron insertion with TAPP is shown in scheme 37b. The product was 
verified by mass spectrometry and UV/Vis spectrometry. MALDI-TOFF gave a peak at 1631 
which was indicative of an MH
+
 ion. The UV/Vis spectrum showed notable broadening of 
the Soret band at 412 nm and a reduction in the number of Q bands, characteristic of iron 
insertion into a porphyrin. 
 
4.3.6.3 Control reaction – test of purity of iodosylbenzene 
As stated beforehand, in order to verify that the low yields are accurate and the 
iodosylbenzene used is analytically pure, a known reaction was to be repeated. The general 
catalytic procedure, described in 4.3.4, was used and the yields obtained are tabulated 
overleaf in table 6. 
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 Yield of total oxidation 
products (%) 
Yield of cyclooctene oxide 
 (%) 
TAPP-Fe(III) 27 (±1.6) 20 (±1.5) 
 
Table 6 – Table to show the percentage yields obtained for TAPP-Fe (III) in 
dichloromethane. 
 
From the results tabulated, the percentage yield obtained for all oxidation products is 
approximately 30% which is in accordance for previous results obtained within the group, 
thus providing confidence in the analytical purity of iodosylbenzene synthesised. This 
confirms that dodecane and the oil soluble porphyrin synthesised are not the optimum solvent 
and catalyst for this procedure. Nevertheless, though the yields are inherently low, they are 
still measurable. For a proof of principle, a high yielding reaction is not a necessity; therefore 
this reaction will be suitable to determine the effect, if any, upon encapsulation within a 
colloidosome structure. 
 
4.3.6.4 Colloidosome Encapsulation 
The particles used for this study were provided by Dr. Kate Kirkham and were synthesised by 
an aqueous emulsification polymerisation using a PGMA50 macromonomer.
19,60
 The latex 
particles, provided by the Armes group, each have a hydroxyl rich surface as a result of 
PGMA50 chains. These groups determine the hydrophilicity of the particle. It was also 
discovered that these PGMA50 chains could be easily cross-linked to form urethane 
bonds.
20,61
 For the purpose of this research, the cross-linker used was a polymeric 
diisocyanate (tolylene 2, 4-diisocyanate-terminated poly (propylene glycol) [PPG-TDI]. The 
structure of PPG-TDI can be seen in figure 112.
20
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Figure 112 – Figure to show the chemical structure of the oil soluble PPG-TDI cross-linker 
which is used in the covalent cross-linking of the colloidosomes used in this research.
18
 
 
This is specifically oil soluble and commercially available. As this material is completely 
insoluble in water, cross-linking will be confined to the oil interior. Another added advantage 
to this cross-linking step is the mild conditions required. The cross-linker is dissolved in the 
oil phase and homogenised with the aqueous phase at room temperature and after a period of 
20 minutes, covalent cross-linking is achieved. Cross-linking can be verified by optical 
microscopy, whereby the colloidosomes, after an alcohol challenge, remain intact. A 
schematic diagram for this step can be seen in scheme 38.
20
 
 
 
 
Scheme 38– Schematic representation of covalent cross-linking of a colloidosome with the 
oil soluble cross-linker, PPG-TDI. The amide bond formation, which leads to crosslinking, is 
highlighted above.
20 
 
4.3.6.5 Encapsulation of porphyrin-Fe(III) complex into covalently cross-linked 
colloidosomes 
Firstly, prior to carrying out the reaction, it was necessary to verify that encapsulation of the 
iron porphyrin did not interfere with the synthesis of the colloidosome. The oil phase 
20ºC, 20 
minutes 
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consisted of dodecane, the iron porphyrin catalyst and the cross linker, PPG-TDI. The 
aqueous phase was made up of 1% wt. aqueous solution of 125 nm PGMA50-PS particles. 
Firstly the iron porphyrin complex and PPG-TDI were dissolved in dodecane and 
homogenised with the aqueous phase at 12,000 rpm for 2 minutes to generate the emulsion. 
The emulsion gave two distinct layers, the oil layer was coloured as a result of the brown iron 
porphyrin dissolved. The droplets were visualised by optical microscopy to verify that the 
initial emulsification was successful. The image from the microscope for the initial 
emulsification can be visualised in figure 113. 
 
                                                 
Figure 113 – Figure to show the optical microscopic image of the emulsion containing the 
iron porphyrin complex. 
 
The aqueous layer at the bottom of the vial remained clear, typical of successful 
homogenisation and the droplets, seen by microscopy, were similar to previous images 
without a porphyrin complex present. This provided confidence that the iron porphyrin 
catalyst is not reacting with the cross-linker in the oil phase. The droplet distribution was then 
measured via laser diffraction and the results can be seen in figure 114 below. 
 
 
 
 
 
 
 
 
 
 
 
52 ± 19 µm 
 1   10   100   1000   3000  
 Droplet Size (µm) 
 
 
100 µm 
Figure 114 – A graph to show the droplet distribution by laser diffraction. 
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A Gaussian distribution is desired as it means that there is no skew on droplet sizes, therefore, 
the presence of the iron porphyrin complex has not had an adverse effect upon distribution. 
The following stage was to confirm that cross-linking was successful. This was performed by 
an alcohol challenge; whereby a few drops of the emulsion were added to a vial of ethanol 
and shaken. This was then visualised by optical microscopy and the results of the alcohol 
challenge can be seen in figure 115.  
 
 
  
Figure 115 – Figure to show the optical microscope images of colloidosome shells after the 
alcohol challenge. 
 
The next step was the encapsulation of the substrate and catalyst and, after homogenisation 
and crosslinking, the reaction could occur. 
 
4.3.6.6 Background reaction 
As mentioned previously in 4.3.6, there is an unavoidable background reaction which occurs. 
The background reaction is a representation of how well the oxidation reaction proceeds 
without a catalyst present. Therefore, initial blank experiments within the colloidosome were 
performed. Blank experiments, without a catalyst, are required to determine the extent of the 
background reaction. These control reactions are important as all yields obtained will be 
quoted relative to the background reaction. After homogenisation and cross-linking, the 
colloidosome was injected into a vial, containing iodosylbenzene, under an atmosphere of 
nitrogen. The reaction mixture was then stirred in the dark for a period of 30 minutes 
(scheme 39). 
 
100 µm 
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Scheme 39 – Reaction scheme for the background oxidation reaction which takes place in the 
absence of a catalyst.  
 
The oil phase was removed by extraction with dichloromethane and filtered through a 
Whatman
® 
GD/X syringe filter into a GC vial for analysis. The results, along with the control 
experiments (in dodecane), are tabulated overleaf in table 7. As mentioned previously in this 
section, the yields obtained in dodecane solvent were low, whereas, dichloromethane solvent 
gave a yield of total oxidation products of around 30%. Therefore, dodecane is not an 
optimum solvent for this particular reaction. However, we are restricted by the solvent 
applicable to colloidosome synthesis. The low yields predicted are disappointing, but are 
unavoidable. In dodecane, the yield of oxidation products was 2.2% whereas, in the 
colloidosome, this yield increased to 3.6%. The background reaction is faster within error and 
numerous repeats were performed which showed consistent results. This gave confidence that 
the colloidosome provided a better environment for the reaction. As yields are still 
measurable and repeatable, for a proof of principle, a reaction can be carried out regardless of 
low yields. The results tabulated overleaf have been normalised so that the control reaction in 
dodecane equates to 1. 
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From the blank experiment, it is evident that the colloidosome is having a positive effect 
upon the yield of the background reaction. Therefore; once the catalyst is incorporated, it is 
important to see if a similar effect is observed. 
 
4.3.6.7 General catalytic procedure - Colloidosome 
In a typical experiment 0.1 mmol of iodosylbenzene was added to a reaction vial, which was 
sealed and degassed thoroughly using low vacuum/N2. A colloidosome was synthesised by 
the homogenisation of a 2 mL solution of the solvent (Dodecane) containing both 1 mmol 
cyclooctene substrate, 2.5 μmol porphyrin containing catalyst and the PPG-TDI cross-linker 
and a 2 mL solution of the aqueous phase (1 wt. % aqueous solution of 125 nm PGMA50-PS 
particles). Homogenisation took place for a period of 2 minutes at 12000 rpm. The 
colloidosome was injected via a syringe and the suspension was then stirred in the dark for a 
period of thirty minutes under an atmosphere of nitrogen. After completion, the suspension 
was extracted using dichloromethane (3 mL) and the organic layer was collected and filtered 
using a Whatman
® 
GD/X syringe filter with a pore size of 0.45 µm. The filtrate was 
transferred into a GC vial for analysis via manual injection. 
 
 Reaction in 
Dodecane (no 
porphyrin)  
Reaction in Colloidosome 
(no porphyrin)  
 
Colloidosome 
Enhancement 
Relative yield of 
all oxidation 
products 
 
1.00 (±0.32) 
 
1.63 (±0.06) 
 
63% 
Table 7– A Table to show the relative yields of the background reaction for all oxidation 
products in both dodecane and the colloidosome without porphyrin catalyst. 
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Scheme 40 – Reaction scheme for cyclooctene in the presence of an iron porphyrin catalyst 
and the yields obtained after encapsulation within a colloidosome. 
 
4.3.6.8 The effect of encapsulation within a colloidosome upon catalysis 
With addition of the iron porphyrin catalyst, a similar enhancement effect was observed 
within the colloidosome compared to the reaction in dodecane alone. The results for all 
oxidation products, both the raw data and taking into account the background reaction, are 
tabulated below in table 8. 
 
Table 8 - A Table to show the relative percentage yields for all oxidation products when 
porphyrin catalyst is added, both the raw data and the data accounting for the background 
reaction is shown (in all cases final data normalised to the result obtained in dodecane). 
  Total Product (i.e. data including the 
background reaction) 
  Porphyrin catalysis (i.e. Data minus 
background reaction) 
  Dodecane Colloidosome Colloidosome 
Enhancement 
  Dodecane Colloidosome Colloidosome 
Enhancement 
All 
Oxidation 
Products 
1.00 
(±0.16) 
2.33 
(±0.10) 
233%   1.00 
(±0.34) 
3.99 
(±0.17) 
399% 
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Results have also shown that the oxidation reaction, in the presence of a catalyst, is also faster 
in a colloidosome. Numerous repeats were performed and consistent results were obtained. 
The estimated error is lower than the difference, meaning yields are both valid and 
measurable, and also lie within the limits of the technique. In terms of all possible oxidation 
products, there is a definite enhancement effect with encapsulation in a colloidosome. 
Specifically looking at cyclooctene oxide, the yields for the background reaction were 
immeasurable. Therefore, in order to gain a basic understanding upon the effect on the yield 
of this particular oxidation product, the raw data was contrasted for both dodecane and the 
colloidosome. The results are shown below in both figure 116 and table 9.  
 
 
Figure 116 – A chart to show the effect of the colloidosome upon the relative yields of 
oxidation products. The dotted line indicates the result if there is no effect upon encapsulation 
within the colloidosome. 
 
 
 
 
 
0
0.5
1
1.5
2
2.5
Total Products Cyclooctene Oxide Other Oxidation
Products
Dodecane
Colloidosome
229 
 
 Total 
Products 
Cyclooctene 
oxide 
Other oxidation 
products 
Relative yield in dodecane 1.00 1.00 1.00 
Relative yield in 
colloidosome 
2.33 0.57 1.38 
Colloidosome effect (+) 233% (-) 43% (+) 38% 
Change in product 
distribution 
/ 81% 
 
Table 9 – Table to show the relative yields (using raw data) and the product distributions for 
the porphyrin catalysed reactions in dodecane and colloidosome.  The shift in product 
distribution is calculated by taking the difference in the colloidosome effect for the 
cyclooctene and the other oxidation products. 
 
From analysis of the raw data it appears that, whilst there is an increase in yield of all 
oxidation products when the reaction occurs within the colloidosome, the yield of 
cyclooctene oxide is reduced. There are a few potential reasons for this result. A possible 
explanation for this outcome is that cyclooctene oxide generated could react with the 
polymeric structure of the colloidosome, thereby leading to a lower yield. In order to confirm 
whether this is taking place, a control reaction is performed. Cyclooctene oxide is dissolved 
into the dodecane phase, prior to homogenisation, and the reaction conditions are 
implemented. Upon completion, the reaction mixture is extracted with dichloromethane and 
filtered, as before, into a GC vial and analysed. The area present for cyclooctene oxide on 
both initial and final GC plots is contrasted. The result for the control reaction is shown in 
scheme 41. 
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Scheme 41 – Control reaction to demonstrate whether cyclooctene interacts with the 
colloidosome. 
 
From the control reaction, 90% of cyclooctene was present within the dodecane phase of the 
colloidosome. This means that one should consider a 10% error in the extraction procedure 
with dichloromethane to extract the internal oil phase. As the results displayed show 
selectivity greater than 10%, this error does not affect the trends seen above. From the data 
obtained it is evident that cyclooctene oxide is not interacting with the colloidosome, 
meaning that the colloidosome is having an effect on the product distribution of the reaction. 
It was initially hypothesised that the effect of the colloidosome, if any, would not alter the 
product distribution. Though the yields for this reaction in dodecane are low, it is evident that 
there are significant changes to the yields and relative product distribution. The change in 
selectivity experienced is highly significant. 
 
 Upon documentation of the results, it was postulated that there were numerous possibilities 
to explain the increase in yield of products. The initial hypothesis is that the reaction is taking 
place within dodecane core. However, the yield could be elevated as a result of stabilisation 
of the reaction by the polystyrene (PS) particles of the colloidosome. It is possible that the PS 
could provide a different environment. As mentioned beforehand, catalysis of oxidation 
involves an iron porphyrin. In order to deduce the likelihood that the porphyrin catalyst is 
soluble in polystyrene, initial solubility tests involving toluene were performed. Toluene is 
similar in structure to polystyrene so can be presumed to have similar solvent properties. The 
porphyrin catalyst was found to be highly soluble in toluene, so it can be postulated that the 
PS is acting as an additional solvent system. The PS could be providing a more efficient 
solvent system for oxidation to that of dodecane, thus resulting in an enhanced yield of 
products. Consequently, a third location for catalysis to take place would be at the oil/particle 
interface. The results show that the use of a colloidosome leads to an enhanced total yield; 
however, the exact reasoning behind this is still unknown. The possible locations for 
oxidation, stated above, can be visualised in figure 117 
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Figure 117 – Figure to show the possible locations within a colloidosome structure where 
oxidation of cyclooctene could potentially take place. (A) within the dodecane oil core (B) 
within the PS particle, and (C) at the dodecane oil/PS particle interface. 
 
The colloidosome was also affecting the product distribution of this particular oxidation 
reaction. The porphyrin catalyst used for this research contains iron (III) and there are several 
possible pathways for epoxidation which are presented below in scheme 42. 62 
 
 
Scheme 42  – Representation of the possible pathways possible for the epoxidation of an 
alkene. Pathway 1 represents the direct insertion of an oxygen atom, pathway 2 represents 
electrophilic addition followed by ring closure and pathway 3 represents the reversible 
formation of an electrocyclic metallooxetane followed by dissociation to generate the epoxide 
or other oxidation products.
62
 
 
The epoxide can result from numerous pathways and, although not shown in scheme 42, 
there can also be other intermediates generated, which could possibly be influenced by the 
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colloidosome.
62
 Therefore, it is evident that alkene oxidation involves a complicated 
mechanism with numerous viable routes to the products. A possible explanation for the 
change in product distribution could be a result of stabilisation by some aspect/region of the 
colloidosome of a particular intermediate, giving rise to the alcohol. Stabilisation could occur 
through cation-π interactions between the positively charged intermediate and the face of an 
electron rich benzene ring present within the colloidosome structure. Furthermore, if the 
reaction is taking place within the PS particles instead of the dodecane core, the different 
solvent environment could account for the stabilisation of a different intermediate. 
 
As mentioned beforehand, in addition to an epoxide and an alcohol, another product which 
can be generated is a ketone. In 19 9, Ostović and Bruice63 carried out research on the 
catalysed epoxidation of alkenes by use of a sterically hindered iron (III) porphyrin 
macrocycle. This work demonstrated that the presence of a heavy iron atom within the 
porphyrin macrocycle can allow the mixing of spin states. This work showed that, following 
formation of a charge transfer complex and the subsequent change in spin state, there are two 
possible oxidation pathways possible; the first being concerted oxygen insertion to give an 
epoxide and the second being electron transfer to the porphyrin π-cation radical moiety to 
give a ketone. These two pathways are illustrated overleaf in scheme 43. 
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Scheme 43 – Representation of the two possible pathways for the oxidation of an alkene via 
an iron porphyrin catalyst. Route (i) shows a concerted mechanism for the insertion of an 
oxygen atom and route (ii) represents the electron transfer to the porphyrin π-cation radical 
moiety.
63 
 
It can be postulated that, within a colloidosome, pathway (ii) is preferred over pathway (i), 
meaning the ketone would be the dominant product. Finally, another explanation for the 
change in product distribution could be that the environment within the colloidosome 
promotes the rearrangement of the epoxide into the ketone. Each of these explanations could 
account for the reduction in the level of cyclooctene oxide compared to other oxidation 
products, when catalysis takes place within a colloidosome.  
 
Unfortunately, due to time restraints, control reactions involving the use of PS particles, prior 
to emulsification, could not be attempted. Future work, relating to this project, would be to 
investigate the ability of PS as a solvent. This would provide more insight into the role of the 
PS particles during this reaction. Furthermore, future work in this area would involve finding 
a suitable reaction for dodecane as a solvent, and also investigating different types of 
catalysis reactions to examine whether similar effects are observed. In addition to this, similar 
micelle structures could be investigated. Furthermore, if the product distribution is altered for 
other reactions, colloidosome catalysis could be a useful tool in selectivity of a desired 
product which, under usual condition, is perhaps a minor product, giving rise to a potential 
novel use for these microcapsules. 
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Chapter 5 - Experimental 
5.1 Instrumentation 
Infrared (IR) Spectroscopy 
IR spectra were recorded using a Perkin-Elmer UATR Infrared spectrometer. Spectra were analysed 
with Spectrum100 software and positions of peaks are stated as wave numbers (cm
-1
). 
 
NMR Spectroscopy 
All NMR samples were prepared using deuterated solvents supplied by Sigma Aldrich. 
1
H NMR and 
13
C NMR spectra were recorded using a Brucker AV1400 MHz machine.                                          
Chemical shifts are quoted using ppm, coupling constants are quoted in Hertz and anomalous impurity 
and solvent peaks are labelled and referenced to residual solvent signals, with Tetramethylsilane δ=0 
at =0 as the reference. The NMR spectra were analysed using Topspin 3.0 NMR software. 
 
NMR Titrations 
The anion receptor, N, N’- Bis-(3-acetoxy-phenyl)-isophthalamide, and the three hyperbranched 
polymers of varying molecular weight, bearing this receptor as a core molecule, were each titrated 
against a variety of anionic guests. Each titration began with 0.7 mL of the host species at the correct 
concentration in deuterated chloroform in an NMR tube. The anionic guest, at the correct 
concentration in deuterated chloroform, was added in aliquots (10-25 μL) to the host. NMR scans (32) 
were run following each addition and the position of the NH chemical shift (ppm) was monitored. 
Solutions were made up fresh and used immediately after preparation and anionic guests were added 
as tetrabutylammonium salts. Topspin 2.6 software was used to process the NMR spectra generated.  
 
Mass Spectrometry 
The form of ionisation used was dependent on the molecular weight of the sample in question. For 
samples with a low molecular weight, an Electrospray ionisation (ES) was used to record spectra. The 
instrument used was a WATERS LCT mass spectrometer. For samples with a high molecular weight, 
Matrix assisted laser desorption ionisation (MALDI) was required. The instrumentation used was a 
BRUKER REFLEX III MALDI-ToF mass spectrometer. 
 
Gel Permeation Chromatography 
Analytical THF GPC data was obtained at room temperature using either a high molecular weight 
column (3x300 mm PL gel 10 µm mixed-B), or a low molecular weight column (2x600 mm PL gel 
5um (500 Å)). Calibration was achieved by using polystyrene standards (Mn 220-1, 1,000,000 Da) 
and molecular weights are thus reported relative to these specific standards used. The samples were 
run using Fisher GPC grade THF as a solvent stabilised with 0.025 % BHT (which was supplied to 
the columns by a Waters 515 HPLC Pump at 1.00  mLmin
-1
). Toluene was added to prepared sample 
as a flow marker, before injection through a 200 µL sample loop with a Gilson 234 Auto Injector. The 
concentration of a sample was studied using an Erma ERC-7512 refractive index detector and, where 
applicable, by UV using a Waters Millipore Lambda Max 481 LC Spectrophotometer. Aqueous GPC 
data was acquired using a Millipore Waters Lambda-Max 481 LC spectrometer with a LMW/HMW 
column. The eluent which was used was NaNO3/NaH2PO4 (pH=7) buffer solution (unless stated 
otherwise). The data attained was then analysed using cirrus GPC-online software. Samples were 
filtered using Whatman
® 
GD/X syringe filters with a pore size of 0.45 µm prior to analysis. 
 
UV/Vis spectroscopy 
The ultraviolet absorbance was recorded on an Analytik Jena AG Specord s600 UV/Vis Spectrometer 
and analysed using its attached Software (WinASPECT). 
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Gas Chromatography 
Gas chromatography results were obtained using a PerkinElmer Clarus 400 Gas Chromatograph. 
Samples were performed using a hydrogen gas flow and by means of an Altech AT1 non-polar 
column (length 30 metres, ID: 0.32 mm, Film Thickness: 5.00 um). The injection temperature was 
250 ˚C; the temperature of the oven remained at 50 ˚C for 5 minutes and then subsequently increased 
to 250 ˚C over a period of 20 minutes. All data was processed using Total Chrome Nav software. 
 
Fluorescence Spectroscopy  
Fluorescence results were obtained using a HORIBA Scientific Fluoromax-4 spectrofluorometer 
using its attached software (FluorEssence V3). 
 
Fluorescence Titrations 
Fluorescence labelled PAMAM dendrimers, 33 and 34, were each titrated against cytochrome-c (from 
equine heart). Each 10
-6 
M solution of the fluorescence labelled dendrimers was prepared using ultra-
pure water. A solution containing a large excess (5x10
-3 
M) of the guest, cytochrome-c, was then 
prepared using the corresponding dendrimer solution to ensure constant concentration of dendrimer 
throughout the titration. The dendrimer solution was accurately measured (3 mL) into a quartz cuvette 
and aliquots of ligand solution (between 10 μL and 50 μL) were added. Fluorescence emission scans 
were taken after each addition, monitoring the quenching of the emission spectrum of the labelled 
dendrimer (508 nm). Solutions were made fresh and used immediately after preparation. 
 
Dynamic light scattering (DLS) 
DLS results were obtained using the Brookhaven instrument 90 Plus Particle Size Analyser 
(Holtsville, NY, USA) 35 mW solid state standard laser. This instrumentation was used to determine 
the hydrodynamic diameter of nanoparticles. Particle sizing software 9kpsdw32.exe.ver.3.80 was used 
for characterisation. Light was scattered at an angle of 90 ° with each run lasting 2 minutes at a 
temperature of 37.5 °C. Samples were filtered using Whatman
® 
GD/X syringe filters with a pore size 
of 0.45 µm, prior to analysis. Results reported are based upon volume distribution. 
 
pH measurement 
The pH of the buffer solutions prepared was substantiated using a pH 210 Microprocessor pH Meter 
from Hanna Instruments Ltd. (Leighton Buzzard, UK). The device was calibrated using pH 4.0 and 
pH 7.0 standard solutions, prepared with buffer tablets (Sigma-Aldrich, Poole, UK). 
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5.2 Synthetic procedures for Protein binding 
The PAMAM dendrimers were synthesised in collaboration with a 4
th
 year project student. 
 
5.2.1 General procedures for synthesis of PAMAM dendrimers 
 
5.2.1.1 General procedure for synthesis of half generation PAMAM dendrimers 
Methyl acrylate was added drop-wise over a period of 30 minutes to a solution of the previous 
diamine intermediate (or ethylene diamine (EDA) in the case of G-0.5) dissolved in methanol (various 
amounts) in a 500 mL round bottom flask at 0 °C. The reaction was then stirred at room temperature 
for a given amount of time depending on the generation of dendrimer in question. The excess methyl 
acrylate and solvent were then removed by rotary evaporation at 40 °C and then placed under a high 
vacuum to give the desired half generation PAMAM dendrimer. 
 
5.2.1.2 General procedure for synthesis of whole generation PAMAM dendrimers 
The ester terminated intermediate generated previously was dissolved in methanol (various amounts) 
and added drop-wise over period of 30 minutes to EDA in a 500 mL round bottom flask at 0 °C. The 
reaction was subsequently stirred at room temperature for a given amount of time depending on the 
generation of dendrimer in question. The solvent was removed via rotary evaporation at 40 °C and 
then excess EDA was removed by washing the product with an azeotropic mixture of toluene: 
methanol in the ratio 9:1. The purification, by way of an azeotropic wash, was repeated until no 
further trace of EDA could be detected analytically, generating the desired whole generation PAMAM 
dendrimer. 
 
5.2.2 Synthesis of a PAMAM dendrimer holding 4 terminal OMe terminal groups (28) 
 
 
 
Figure 27 page 61 
Scheme 6 page 64 
 
 
Yield 14.12 g, 82% 
1
HNMR (CD3OD, 400 MHz) δH 3.68 (s, 12H, CH3), 2.79 (t, 8H, NCH2CH2C=O, 
J=7.0), 2.54 (s, 4H, NCH2CH2N), 2.49 (t, 8H, OC=OCH2, J=7.0) 
13
CNMR (CD3OD, 400 MHz) δC 
173.18, 49.51, 47.74, 32.01 FTIR (cm
-1
) 2952 (C-H-sp
2
), 1731 (ester carbonyl), 1436 (CH2 bend), 
1357, 1329, 1194, 1171, 1042 ES-MS 405 (MH+), 427 (MNa+)  
 
 
 
 
 
 
 
 
The general procedure was followed where methyl acrylate 
(25.10 g, 0.29 moles) was added to EDA (2.56 g, 0.04 moles) 
dissolved in methanol (20 mL). The reaction was then stirred at 
room temperature for 24 hours. Purification yielded a light 
yellow oil. 
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5.2.3 Synthesis of a PAMAM dendrimer holding 4 terminal NH2 terminal groups  
 
 
 
Yield 6.34 g, 74 % 
1
HNMR (CD3OD, 400 MHz) δH  4.92 (s, 4H, NH), 3.69 (S, 8H, NH2), 3.33-3.27 
(mm, 16H, H2NCH2 + CH2NH), 2.81-2.41 (m, 20H, C=OCH2CH2 + NCH2CH2N) 
13
CNMR (CD3OD, 
400 MHz) δC  173.32, 52.36, 49.10 , 48.04, 37.08, 32.18 FTIR (cm
-1
) 3274 (amide N-H stretch), 3072, 
2926 (CH-sp
2
), 2865 (CH-sp
3
), 1637 (amide C=O stretch), 1547, 1438, 1358, 1258, 1194, 112 ES-MS 
517 (MH+) 
 
5.2.4 Synthesis of a PAMAM dendrimer holding 8 terminal OMe terminal groups  
 
 
 
Yield 3.23 g, 72 %
1
HNMR (CD3OD, 400 MHz) δH   4.91 (s, 4H, NH), 3.69 (s, 24H, CH3), 3.33-3.28 
(m, 24H, NHCH2 + NHCH2CH2NCH2) , 2.87- 2.48 (mm, 44H, NCH2CH2N + NCH2CH2C=ONH + 
NHCH2CH2N + CH3OC=OCH2)
13
C-NMR (CD3OD, 400 MHz) δC  173.35, 173.04, 52.35, 50.71, 
49.42, 49.10, 37.09, 32.19 31.89 FTIR (cm
-1
) 3274 (Amide N-H stretch), 2952 (C-H-sp
2
), 2825 (C-H-
sp
3
), 1730 (ester C=O stretch), 1643 (amide C=O stretch), 1536, 1436, 137, 1195, 1175, 1042 ES-MS 
1206 (MH+) 
 
 
 
 
 
 
 
The general procedure was followed where the 
ester terminated intermediate (6.7 g, 0.02 
moles) was dissolved in methanol (20 mL) and 
added, drop wise, to EDA (48.88 g, 0.82 
moles). The reaction was allowed to react for 5 
days. Purification yielded a yellow/brown oil 
 
 
The general procedure 
was followed where 
methyl acrylate (7.32 g, 
0.09 moles) was added to 
the diamine intermediate 
(2.51 g, 4.86 mmoles) 
dissolved in methanol 
(30 mL). The reaction 
was then stirred at room 
temperature for 24 hours. 
Purification yielded a 
viscous yellow/brown 
oil. 
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5.2.5 Synthesis of a PAMAM dendrimer holding 8 terminal NH2 terminal groups  
 
 
 
 
The general procedure was followed where the ester terminated intermediate (6.62 g, 5.49 mmoles) 
was dissolved in methanol (30 mL) and added, drop wise, to EDA (51.21 g, 0.85 moles). The reaction 
was allowed to react for 7 days. Purification yielded a deep orange viscous oil. 
 
 Yield 7.12 g, 90 % 
1
HNMR (CD3OD, 400 MHz) δH 4.91 (s, 12H, NH), 3.37 (s, 14H , NH2), 3.33-3.27 
(m, 24H , NHCH2CH2N + NH2CH2CH2NH)  2.83-2.16 (mm, 76H, NH2CH2CH2NH + NCH2CH2C=O 
+ NCH2CH2NH + NCH2CH2N) 
13
CNMR (CD3OD, 400 MHz) δC  176.53, 52.53, 50.17, 49.74, 44.40, 
43.42, 40.00, 35.90 FTIR (cm
-1
) 3274 (amide N-H stretch), 3064, 2932 (C-H-sp
2
), 2824 (C-H-sp
3
), 
1638 (amide C=O), 1546, 1440, 1365, 1280, 1195, 1126 ES-MS 1430 (MH+) MALDI-TOF MS 1430 
(MH+), 1452 (MNa+), 1468 (MK+) 
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5.2.6 Synthesis of a PAMAM dendrimer holding 16 terminal OMe terminal groups  
 
 
 
The general procedure was followed where methyl acrylate (2.81 g, 0.03 moles) was added to the 
diamine intermediate (1.25 g, 0.87 mmoles) dissolved in methanol (30 mL). The reaction was then 
stirred at room temperature for 2 days. Purification yielded a honey coloured, extremely viscous oil. 
 
Yield 1.82 g, 73 % 
1
HNMR (CD3OD, 400 MHz) δH  4.92 (s, 12H, NH), 3.69 (s, 48H, CH3), 3.30 (m, 
12H, NHCH2CH2N), 2.80-2.41 (mm, 152H, OC=OCH2CH2N + NCH2CH2NH + NHC=OCH2CH2N + 
NCH2CH2N) 
13
CNMR (CD3OD, 400 MHz)  δC  173.34, 173.23, 52.38, 52.08, 50.82, 49.66, 49.09, 
48.03, 37.25, 33.33 32.18  FTIR (cm
-1
) 3293 (amide N-H stretch), 2950 (C-H-sp
2
), 2834 (C-H-sp
3
), 
1731 (ester C=O stretch), 1640 (amide C=O stretch), 1536, 1436, 1357, 1196, 1177, 1043 MALDI-
TOF MS 2807 (MH+), 2829 (MNa+), 2845 (MK+) 
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5.2.7 Synthesis of a PAMAM dendrimer holding 16 terminal NH2 terminal groups  
 
 
 
The general procedure was followed where the ester terminated intermediate (1.71 g, 0.62 mmoles)  
was dissolved in methanol (30 mL) and added, drop wise, to EDA (7.20 g, 0.12 moles). The reaction 
was allowed to react for 7 days. Purification gave a deep orange and extremely viscous oil. 
 
Yield 1.01 g, 52 % 
1
HNMR (CD3OD, 400 MHz) δH  4.93 (s, 28H, NH), 3.6873 (s, 32H, NH2), 3.34-
3.28 (m, 56H, NHCH2CH2N + NH2CH2CH2NH)  2.85-2.41 (mm, 172H, NH2CH2CH2NH + 
NCH2CH2C=O + NCH2CH2NH + NCH2CH2N) 
13
CNMR (CD3OD, 400 MHz) δC  173.33, 52.39, 
50.84, 49.64, 48.03, 37.23, 33.32, 32.19 FTIR (cm
-1
) 3278 (amide N-H stretch), 3074, 2928 (C-H-
sp
2
), 2864 (C-H-sp
3
), 1637 (amide C=O), 1548, 1435, 1359, 1285, 1194, 1110, 1032  MALDI-TOF 
MS 3260 
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5.2.8 Synthesis of a PAMAM dendrimer holding 32 terminal OMe terminal groups  
 
 
 
 
The general procedure was followed where methyl acrylate (1.92 g, 0.02 moles) was added to the 
diamine intermediate (1.03 g, 0.30 mmoles) dissolved in methanol (40 mL). The reaction was then 
stirred at room temperature for 3 days. Purification yielded a Viscous yellow/orange oil. 
 
Yield 0.92 g, 47 % 
1
HNMR (CD3OD, 400 MHz) δH  4.92 (s, 28H, NH), 3.87 (s, 96H, CH3), 3.34-3.28 
(m, 120H, OC=OCH2CH2N + NHCH2CH2N), 2.85-2.41 (mm, 236H, OC=OCH2CH2N + 
NHC=OCH2CH2N + NHCH2CH2N, NCH2CH2N) 
13
CNMR (CD3OD, 400 MHz) δC  173.33, 173.23, 
52.39, 52.09, 50.84, 49.64, 48.03, 37.22, 33.33 32.19 FTIR (cm
-1
) 3274 (amide N-H stretch), 2951 (C-
H-sp
2
), 2825 (C-H-sp
3
), 1731 (ester C=O stretch), 1640 (amide C=O stretch), 1544, 1436, 1357, 1196, 
1043 MALDI-TOF MS 6034 (MNa+) 
 
 
 
 
245 
 
5.3 Protein Binding Assay -The inhibition of α-Chymotrypsin using PAMAM 
dendrimers 
 
5.3.1 Preparation for α-Chymotrypsin binding assay 
 
5.3.1.1 Preparation of Buffer Solution 
1.75 g monosodium dihydrogen phosphate and 14.48 g of disodium hydrogen phosphate were 
dissolved in 1000 mL of distilled water. This gave a buffer of concentration 0.1M and pH 7.4. 
 
5.3.1.2 Preparation of Protein Solution 
2.6 mg α-chymotrypsin was dissolved in 100 mL (1 x 10-6 M) phosphate buffer (pH=7.4, 
0.1 M). 
 
5.3.1.3 Hydrolysis of PAMAM dendrimers 
Each dendrimer was dissolved in 10mL of methanol and 1 mL of distilled water was added with a 
stoichiometric amount (relative to the number of end groups) of NaOH and ammonium chloride 
added to a 50 mL round bottom flask equipped with a magnetic flea and reflux condenser. The 
mixture was heated at 30 ºC for 24 hours. Upon completion, the solvent was removed by rotary 
evaporation. 
 
5.3.2 Assay of Chymotrypsin Activity 
45.4 mg BTNA was added in 10 mL MeOH. For each run the cuvette began with 50 μL BTNA, in 
addition tol 2 mL protein-buffer background solution. Hydrolysis was followed by monitoring product 
formation at 410 nm over a time period of 7500 s at RT. All absorption readings are recorded at least 
three times. 
 
5.4 Protein Binding Assay for Circular Dichroism (CD) Spectroscopy 
 
5.4.1 Preparation of Buffer Solution  
1.75 g monosodium dihydrogen phosphate and 14.48 g of disodium hydrogen phosphate were 
dissolved in 1000 mL of distilled water. This gave a buffer of concentration 0.1M and pH 7.4. 
 
5.4.2 Preparation of dendrimer solutions for Circular Dichroism analysis 
Various PAMAM dendrimer solutions, G1.5, G2.5, G3.5 and G4.5 were made up in buffer solution to 
create a stock solution of concentration 1x10
-5 
M. These dendrimer stock solutions were used to 
prepare dendrimer solutions of a concentration 2x10
-6 
M by extracting 2 mL of each solution into 4 
respective 10 mL volumetric flasks and diluting down with buffer solution. 
 
5.4.3 Preparation of protein solutions 
 
5.4.3.1 Chymotrypsin: 5.2 mg Chymotrypsin was dissolved in 100 mL buffer to give a solution with 
a concentration 2x10
-6 
M. 1 mL of this was extracted and dissolved in 10 mL buffer solution giving a 
second diluted solution of 1x10
-6 
M. 
 
5.4.3.2 Cytochrome-C: 2.5 mg Cytochrome-c was dissolved in 100 mL buffer to give a solution with 
concentration 2x10
-6 
M. 1 mL of this was extracted and dissolved in 10 mL buffer solution giving a 
second diluted solution of 1x10
-6 
M. 
 
A CD spectrum for each protein at concentration 1x10
-6 
M was run. 
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5.4.4 CD Analysis of Protein-Dendrimer solutions in a 1:1 ratio of concentration 
 
5.4.4.1 Chymotrypsin: The various dendrimer solutions (G1.5, G2.5, G3.5 and G4.5 2x10-6M) and 
Chymotrypsin solution (2 x 10
-6 
M) were mixed in equal volume (1 mL: 1 mL) to four respective 
sample vials. Each sample was transferred into a 10 mm quartz cuvette and a CD spectrum was 
generated for each at 37 °C. 
  
5.4.4.2 Cytochrome-C: The various dendrimer solutions (G1.5, G2.5, G3.5 and G4.5 2x10
-6
M) and 
Cytochrome-c solution (2 x 10
-6 
M) were mixed in equal volume (1 mL: 1 mL) to four respective 
sample vials. Each sample was transferred into a 10 mm quartz cuvette and a CD spectrum was 
generated for each at 37 °C. 
 
 
5.4.5 CD Analysis of Protein-Dendrimer solutions in a 1:5 concentration ratio 
 
5.4.5.1 Chymotrypsin: The various dendrimer solutions (G1.5, G2.5, G3.5 and G4.5 1 x 10
-5
M) and 
Chymotrypsin solution (2 x 10
-6 
M) were mixed in equal volume (1 mL: 1 mL) to four respective 
sample vials. Each sample was transferred into a 10 mm quartz cuvette and a CD spectrum was 
generated for each at 37 °C. 
 
5.4.5.2 Cytochrome-C: The various dendrimer solutions (G1.5, G2.5, G3.5 and G4.5 1 x 10
-5
M) and 
Cytochrome-c solution (2 x 10
-6 
M) were mixed in equal volume (1 mL: 1 mL) to four respective 
sample vials. Each sample was transferred into a 10 mm quartz cuvette and a CD spectrum was 
generated for each at 37 °C.  
 
5.4.6 Circular Dichroism Analysis involving temperature variation 
 
5.4.6.1 Chymotrypsin:  To carry out a variable temperature CD spectrum, the appropriate absorption 
wavelength for Chymotrypsin was selected, which was determined from previous CD analysis. The 
wavelength of choice was found to be 230 nm, and the protein in buffer solution (2 mL), giving a 
concentration of 1x10
-6 
M, was transferred to a 10 mm quartz cuvette and heated by 1 °C per minute 
from 37 °C to approximately 85 °C.  The next stage was to put 1 mL Chymotrypsin in buffer solution 
(2x10
-6 
M) and 1 mL G3.5 PAMAM Dendrimer in buffer solution (1x10
-5 
M) into a 10 mm quartz 
cuvette and place it into the CD spectrometer. This was then heated by 1 °C per minute from 37 °C to 
approximately 85 °C. 
 
5.4.6.2 Cytochrome-C: To carry out a variable temperature CD spectrum, the appropriate absorption 
wavelength for Cytochrome-C was selected, which was determined from previous CD analysis. The 
wavelength of choice was found to be 222 nm, and the protein in buffer solution (2 mL), giving a 
concentration of 1x10
-6 
M, was transferred to a 10 mm quartz cuvette and heated by 1 °C per minute 
from 37 °C to approximately 95 °C.  The next stage was to put 1 mL Cytochrome-C in buffer solution 
(2x10
-6 
M) and 1 mL G2.5 PAMAM Dendrimer in buffer solution (1x10
-5 
M) into a 10 mm quartz 
cuvette and place it into the CD spectrometer. This was then heated by 1 °C per minute from 37 °C to 
approximately 95 °C. 
 
5.4.7 Presentation of CD data 
The CD spectrometer displayed spectra with temperature in degrees Celsius (ºC) along the x-axis and 
CD in millidegrees along the y-axis. The data along the y-axis was converted into percentage 
unfolding for data analysis. 
 
This was performed using the following formula: 
Percentage unfolding for n
th
 data point = [(PN – PI)/ (PF – PI)] X 100 
Where PN = n
th 
CD
 
data point,   PI = initial CD data point and PF = final CD data point. 
CD data was transferred into a database and this calculation was performed using Microsoft Excel.  
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5.5 Synthetic procedures for Anion Binding 
 
5.5.1 Synthesis of 3,5diacetoxybenzoic acid (91) 
 
 
Scheme 12 page 120 
Scheme 16 page 132 
Scheme 17 page 133 
 
The compound was dissolved in 130 mL of refluxing chloroform and then filtered hot. This was 
followed by the addition of 45 mL of Petroleum ether 40:60 to the mother liquor, precipitating a white 
solid. The mixture was then left overnight to further the recrystalisation process. 
 
The white solid was isolated by filtration and thoroughly washed with ice cold petroleum ether. The 
product obtained was then left in a vacuum desiccator overnight to dry thoroughly. Mother liquor 
obtained from filtration was rotary evaporated and re-disolved in refluxing chloroform and the 
recrystalisation process was repeated further to obtain as much 3,5-diacetoxybenzoic acid as possible. 
 
Yield 41.23 g, 34 % 
1
H NMR (CDCl3, 400 MHz) δH 10.32 (br s, 1H, COOH), 7.75 (d, 2H, Ar o-CH, 
J=2.0), 7.20 (t, 1H, Ar p-CH, J=2.0), 2.32 (s, 6H, -CH3) 
13
CNMR (CDCl3, 400 MHz) δC 170.24, 
168.79, 151.02, 131.37, 120.82, 121.03, 121.12, 21.00 FTIR (cm
-1
) 3400-2400, 1764 (COOR), 1688
 
(COOH), 1603,  EA %: Carbon (Expected value: 55.47 %) Found: 55.17 % Hydrogen (Expected 
value: 4.23 %) Found: 3.86 % ES-MS 237 (MH
-
) m.p. 161-1 2 ˚C 
 
5.5.2 Synthesis of N, N’- Bis-(4-hydroxy-phenyl)-isophthalamide (94) 
 
 
 
Scheme 14 page 123 
 
A second 100 mL 2 neck round bottom flask was oven dried and isophthaloyl chloride (0.51 g, 2.51 
mmol) was added and the flask was allowed to cool under nitrogen; when cool NMP (30 mL) was 
added. 4-aminophenol, NMP and triethylamine were stirred together and the flask was heated to 60 
°C. Isophthaloyl chloride solution was then added via a syringe, dropwise, over a period of 10 
minutes and the reaction was left to stir for 30 minutes. The temperature was then raised to 80 °C and 
left for an additional 20 minutes. The solution was filtered and the crystals (salt by-product) were 
washed with cold methanol. The mother liquor was vacuum distilled in order to remove the NMP 
solvent (NB. NMP has a boiling point of 202 ºC).  Once all the solvent had been removed, methanol 
A 250 mL round bottom flask was equipped with a magnetic stirrer bar 
and charged with 3, 5-dihydroxybenzoic acid (50.02 g, 0.32 moles) and 
acetic anhydride (150 mL) and fitted with a reflux condenser. There 
was a large quantity of acid being used, therefore efficient stirring was 
essential to complete dissolution. The reaction mixture was heated to 
reflux (160 °C) and left to reflux for 5-6 hours, giving rise to a brown 
solution. Excess acetic anhydride and acetic acid by-product was 
removed under high vacuum via vacuum distillation, ensuring that the 
solution is not heated above 80 °C at all times, to avoid polymerisation 
of the monomer.  
 
Triethylamine was vacuum distilled in the 
presence of the drying agent calcium hydride. A 
100 mL 2 necked round bottom flask was oven 
dried, to this 4-aminophenol (0.59 g, 5.41 mmol) 
was added and the flask was cooled under 
nitrogen. When cool, dry triethylamine (0.76 
mL, 7.51 mmol) and NMP (30 mL), were added 
via syringe and hypodermic needle through a 
fresh suba seal. 
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was added to the reaction flask and swirled. The white solid produced was filtered off and washed 
thoroughly with ice cold methanol and finally placed in a vacuum desiccator to ensure complete 
dryness is achieved. 
 
Yield 2.71 g, 31 % 
1
HNMR (CD3SOCD3, 400 MHz) δH 10.21 (s, 2H, OH) 9.33 (s, 2H NH)
 
8.48 (s, 
1H, Ar-C=OCCHCC=O) 8.09 (dd, 2H, Ar-CH, J=8.0, 1.5) 7.66 (t, 1H, Ar-CH, J =8.0) 7.58 (d, 4H, 
Phenol NHCCH, J= 9.0) 6.80 (d, 4H, Phenol CHCOH, J=9.0) 
13
CNMR (CD3SOCD3, 400 MHz) δC 
164.99, 154. 27, 135.82, 131.05, 130.71, 128.95, 127.20, 122.71, 115.50 FTIR (cm
-1
) 3276 (OH) 
3000-3020 (aromatic C-H stretch) 1644 (amide C=O stretch) 1610 (aromatic C=C bend), 1522, 1540, 
1422, 1240 EA %: Carbon (Expected value: 68.96 %) Found: 66.15 % Hydrogen (Expected value: 
4.63 %) Found: 4.63 % Nitrogen (Expected value: 8.04%) Found: 7.84 ES-MS 349 (MH
+
) m.p. 317-
319 ˚C 
 
5.5.3 Acetylation of N, N’- Bis-(4-hydroxy-phenyl)-isophthalamide (93) 
 
 
 
Figure 67 page 122 
Scheme 14 page 123 
Figure 69 page 124 
Scheme 17 page 133 
 
 
Yield: 192 mg, 31% 
1
HNMR (d
6
-DMSO, 400 MHz) δH 10.53 (s, 2H. NH)  8.54 (s, 1H, Ar-
COCCHCCO) 8.16  (dd, 2H, Ar-COCCH, J=2.0, 8.) 7.83 (m, 4H, Ar-CH3COOCCH) 7.72 (t, 1H, Ar-
COCCHCHCHCCO J=8.0) 7.17-7.13 (m, 4H, Ar-CH3COOCCHCH) 2.28 (s, 6H, CH3) 
13
CNMR (d
6
-
DMSO, 400 MHz)  δC  169.8, 165.5, 146.8, 137.1, 135.5, 131.2, 129.1, 127.5, 122.4, 121.8 FTIR (cm
-
1
) 3000.1-3030.6 (aromatic region) 1703.2 (amide CO) 1610.9 (aromatic C=C) 1561, 1510, 1427, 
1229 ES-MS 433 (MH
+
) EA %: Carbon (Expected value: 66.66 %) Found: 66.32 % Hydrogen 
(Expected value: 4.66 %) Found: 4.47 % Nitrogen (Expected value: 6.48 %) Found: 6.42 % m.p. 258-
2 0 ˚C 
 
5.5.4 Synthesis of  N, N’- Bis-(3-hydroxy-phenyl)-isophthalamide (101) 
 
 
 
 
Scheme 18 page 134 
Figure 72 page 135 
 
An oven dried round bottom flask was 
charged with N, N’- Bis-(4-hydroxy-
phenyl)-isophthalamide (0.5 g, 1.4 mmol) 
and dissolved in anhydrous pyridine (75 
mL). The flask was degassed with Argon 
before addition of acetyl chloride (0.61 
mL, 7.8 mmol). The mixture was then 
stirred at room temperature for a period of 
4 hours. Pyridine was then removed via 
vacuum distillation and the crude product 
was purified by column chromatography. 
The crude product was loaded in a 
minimum amount of chloroform and 
eluted with ethyl acetate (Rf = 0.84) 
 
3-Aminophenol (13.10 g, 0.119 mol) and 
anhydrous N, N’-Dimethylacetamide (75 mL) 
was added to a 250 mL round bottom flask 
under an inert atmosphere of argon. 
Isophthaloyl chloride (12.18 g, 0.060 mol) was 
added after cooling the solution to 0 ºC. The 
reaction was stirred for 6 hours, during which 
the temperature was allowed to rise to room 
temperature. The reaction mixture was then 
poured into 1 L of ice cold distilled water and 
filtered. 
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The filtrate was washed several times with distilled water and the pH of the filtrate was monitored 
using litmus paper. Purification was achieved by dissolving the crude product in a minimum amount 
of hot ethanol followed by a hot filtration. The filtrate was subsequently added to an excess of ice cold 
distilled water and filtered. The crystals were dried under vacuum at 100 ºC. 
Crude yield 17.5186 g ,84 % Pure Yield 11.14 g, 64% 
1
HNMR (CD3SOCD3, 400 MHz) δH 10.31 (s, 
2H, OH) 9.47 (s, 2H, NH) 8.47 (s, 1H, Ar-OCCCHCCO) 8.11 (dd, 2H, Ar-COCCH, J=8.0, 2.0) 7.68 
(t, 1H, Ar-COCCHCH, J=8.0) 7.39 (m, 2H, Ar-NHCCHCOH) 7.20-7.12 (bm, 4H, Ar-NHCCHCH) 
6.53 (bm, 2H, Ar-NHCCHCOHCH) 
13
 CNMR (CD3SOCD3, 400 MHz) δc 107.9, 111.4, 111.6, 127.4, 
129.0, 129.8, 131.1, 135.7, 140.5, 158.0, 165.5 FTIR (cm
-1
) 3364 (N-H stretch), 3188 (OH stretch), 
1646, 1604 (amide C=O stretch), 1547, 1489, 1450, 1266, 683 EA %: Carbon (Expected value: 68.96 
%) Found: 68.53 % Hydrogen (Expected value: 4.63 %) Found: 4.81 % Nitrogen (Expected value: 
8.04%) Found: 7.89 % ES-MS 349.1 (MH
+
) m.p. 247-249 ˚C 
 
5.5.5 Acetylation of  N, N’- Bis-(3-hydroxy-phenyl)-isophthalamide (100) 
 
 
 
 
Scheme 18 page 134 
Figure 73 page 136 
Figure 74 page 137 
 
Pyridine was then removed via vacuum distillation and dissolved in dichloromethane. This was 
followed by washings with saturated sodium hydrogen carbonate solution and distilled water to 
remove any trace amounts of acid. The organic layer was then reduced down and dissolved again in 
chloroform and filtered by gravity. A cream solid was collected and purified by recrystalisation. The 
crude cream solid was dissolved in a minimum amount of hot dichloromethane and petroleum ether 
(40:60) was added drop wise until the yellow solution remained cloudy. The solvent was left to 
evaporate slowly yielding cream coloured crystals. 
 
Yield 800 mg, 65% 
1
HNMR ((CD3)2CO, 400 MHz) δH 9.86 (s, 2H, NH) 8.55 (s, 1H, Ar-
OCCCHCCO) 8.20 (dd, 2H, Ar-COCCH, J=8.0, 2.0) 7.81 (t, 1H, Ar-COCCHCHCHCCO J=2.0) 7.70-
7.66 (bm, 4H, Ar-CONHCCHCHCHCO, Ar -CONHCCHCO) 7.40-7.38 (bm, 2H, Ar-
CONHCCHCHCHCO) 6.92 (dd, 2H, Ar-CONHCCHCHCHCO, J=8.0, 1.0) 2.30 (s, 6H, OCH3) 13 
CNMR ((CD3)2CO, 400 MHz) δc 168.8, 164.9, 151.3, 140.3, 135.4, 130.6, 129.3, 128.8, 126.5, 117.2, 
117.2, 117.0, 113.6, 20.1 FTIR (cm
-1
) 3050-3100 (aromatic C-H stretch), 1764 (acetate C=O stretch), 
1646, 1603 (amide C=O), 1543, 1483, 1433, 1196, 681 EA %: Carbon (Expected value: 66.66 % ) 
Found: 65.88 % Hydrogen (Expected value: 4.66 %) Found: 4.45 % Nitrogen (Expected value: 
6.48%) Found: 6.40 %  ES-MS 433.1406 (MH
+
) m.p. 178-1 0 ˚C 
 
 
 
An oven dried round bottom flask was charged 
with N, N’- Bis-(3-hydroxy-phenyl)-
isophthalamide (1.0 g, 2.9 mmol) and 
dissolved in anhydrous pyridine (75 mL). The 
flask was degassed with Argon before addition 
of acetyl chloride (1.22 mL, 17.2 mmol). The 
mixture was then stirred at room temperature 
for a period of 4 hours. 
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5.6 Synthetic procedures involving the polymerisation of 3, 5-diacetoxybenzoic 
acid 
  
5.6.1General procedure for the polymerisation of 3, 5-diacetoxybenzoic acid  
3, 5-Diacetoxy benzoic acid (various amounts) and diphenyl ether (various amounts) were dispensed 
into a 250 mL round bottom flask, which was then thoroughly degassed and flushed with nitrogen. 
The mixture was heated to 225 °C and stirred for a period of 45 minutes. The temperature was 
reduced to 180 °C and the reaction was subsequently placed under reduced pressure for 4 hours. The 
crude mixture was dissolved in refluxing THF and precipitated into ice cold methanol (800 mL) and 
placed in a freezer overnight to maximise precipitation. The resulting solid was filtered off and 
washed with ice cold methanol, yielding the polymer. 
 
5.6.2 Polymerisation of 3, 5-diacetoxybenzoic acid (97) 
 
              Scheme 16 page 132 
                                                                                                                                     Scheme 17 page 133  
           
The general procedure was followed where 3, 5-Diacetoxy benzoic acid (3.95 g, 0.02 mol) and 
diphenyl ether (3.95 g, 0.02 mol) were reacted together, yielding the polymer (white solid powder). 
 
Yield 2.42 g, 61 % (by mass) 
1
HNMR (CD3SOCD3, 400 MHz) δH 8.20-8.02 (br d, 1H, [Polymer] Ar 
p-CH) 7.96-7.79 (br d, 2H, [Polymer] Ar o-CH) 2.38 (br s, 3H [Polymer] CH3) 
13
CNMR (CDCl3, 400 
MHz)  δC 168.8, 162.8, 151.2, 130.9, 130.7, 121.3, 120.9, 21.0 FTIR (cm
-1
) 2972,
 
2209, 2039 
(aromatic C-H stretch) 1742 (ester C=O stretch) 1367, 1276 GPC Mn = 23535 Mw = 59502 PD = 2.53 
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5.6.3 Polymerisation of 3, 5-diacetoxybenzoic acid with 4-Nitrophenyl acetate core using a 1:20 
ratio  
 
 
 
The general procedure was followed where 3, 5-Diacetoxy benzoic acid (3.95 g, 0.02 mol), 4-
Nitrophenyl acetate (150.0 mg, 0.83 mmol) and diphenyl ether (4.10 g, 0.02 mol) were reacted 
together, yielding the polymer (white solid powder). 
 
Yield 3.23 g, 79% (by mass)
1
HNMR (CDCl3, 400 MHz) δH 8.39-8.31 (br d, 2H, [Core] Ar CHCNO2) 
8.09-7.93 (br d, 1H, [Polymer] Ar p-CH) 7.92-7.77 (br d, 2H, [Polymer] Ar o-CH) 2.39 (br s, 3H, 
[Polymer] CH3) 
13
CNMR (CDCl3, 400 MHz)  δC 168.74, 162.78, 151.18, 130.92, 121.32, 21.02 FTIR 
(cm
-1
) 2972, 2930, 2505 (aromatic C-H stretch) 1743 (ester C=O stretch) 1593, 1443, 1369, 1277, 755 
(C-H aromatic ortho) GPC Mn = 8992 Mw = 21745 PD = 2.42 
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5.6.4 Polymerisation of 3, 5-diacetoxybenzoic acid with N, N’- Bis-(4-acetoxy-phenyl)-
isophthalamide core using a 1:20 ratio (98) 
 
 
Scheme 17 page 133 
 
The general procedure was followed where 3, 5-Diacetoxy benzoic acid (2.18 g, 9.15 mmol), 4- N, 
N’- Bis-(4-acetoxy-phenyl)-isophthalamide (0.25 g, 0.72 mmol) and diphenyl ether (3.01 g, 17.68 
mmol) were reacted together, yielding the polymer (cream coloured solid powder). 
 
Yield 462 mg, 19 % (by mass) HNMR (C4D8O, 400 MHz) δH  7.76 (br s, 1H, [Core] C=OCCHCC=O) 
7.17 (br s, 1H, [Core] Ar-CH) 6.68 (br s, 2H, [Core] Ar-CH) 6.37-6.16 (br d, 1H, [Polymer] Ar p-CH) 
6.12-5.96 (br d, 2H, [Polymer] Ar o-CH) 0.44 (br s, 3H, [Polymer] CH3) 
13
CNMR (C4D8), 400 MHz)  
δC 166.09, 160.78, 149.75, 129.37, 118.61, 22.48  FTIR (cm
-1
) 2972, 2931, 2505 (aromatic C-H 
stretch) 1742 (ester C=O stretch) 1442, 1277, 754 GPC Mn = 2934 Mw = 4801 PD = 1.64 
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5.7 Polymerisation of 3, 5-diacetoxybenzoic acid with N, N’- Bis-(3-acetoxy-
phenyl)-isophthalamide core  
 
 
5.7.1 Polymerisation of 3, 5-diacetoxybenzoic acid with N, N’- Bis-(3-acetoxy-phenyl)-
isophthalamide core using a 1:1 ratio (104) 
 
 
 
Figure 81 page 149 
Figure 82 page 150 
 
 
The general procedure was followed where 3, 5-Diacetoxy benzoic acid (171.10 mg, 0.72 mmol), 4- 
N, N’- Bis-(3-acetoxy-phenyl)-isophthalamide (0.25 g, 0.72 mmol) and diphenyl ether (421.0 mg, 
2.48 mmol) were reacted together, yielding the polymer (light brown/grey solid powder). 
 
Yield 93 mg, 54 % (by mass)
 1
HNMR (CDCl3, 400 MHz) δH 8.57-8.74 (bm, 2H, [Core] NH) 8.06-
8.33 (bm, 1H, [Core] Ar-OCCCHCCO, 2H, [Core] Ar-COCCH) 7.67-8.04 (bm, 1H [Core] Ar-
COCCHCHCHCCO, 2H [Polymer] Ar p-CH) 7.47-7.66 (bm, 4H, [Core] Ar-CONHCCHCHCHCO, 
Ar –CONHCCHCO2H) 7.04-7.46  (bm, 2H, [Core] Ar-CONHCCHCO, 2H, [Polymer] Ar o-CH) 
6.71-6.94 (bm, 2H, [Core] Ar-CONHCCHCHCHCO) 2.34 (bs, 3H, [Polymer] CH3) 
13
CNMR (CDCl3, 
400 MHz)  δC 169.7, 168.8, 164.5, 163.8, 163.5, 162.8, 151.2, 139.0, 133.3, 131.3, 130.7, 129.5, 
129.2, 128.3, 125.6, 121.3, 120.9, 117.5, 113.9, 21.0 FTIR (cm
-1
) 2000-2050 (aromatic C-H) 1740 
(ester C=O stretch) 1370, 1287, 757 GPC Mn = 1554 Mw = 2390 PD = 1.54  Mn (NMR estimation) = 
2034 
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5.7.2 Polymerisation of 3, 5-diacetoxybenzoic acid with N, N’- Bis-(3-acetoxy-phenyl)-
isophthalamide core using a 1:5 ratio (103) 
 
 
 
Figure 76 page 140 
Figure 77 page 141 
 
The general procedure was followed where 3, 5-Diacetoxy benzoic acid (688 mg, 2.89 mmol), 4- N, 
N’- Bis-(3-acetoxy-phenyl)-isophthalamide (0.25 g, 0.72 mmol) and diphenyl ether (0.95 g, 5.58 
mmol) were reacted together, yielding the polymer, which was a light brown/grey solid powder in 
appearance. 
 
Yield 488.2 mg, 71 % (by mass) 
1
HNMR (CDCl3, 400 MHz) δH 8.55-8.67 (bm, 2H, [Core] NH) 8.20-
8.33 (bm, 1H, [Core] Ar-OCCCHCCO, 2H, [Core] Ar-COCCH) 7.65-8.08 (bm, 1H [Core] Ar-
COCCHCHCHCCO, 2H [Polymer] Ar p-CH) 7.40-7.64 (bm, 4H, [Core] Ar-CONHCCHCHCHCO, 
Ar -CONHCCHCO2H) 7.19-7.39  (bm, 2H, [Core] Ar-CONHCCHCO, 2H, [Polymer] Ar o-CH) 6.72-
6.90 (bm, 2H, [Core] Ar-CONHCCHCHCHCO) 2.25 (bs, 3H, [Polymer] CH3) ) 
13
CNMR (CDCl3, 
400 MHz)  δC  168.8, 163.8, 162.8, 151.2, 139.1, 130.9, 130.7, 129.7, 121.3, 120.9, 117.5, 114.0, 21.0 
FTIR (cm
-1
) 2009-2158 (aromatic C-H) 1741 (ester C=O stretch) 1369, 1286, 757 GPC Mn = 4009 Mw 
= 12973 PD = 3.2 Mn (NMR estimation) = 4670 
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5.7.3 Polymerisation of 3, 5-diacetoxybenzoic acid with N, N’- Bis-(3-acetoxy-phenyl)-
isophthalamide core using a 1:20 ratio (105) 
 
Figure 83 page 151 
Figure 84 page 152 
 
The general procedure was followed where 3, 5-Diacetoxy benzoic acid (2.18 g, 9.15 mmol), 4- N, 
N’- Bis-(3-acetoxy-phenyl)-isophthalamide (0.25 g, 0.72 mmol) and diphenyl ether (3.01 g, 17.68 
mmol) were reacted together, yielding the polymer (white solid powder). 
 
Yield 1.42 g, 65% (my mass)
1
HNMR (CDCl3, 400 MHz) δH 8.50-8.71 (bm, 2H, [Core] NH) 8.22-8.43 
(bm, 1H, [Core] Ar-OCCCHCCO) 8.09-8.19 (bm, 2H, [Core] Ar-COCCH) 7.75-8.11 (bm, 1H [Core] 
Ar-COCCHCHCHCCO, 2H [Polymer] Ar p-CH) 7.19-7.62 (bm, 4H, [Core] Ar-
CONHCCHCHCHCO, Ar -CONHCCHCO2H, [Core] Ar-CONHCCHCO, 2H, [Polymer] Ar o-CH) 
6.72-6.89 (bm, 2H, [Core] Ar-CONHCCHCHCHCO) 2.31 (bs, 3H, [Polymer] CH3) 
13
CNMR (CDCl3, 
400 MHz)  δC 168.8, 162.8, 151.2, 130.9, 130.7, 129.7, 123.2, 121.3, 120.9, 118.9, 21.0 FTIR (cm
-1
) 
2972, 2931, 2505 (aromatic C-H stretch), 1742 (ester C=O stretch), 1442, 1277, 754 GPC Mn = 10343 
Mw = 42137 PD = 4.07 Mn (NMR estimation) = 12,299 
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5.7.4 Synthesis of Polyglycidol with 4-Nitrophenol core (109) 
 
 
 
 
Scheme 22 page 166 
 
 
Yield 473 mg, 14 % (by mass) 
1
HNMR (D2O, 400 MHz) δH 8.20 (s, 1H, [Core] CHCNO2) 3.95-3.20 
(bm, 4H [Polymer] OH, CH, CH2) (D2O, 400 MHz) δC 79.37, 72.09, 62.53 FTIR (cm
-1
) 3360 (O-H 
stretch) 2869-2970 (C-H stretch) GPC Mn = 12715 Mw = 52970 PD = 4.17 
 
 
 
 
 
 
 
 
 
 
Para-nitro phenol (0.25 g, 2.29 mmol) was added 
to Diethylene glycol dimethyl ether (20 mL) in a 
100mL round bottomed flask. The solution was 
heated to 50 ºC until all the Nitro phenol was 
dissolved before raising the temperature to 90 ºC. 
After 20 minutes, sodium hydride (14.4 mg, 0.6 
mmol) was added to the solution (the solution 
turned from colourless to yellow). The solution 
was left stirring for a period of 90 minutes. 
Glycidol (3.03 mL, 0.05 moles) was added, drop-
wise, over a period of 12 hours using a syringe 
pump. The reaction mixture was then left to react 
for a further 5 hours. The reaction mixture was 
cooled to room temperature and then the solvent 
was decanted off. Methanol (50 mL) was added to 
the reaction mixture and left stirring until 
dissolution was complete. The solution was then 
added, drop-wise, to ice cold acetone (400 mL). 
Once addition was complete, the mixture was 
covered with tin foil and left stirring for 1 hour 
before decanting the solvent. Acetone (400 ml) 
was added to the product again, before covering 
with aluminium foil and stirring for a further 
hour. The acetone was disposed and the product 
was dried overnight in a vacuum oven to give 
hyperbranched polyglycidol as golden brown, 
viscous oil. 
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5.8 Di-block encapsulation studies 
5.8.1 Synthesis of mPEG-b-PCL di-block copolymer (112) † 
  
Scheme 23 page 171 
 
 
 
 
 
 
(i)  
mPEG (3.001 g, 1.501 mmol) was reacted with PCL (0.97 mL) to give mPEG-b-PCL5 (14.606 g, 99 
%) 
1
HNMR (CDCl3, 400 MHZ) δH 4.24 (2H, m, OCH2CH2OCO), 4.07 ( 12H, t, CH2OH J=6.5), 3.65 
(180H,  s, OCH2CH2O), 3.39 (3H, s, CH3O), 2.32 (11H,  t, α-CH2 J=7.5), 1.   (21H,  m, β and δ-
CH2), 1.39 ( 10H, m, γ-CH2) 
13
CNMR (CDCl3, 400 MHZ) δC 173.6, 70.5, 64.1, 34.1, 28.3, 25.5, 24.6  
FTIR (cm
-1
) 3417, 1721, 1239, 1106, 732 GPC (LMW, THF) (n=5) Mn = 1921 PD = 1.20 
(ii)  
mPEG (3.001 g, 1.501 mmol) was reacted with PCL (1.83 mL, 16.5 mmol) to give mPEG-b-PCL10 
(4.151 g, 85 %) 
1
HNMR (CDCl3, 400 MHZ) δH 4.24 (2H, m, OCH2CH2OCO), 4.07 (23H, t, CH2OH, J 
= 6.5) 3.66 (181H, s, OCH2CH2O), 3.39 (3H, s, CH3O), 2.32 (25H, t, α-CH2, J = 7.5), 1.   (49H, m, β 
and δ-CH2), 1.39 (25H, m, γ-CH2) 
13
CNMR (CDCl3, 400 MHZ) δC 173.6, 70.5, 64.1, 34.1, 28.3, 25.5, 
24.6  FTIR (cm
-1
) 3417, 1722, 1240, 1104, 731 GPC (LMW, THF) (n=10) Mn = 2506 PD = 1.18 
 (iii)  
mPEG (3.001 g, 1.501 mmol) was reacted with PCL (1.83 mL, 16.5 mmol) to give mPEG-b-PCL10 
(4.151 g, 85 %) 
1
HNMR (CDCl3, 400 MHZ) δH 4.23 (2H, m, OCH2CH2OCO), 4.07 (44H, t, CH2OH, J 
= 6.5) 3.66 (182H, s, OCH2CH2O), 3.39 (3H, s, CH3O), 2.32 (4 H, t, α-CH2, J = 7.5), 1.   (9 H, m, β 
and δ-CH2), 1.39 (4 H, m, γ-CH2) 
13
CNMR (CDCl3, 400 MHZ) δC 173.6, 70.5, 64.1, 34.1, 28.3, 25.5, 
24.6  FTIR (cm
-1
) 3417, 1723, 1240, 1104, 731 GPC (LMW, THF) (n=20) Mn = 4344 PD = 1.23 
 
 
 
Oven-dried mPEG (3.001 g, 1.501 mmol) was added 
to a 50 mL two-neck round-bottom flask and stirred 
for 1 h at 130 °C under vacuum. Then the apparatus 
was refilled with nitrogen and ε-caprolactone (varied 
in ratio to the mPEG monomer units) was added 
using 10 mL syringe followed tin(II)2-ethyl 
hexanoate (0.05 % w/w). The reaction mixture was 
stirred for 24 hours at 130 °C to yield white solid at 
ambient temperature which was dissolved in 
dichloromethane and precipitated into petroleum 
ether 40-60 to yield methyl polyethylene glycol-
block-poly(ε-caprolactone) as a white solid. 
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(iv) 
mPEG (3.001 g, 1.501 mmol) was reacted with PCL (1.83 mL, 16.5 mmol) to give mPEG-b-
PCL10 (4.151 g, 85 %) 1HNMR (CDCl3, 400 MHZ) δH 4.23 (2H, m, OCH2CH2OCO), 4.07 
(138H, t, CH2OH, J = 6.5) 3.65 (172H, s, OCH2CH2O), 3.39 (3H, s, CH3O), 2.32 (140H, t, α-
CH2, J = 7.5), 1.   (290H, m, β and δ-CH2), 1.39 (14 H, m, γ-CH2) 
13
CNMR (CDCl3, 400 
MHZ) δC 173.6, 70.5, 64.1, 34.1, 28.3, 25.5, 24.6  FTIR (cm
-1
) 3417, 1722, 1239, 1106, 732 GPC 
(LMW, THF) (n=60) Mn = 7772 PD = 1.34 
† The synthesis of mPEG-b-PCL di-block copolymers of varying chain length were prepared and 
analysed by Caroline Glover, a 4
th
 year project student 
5.8.2 Micelle formation  
Micelle samples of di-block copolymers were prepared by direct dissolution method in which an 
aqueous solution of polymer (1 mg mL
-1
) was vigorously stirred on the shaker for 30 minutes.  
 
5.8.3 HBP loaded micelle formation 
HBP loaded polymeric micelles were prepared by an oil-in-water emulsion method for the slightly 
water soluble mPEG-PCL di-block copolymer. This method involved dropwise addition of HBP 
dissolved in a suitable organic solvent to the preformed micelle solution. The mixture was stirred for 
1.5 hours to remove organic solvent by evaporation. Un-loaded HBP was removed by filtration 
through Whatman® GD/X syringe filter. 
 
5.8.4 Synthesis of tetraphenyl porphyrin (115) 
 
 
Scheme 24 page 173 
 
Yield 2.92 g, 19 % 
1
HNMR (CDCl3, 400 MHZ) δH 8.90 (s, 8H, Pyrrolic-CH) 8.27 (8H, dd, Phenylic o-
CH J = 2, 7.5) 7.81 (m, 12H, Phenylic m-CH, Phenylic p-CH)
 
-2.71 (s, 2H, NH) 
13
CNMR (CDCl3, 
400 MHZ) δC 142.2, 134.6, 132.3, 127.7, 126.7, 120.2  FTIR (cm
-1
) 3315 (amine N-H stretch) 3030-
3054 (aromatic and alkene C-H stretch) 1594, 1441, 795, 695 EA %: Carbon (Expected value: 85.97 
%) Found: 85.34 % Hydrogen (Expected value: 4.92 %) Found: 4.61 % Nitrogen (Expected value: 
9.11 %) Found: 8.96 % ES-MS 615 MH
+
 (expected 616) UV absorbance (CHCl3) λmax (nm) 418.5, 
515.0, 550.5, 590.5, 645.0 
 
Pyrrole (7.00 mL, 0.101 mol) was added to a refluxing 
solution of benzaldehyde (10.0 mL, 0.0985 mol) in propionic 
acid (375 mL) and stirred for 30 minutes under reflux. The 
reaction mixture was left to cool to ambient temperature and 
then filtered under vacuum to give meso-tetraphenyl 
porphyrin (2.8 g, 18%) as a purple powder;  
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5.8.2 Synthesis of 5, 10, 15, 20-tetrakis(3, 5-dimethoxyphenyl)-21H, 23H-Porphyrin (118) 
 
 
Scheme 25 page 175 
Scheme 26 page 176 
 
Yield 2.45 g, 14% 
1
H NMR (CDCl3, 400 MHz) δH  8.97 (s,  H, pyrrolic β-CH) 7.43 (d, 8H, phenylic 
o-CH, J=2.0) 6.93 (t, 4H, phenylic p-CH, J=2.0) 3.99 (s, 24H, OCH3) -2.80 (s, 2H, NH) 
13
C NMR 
(CDCl3, 400 MHz) δC 158.9, 114.0, 119.8, 113.8, 100.2, 55.3 FTIR (cm
-1
) 1157 ES-MS 855 (MH
+
) 
UV absorbance (CH3OH) λmax (nm) 421, 515, 550, 589, 649.5  
 
5.8.3 Synthesis of 5, 10, 15, 20-tetrakis (3, 5-dihydroxyphenyl)-21H, 23H-porphyrin (119) 
 
 
 
Scheme 26 page 176 
Yield 216 mg, 72%; 
1
H NMR (CD3OD, 400 MHz) δH 9.03 (s,  H, pyrrolic β-CH) 7.20 (d, 8H, 
phenylic o-CH, J=2.0) 6.76 (t, 4H phenylic p-CH, J=2.0) 
13
C NMR (CD3OD, 400 MHz) δC 156.5, 
143.7, 120.0, 114.4, 101.8 FTIR (cm
-1
) 3205 (O-H stretch) UV absorbance (CH3OH) λmax (nm) 417.5, 
513, 546.5, 587.5, 645 ES-MS 743 (MH
+
) 
Freshly distilled pyrrole (5.54 mL, 80 mmol) and 
3, 5-dimethoxybenzaldehyde (13.28 g, 80 mmol) 
was added to refluxing propionic acid (300 mL). 
The mixture was refluxed for 30 minutes, allowed 
to cool to room temperature and obtained via 
vacuum filtration. The product collected was 
subsequently washed with ice cold methanol until 
washings were colourless. 
 
A round bottom flask was charged with 5, 10, 15, 20-
tetrakis (3, 5-dimethoxyphenyl) porphyrin (300 mg, 
0.35 mmol), anhydrous dichloromethane (10 mL) and 
degassed. Boron tribromide (1.14 mL, 11.83 mmol) 
was added via a syringe and the reaction mixture was 
gently stirred under nitrogen at room temperature for 5 
hours. The reaction was then quenched carefully with 
distilled water (1.5 mL, 0.08 mol) and stirred further 
for a period of 20 minutes. The crude reaction mixture 
was then transferred to a separation funnel along with 
ethyl acetate and water, and neutralised with sodium 
hydrogen carbonate. The resulting insoluble impurities 
which formed at the solvent interface were removed by 
filtration of the entire solution. The organic layer was 
collected and the solvent was removed to yield the 
porphyrin. 
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5.9 Synthetic procedures for Colloidosome Catalysis 
5.9.1 Synthesis of 4-(hexadecyloxy) benzaldehyde via the Williamson reaction (135) 
 
 
Scheme 30 page 207 
Figure 110 page 208 
Scheme 32 page 211 
Yield 3.26 g, 57% 
1
H NMR (CDCl3, 400 MHz) δH 9.86 (s, 1H, R-CHO), 7.81 (d, 2H, phenylic m-CH, 
J=9.0), 6.97 (d, 2H, phenylic o-CH, J=9.0), 4.02 (t, 2H, OCH2C15H31, J=7.0), 1.80 (m, 2H, 
OCH2CH2C14H29) 1.50-1.20 (bm, 26H, OCH2CH2C14H26CH3), 0.87 (t, 3H, OC15H30CH3, J=7.0); 
13
C 
NMR (CDCl3, 400 MHz) δC 190.8, 164.3, 132.0, 129.7, 114.7, 68.4, 32.0, 29.6, 29.4, 26.0, 22.7, 14.2, 
) FTIR (cm
-1
) 2916, 2848, 2738 (alkyl C-H stretch), 1683 (aldehyde C=O stretch), 1603, 1578, 1509, 
1241 EA %: Carbon (Expected value: 79.71 %) Found: 79.42 % Hydrogen (Expected value: 11.05 %) 
Found: 11.38 % ES MS 347 (MH
+
) m.p. 42-44 ˚C 
5.9.2 Synthesis of 5, 10, 15, 20-Tetra(4-hexadececycloxyphenyl)porphyrin via the Lindsay 
method (137) 
 
 
 
Scheme 32 page 211 
 
 
Yield 1.27 g, 25 % 
1
H-NMR (CDCL3, 400 MHZ) δH  .   (s,  H, pyrrolic β-H), 8.14 (d, 8H, phenylic 
o-CH J=8.0), 7.30 (d, 8H, phenylic m-CH J=8.5), 4.30 (t, 8H, OCH2C15H31, J=6.0), 2.01 (bm, 8H, 
OCH2CH2C14H29) 1.72-1.23 (bm, 104H, OCH2CH2C14H26CH3), 0.91 (t, 12H, OC15H30CH3, J=6.5), -
2.72 (s, 2H, NH), 
13
C-NMR (CDCL3, 400 MHZ) δC 159.0, 158.3, 144.1, 135.6, 134.6, 119.9, 114.3, 
112.71, 100.9, 68.4, 32.0, 29.7, 29.4, 26.3, 22.7, 14.1 FTIR (cm
-1
) 2918, 2850 (alkyl C-H stretch), 
1509, 1241 EA %: Carbon (Expected value: 82.28 %) Found: 81.94 % Hydrogen (Expected value: 
10.10 %) Found: 9.97 % Nitrogen (Expected value: 3.55 %) Found: 3.41 % MALDI TOFF MS 
1575.4 (MH
-
) UV absorbance (CHCl3) λmax (nm) 423.0, 520.0, 557.0, 593.0, 651 
A mixture of bromohexadecane (5.50 g, 18.0 mmol), 4-hydroxybenzaldehyde 
(2.0 g, 16 mmol), potassium carbonate (2.72 g, 19.6 mmol) and a crystal of 18-
crown-6 in anhydrous acetonitrile was refluxed for 3 days. The reaction mixture 
was concentrated in vacuo and the residue was dissolved in diethyl ether/water 
(1:1). The organic layer was washed three times with saturated aqueous sodium 
hydrogen carbonate, once with saturated brine solution and subsequently dried 
over magnesium sulphate. Evaporation of the solvent under vacuo affords the 
crude product. The product was purified by column chromatography and eluted 
with 20:1 petroleum ether 40-60: ethyl acetate. (Rf = 0.83,TLC was visualised 
using anisaldehyde staining). 
 
Boron trifluoride diethyl etherate (37.30 µl, 
0.3 mmol) and a catalytic amount of 
anhydrous ethanol (1.95 mL, 30 mmol) 
were added to a solution of 4-
hexadececycloxybenzaldehyde (1.05g, 3.0 
mmol) and pyrrole (210.2 µL, 3.0 mmol) 
in anhydrous dichloromethane (300 mL, 
4.68 mol, 15.6 mol/L) at room temperature 
under argon. The reaction mixture was 
then stirred for 1hr in an inert gas stream at 
room temperature; 2, 3-dichloro-5, 6-
dicyano-1.4 benzoquinone (619.0 mg, 2.7 
mmol) was added and the mixture was 
stirred for another 1hr. The reaction 
products were separated by flash 
chromatography and eluted with 
chloroform. The target product was 
purified by column chromatography and 
eluted with chloroform. 
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5.9.3 Synthesis of 5, 10, 15, 20-Tetra(4-hexadececycloxyphenyl)porphyrin Iron(III) complex 
(132) 
 
 
 
Figure 109 page 206 
Scheme 32 page 211 
 
 
Yield 25 mg, 50 % FTIR (cm
-1
) 2917, 2849 (alkyl C-H stretch), 1511 (aromatic C=C stretch), 1242 
(C-O) MS-MALDI 1631(MH
+
) UV absorbance (CHCl3) λmax (nm) 412.0, 573.5, 616 
5.9.4 Synthesis of Iodosylbenzene (140) 
 
 
Scheme 33 page 215 
Scheme 34 page 215 
Scheme 39 page 225 
Scheme 40 page 227 
 
 
Yield 1.47 g, 67 %, 
1
HNMR (CD3OD, 400 MHZ) δH 8.05 (m, 2H, Ar o-CH) 7.58 (m, 3H, Ar p-CH, Ar 
m-CH) 
13
CNMR (CDCl3, 400 MHZ) δC 131.9, 130.8, 130.6 FTIR (cm
-1
) 3038 (aromatic C-H stretch) 
1566, 1434, 733, 689 ES-MS 220 (M
+
) 205, 204 (M - O
2-
) accurate mass spec: calculated mass 
220.9463 formula: C6H6OI m.p. 211 ˚C (decomposed) 
 
 
 
3M sodium hydroxide (15 mL) was added over 3 minutes to a beaker 
containing (Diacetoxyiodo) benzene (3.22 g, 0.01 mol) with vigorous stirring. 
The reaction was then left to stand for a period of 45 minutes. Distilled water 
(15 mL) was then added with continual stirring and the solid collected via 
vacuum filtration. The solid was then stirred in excess distilled water for a 
period of 30 minutes and the solid was collected. The final step of purification 
was performed by stirring the collected yellow solid in chloroform for a period 
of 30 minutes. The titled product was collected via vacuum filtration and dried 
in a vacuum desiccator. 
 
5, 10, 15, 20-Tetra(4-
hexadececycloxyphenyl)porphyrin 
(50 mg, 3.17x10
-2 
mmol) was 
dissolved in THF (25 mL) with Iron 
(II) chloride (80.4 mg, 0.634 mmol) 
and 2, 6-lutidine (9.2 µL, 7.93x10
-2 
mmol). The solution was warmed to 
50 ºC under reflux and stirred for 3 
hours. Solvent was then removed via 
rotary evaporation and a 1:1 mix of 
chloroform and water was added to 
the flask. After vigorous shaking 
many insoluble impurities formed at 
the solvent interface and were 
removed via vacuum filtration. The 
organic layer was collected and 
solvent was removed via rotary 
evaporation and eluted through a 
silica column with 1:1 chloroform 
and methanol. 
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5.9.5 Synthesis of 4-acetoxybenzaldehyde (147) 
 
 
Scheme 35 page 217 
Scheme 37 page 219 
 
 
Yield 16.42 g, 61 %, 
1
HNMR (CDCl3, 400 MHZ) δH 10.00 (s, 1H, COH) 7.94 (d, 2H, Ar-H J = 8.5) 
7.30 (d, 2H, Ar-H, J = 8.5) 2.36 (s, 3H, CH3) 
13
CNMR (CDCl3, 400 MHZ) δC 190.9, 168.7, 155.3, 
134.0, 131.3, 122.37, 21.13 FTIR (cm
-1
) 3072 (aromatic C-H stretch) 2830, 2743 (aldehyde C-H 
stretch) 1760 (ester C=O stretch) 1699 ( aldehyde C=O) 1595, 1156, 1187 ES-MS 165 (MH
+
) 
5.9.6 Synthesis of 5, 10, 15, 20- tetrakis (4-acetoxyphenyl)-21H, 23H-porphyrin (149) 
  
 
Scheme 37 page 219 
 
Yield 4.27 g, 25 % 
1
HNMR (CDCl3, 400 MHZ) δH  .93 (s,  H, Pyrrolic β-H) 8.25 (d, 8H, Phenylic o-
CH, J = 8.5) 7.54 (d, 8H, Phenylic m-CH, J = 8.5) 2.53 (s, 12H, CH3) -2.79 (s, 2H, NH) 
13
CNMR 
(CDCl3, 400 MHZ) δC 169.7, 150.6, 139.6, 135.4, 119.9, 119.3, 21.5 FTIR (cm
-1
) 2925-3000 (aromatic 
C-H stretch) 1749 (ester C=O stretch) 1602 (NH bend) 1365,  1185, 1165 ES-MS 847 (M
+
) UV 
absorbance (CHCl3) λmax (nm) 418.0, 514.5, 549.5, 590.5, 646.0 
 
 
 
 
Freshly distilled pyrrole (5.54 mL, 80 mmol) 
and 4-acetoxybenzaldehyde (13.13 g, 80 
mmol) were added to refluxing propionic acid 
(300 mL). The mixture was refluxed for 30 
minutes and then allowed to cool to room 
temperature. The reaction mixture was 
filtered and washed with methanol until 
washings were colourless. 
 
A round bottomed flask was charged with 4-hydroxybenzaldehyde (20.00 g, 
167 mmol), triethylamine (30 mL), and anhydrous THF (600 mL). The flask 
was degassed with argon and stirred under a flow of nitrogen for 10 minutes 
before the addition of acetyl chloride (30 mL, 422 mmol) drop-wise via a 
syringe. The reaction mixture was then stirred for a period of 30 minutes. The 
white solid formed was filtered off via vacuum filtration and the brown filtrate 
was then reduced down using a rotary evaporator. The remaining brown oil 
was dissolved in dichloromethane (100 mL) and washed with saturated 
sodium hydrogen carbonate solution (200 mL), then distilled water (200 mL). 
The washing process was repeated; the organic layer was collected and dried 
over magnesium sulphate. Solvent removal yielded a brown oil. 
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5.9.7 Synthesis of 5, 10, 15, 20-tetrakis(4-acetoxyphenyl)-porphyrin Iron(III) Complex (150) 
 
 
Scheme 37 page 219 
 
 
Yield 645 mg, 81% FTIR (cm
-1
) 2918 (aromatic C-H stretch) 1753 (ester C=O) 119, 1163 (ester C-O 
stretch) 1603 (N-H bend), 1494, 1367 ES-MS 900 (MH
+
) UV absorbance (CHCl3) λmax (nm) 413.5, 
566.5, 609.0  
5.9.8 General catalytic procedure (control reactions) 
In a typical experiment 0.1 mmol of iodosylbenzene was added to a reaction vial, which was sealed 
and degassed thoroughly using low vacuum/N2. A 2 mL solution of the solvent 
(dichloromethane/Dodecane) containing both 1 mmol cyclooctene substrate and 2.5 μmol porphyrin 
containing catalyst was then added via syringe. The suspension was then stirred in the dark for a 
period of thirty minutes under an atmosphere of nitrogen. After completion, the suspension was 
filtered using a Whatman
® 
GD/X syringe filter, with a pore size of 0.45 µm, and transferred into a GC 
vial for analysis via manual injection. 
 
5.9.9 General catalytic procedure – Colloidosome 
In a typical experiment 0.1 mmol of iodosylbenzene was added to a reaction vial, which was sealed 
and degassed thoroughly using low vacuum/N2. A colloidosome was synthesised by the 
homogenisation of a 2 mL solution of the solvent (Dodecane) containing 1 mmol cyclooctene 
substrate, 8mg of PPG-TGI cross-linker and 2.5 μmol porphyrin containing catalyst and a 2 mL 
solution of the aqueous phase (1 wt. % aqueous solution of 125 nm PGMA50-PS particles). 
Homogenisation took place for a period of 2 minutes at 12,000 rpm. The colloidosome was injected 
via a syringe and the suspension was then stirred in the dark for a period of thirty minutes under an 
atmosphere of nitrogen. After completion, the suspension was extracted using dichloromethane (5 
mL) and the organic layer was collected and filtered using a Whatman
® 
GD/X syringe filter with a 
pore size of 0.45 µm. The filtrate was transferred into a GC vial for analysis via manual injection. 
 
*The PGMA50 – PS particles were prepared by Dr Kate Kirkham and the procedures can be found in 
the literature.
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5, 10, 15, 20- tetrakis (4-acetoxyphenyl)-21H, 23H-
porphyrin (750 mg, 0.89 mmol) was added to a 
round bottomed flask equipped with a reflux 
condenser, evacuated and flushed with nitrogen. 
Anhydrous THF (80 mL) and 2, 6 lutidine (0.77 mL, 
6.54 mmol) were added via syringe. Iron (II) 
chloride (1.12g, 13mmol) was added to the reaction 
flask and the solution was then refluxed for 4 hours. 
The solution was exposed to air as it was allowed to 
cool to room temperature. Unreacted Iron (II) 
chloride was removed via vacuum filtration and the 
crude product was dissolved in dichloromethane and 
washed with 1 M HCL followed by distilled water. 
Purification was performed by column 
chromatography with a solvent system of 
dichloromethane: methanol (75:25). 
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i
 This figure was published in [Lin, Q.; Hamilton, A. D. C. R. Chim. 2002, 5, 441-450]. Copyright [2002] 
Elsevier Masson SAS. All rights reserved. 
